{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import network_util\n",
    "import data_util\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_drug_name(s):\n",
    "    match = re.search(r'(\\D+)', s)\n",
    "    if match:\n",
    "        return match.group(1).strip()\n",
    "    return \"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Package</th>\n",
       "      <th>GTIN</th>\n",
       "      <th>Refund_amount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990893423</td>\n",
       "      <td>13.26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990893386</td>\n",
       "      <td>6.64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990109920</td>\n",
       "      <td>3.30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>60</td>\n",
       "      <td>5909990055715</td>\n",
       "      <td>9.44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>30</td>\n",
       "      <td>5909991413590</td>\n",
       "      <td>6.33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4123</th>\n",
       "      <td>56</td>\n",
       "      <td>5909990681228</td>\n",
       "      <td>208.12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4124</th>\n",
       "      <td>1</td>\n",
       "      <td>5909990189212</td>\n",
       "      <td>15.36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4125</th>\n",
       "      <td>10</td>\n",
       "      <td>5909990189229</td>\n",
       "      <td>153.60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4126</th>\n",
       "      <td>100</td>\n",
       "      <td>5909990126729</td>\n",
       "      <td>22.29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4127</th>\n",
       "      <td>100</td>\n",
       "      <td>5909990126828</td>\n",
       "      <td>55.72</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4128 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Package           GTIN  Refund_amount\n",
       "0          30  5909990893423          13.26\n",
       "1          30  5909990893386           6.64\n",
       "2          30  5909990109920           3.30\n",
       "3          60  5909990055715           9.44\n",
       "4          30  5909991413590           6.33\n",
       "...       ...            ...            ...\n",
       "4123       56  5909990681228         208.12\n",
       "4124        1  5909990189212          15.36\n",
       "4125       10  5909990189229         153.60\n",
       "4126      100  5909990126729          22.29\n",
       "4127      100  5909990126828          55.72\n",
       "\n",
       "[4128 rows x 3 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "reimbursed_medicines_path = os.path.join(\"data\", \"Refundowane.xlsx\")\n",
    "reimbursed_medicines_df = data_util.preprocess_reimbursed_dataset(reimbursed_medicines_path, \"A1\", \"D,E,L,Q\")\n",
    "display(reimbursed_medicines_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Package</th>\n",
       "      <th>GTIN</th>\n",
       "      <th>Refund_amount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990109319</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990109210</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>865</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990678648</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>868</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990066667</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1210</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990014934</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1990</th>\n",
       "      <td>50</td>\n",
       "      <td>5909991051112</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2005</th>\n",
       "      <td>30</td>\n",
       "      <td>5909991013318</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009</th>\n",
       "      <td>30</td>\n",
       "      <td>5909990939718</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2012</th>\n",
       "      <td>28</td>\n",
       "      <td>5909990682409</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015</th>\n",
       "      <td>28</td>\n",
       "      <td>5909991132927</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2268</th>\n",
       "      <td>10</td>\n",
       "      <td>5909990719013</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2861</th>\n",
       "      <td>30</td>\n",
       "      <td>5909991050290</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2898</th>\n",
       "      <td>20</td>\n",
       "      <td>5909991289416</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2931</th>\n",
       "      <td>50</td>\n",
       "      <td>5909991033507</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2933</th>\n",
       "      <td>50</td>\n",
       "      <td>5909990112111</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3014</th>\n",
       "      <td>30</td>\n",
       "      <td>5909991125417</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4095</th>\n",
       "      <td>20</td>\n",
       "      <td>5909990045211</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Package           GTIN  Refund_amount\n",
       "20         30  5909990109319            0.0\n",
       "21         30  5909990109210            0.0\n",
       "865        30  5909990678648            0.0\n",
       "868        30  5909990066667            0.0\n",
       "1210       30  5909990014934            0.0\n",
       "1990       50  5909991051112            0.0\n",
       "2005       30  5909991013318            0.0\n",
       "2009       30  5909990939718            0.0\n",
       "2012       28  5909990682409            0.0\n",
       "2015       28  5909991132927            0.0\n",
       "2268       10  5909990719013            0.0\n",
       "2861       30  5909991050290            0.0\n",
       "2898       20  5909991289416            0.0\n",
       "2931       50  5909991033507            0.0\n",
       "2933       50  5909990112111            0.0\n",
       "3014       30  5909991125417            0.0\n",
       "4095       20  5909990045211            0.0"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Leki refundowane z zerową kwotą refundacji\n",
    "reimbursed_medicines_df[reimbursed_medicines_df[\"Refund_amount\"] == 0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "reimbursed_medicines_df = reimbursed_medicines_df[reimbursed_medicines_df[\"Refund_amount\"] != 0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Postać farmaceutyczna</th>\n",
       "      <th>Podmiot odpowiedzialny</th>\n",
       "      <th>Substancja czynna</th>\n",
       "      <th>Nazwa wytwórcy</th>\n",
       "      <th>GTIN</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Koncentrat do sporządzania roztworu do infuzji</td>\n",
       "      <td>Fresenius Kabi Polska Sp. z o.o.</td>\n",
       "      <td>Acidum zoledronicum 4 mg/5 ml</td>\n",
       "      <td>Fresenius Kabi Austria GmbH</td>\n",
       "      <td>5909991023652</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Koncentrat do sporządzania roztworu do infuzji</td>\n",
       "      <td>Fresenius Kabi Polska Sp. z o.o.</td>\n",
       "      <td>Acidum zoledronicum 4 mg/5 ml</td>\n",
       "      <td>Fresenius Kabi Austria GmbH</td>\n",
       "      <td>5909991023669</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Koncentrat do sporządzania roztworu do infuzji</td>\n",
       "      <td>Fresenius Kabi Polska Sp. z o.o.</td>\n",
       "      <td>Acidum zoledronicum 4 mg/5 ml</td>\n",
       "      <td>Fresenius Kabi Austria GmbH</td>\n",
       "      <td>5909991023676</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Krem</td>\n",
       "      <td>Zakłady Farmaceutyczne POLPHARMA S.A.</td>\n",
       "      <td>Mometasoni furoas 1 mg/g</td>\n",
       "      <td>Glenmark Pharmaceuticals s.r.o.</td>\n",
       "      <td>5909991023683</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Krem</td>\n",
       "      <td>Zakłady Farmaceutyczne POLPHARMA S.A.</td>\n",
       "      <td>Mometasoni furoas 1 mg/g</td>\n",
       "      <td>Glenmark Pharmaceuticals s.r.o.</td>\n",
       "      <td>5909991023690</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21906</th>\n",
       "      <td>Tabletki dopochwowe</td>\n",
       "      <td>Delfarma Sp. z o.o.</td>\n",
       "      <td>Progesteronum 100 mg</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5909991527662</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21916</th>\n",
       "      <td>Tabletki</td>\n",
       "      <td>Medezin Sp. z o.o.</td>\n",
       "      <td>tert-Butylamini perindoprilum 8 mg</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5909991527785</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21919</th>\n",
       "      <td>Tabletki</td>\n",
       "      <td>Medezin Sp. z o.o.</td>\n",
       "      <td>Cilostazolum 100 mg</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5909991527969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21919</th>\n",
       "      <td>Tabletki</td>\n",
       "      <td>Medezin Sp. z o.o.</td>\n",
       "      <td>Cilostazolum 100 mg</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5909991527976</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21920</th>\n",
       "      <td>Roztwór do wstrzykiwań</td>\n",
       "      <td>Syn Vet-Pharma Ireland Limited</td>\n",
       "      <td>Cloprostenolum natricum 0.25 mg/1 ml</td>\n",
       "      <td>V.M.D. n.v.</td>\n",
       "      <td>5909991528027</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>62984 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                Postać farmaceutyczna  \\\n",
       "0      Koncentrat do sporządzania roztworu do infuzji   \n",
       "0      Koncentrat do sporządzania roztworu do infuzji   \n",
       "0      Koncentrat do sporządzania roztworu do infuzji   \n",
       "1                                                Krem   \n",
       "1                                                Krem   \n",
       "...                                               ...   \n",
       "21906                             Tabletki dopochwowe   \n",
       "21916                                        Tabletki   \n",
       "21919                                        Tabletki   \n",
       "21919                                        Tabletki   \n",
       "21920                          Roztwór do wstrzykiwań   \n",
       "\n",
       "                      Podmiot odpowiedzialny  \\\n",
       "0           Fresenius Kabi Polska Sp. z o.o.   \n",
       "0           Fresenius Kabi Polska Sp. z o.o.   \n",
       "0           Fresenius Kabi Polska Sp. z o.o.   \n",
       "1      Zakłady Farmaceutyczne POLPHARMA S.A.   \n",
       "1      Zakłady Farmaceutyczne POLPHARMA S.A.   \n",
       "...                                      ...   \n",
       "21906                    Delfarma Sp. z o.o.   \n",
       "21916                     Medezin Sp. z o.o.   \n",
       "21919                     Medezin Sp. z o.o.   \n",
       "21919                     Medezin Sp. z o.o.   \n",
       "21920         Syn Vet-Pharma Ireland Limited   \n",
       "\n",
       "                          Substancja czynna                   Nazwa wytwórcy  \\\n",
       "0             Acidum zoledronicum 4 mg/5 ml      Fresenius Kabi Austria GmbH   \n",
       "0             Acidum zoledronicum 4 mg/5 ml      Fresenius Kabi Austria GmbH   \n",
       "0             Acidum zoledronicum 4 mg/5 ml      Fresenius Kabi Austria GmbH   \n",
       "1                  Mometasoni furoas 1 mg/g  Glenmark Pharmaceuticals s.r.o.   \n",
       "1                  Mometasoni furoas 1 mg/g  Glenmark Pharmaceuticals s.r.o.   \n",
       "...                                     ...                              ...   \n",
       "21906                  Progesteronum 100 mg                              NaN   \n",
       "21916    tert-Butylamini perindoprilum 8 mg                              NaN   \n",
       "21919                   Cilostazolum 100 mg                              NaN   \n",
       "21919                   Cilostazolum 100 mg                              NaN   \n",
       "21920  Cloprostenolum natricum 0.25 mg/1 ml                      V.M.D. n.v.   \n",
       "\n",
       "                GTIN  \n",
       "0      5909991023652  \n",
       "0      5909991023669  \n",
       "0      5909991023676  \n",
       "1      5909991023683  \n",
       "1      5909991023690  \n",
       "...              ...  \n",
       "21906  5909991527662  \n",
       "21916  5909991527785  \n",
       "21919  5909991527969  \n",
       "21919  5909991527976  \n",
       "21920  5909991528027  \n",
       "\n",
       "[62984 rows x 5 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "rpl_path = os.path.join(\"data\", \"RPL_20240102.csv\")\n",
    "rpl_df = data_util.preprocess_rpl_dataset(rpl_path, [8,13,14,15,16])\n",
    "display(rpl_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "AVG = \"mean\"\n",
    "SUM = \"sum\"\n",
    "mode = AVG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_df = pd.merge(reimbursed_medicines_df, rpl_df, how=\"inner\", left_on=\"GTIN\", right_on=\"GTIN\")\n",
    "merged_df = merged_df.rename(\n",
    "    columns={\n",
    "        \"Postać farmaceutyczna\": \"Form\",\n",
    "        \"Podmiot odpowiedzialny\": \"Responsible_entity\",\n",
    "        \"Substancja czynna\": \"Substance\",\n",
    "        \"Nazwa wytwórcy\": \"Producer\",\n",
    "    }\n",
    ")\n",
    "merged_df[\"Responsible_entity\"] = merged_df[\"Responsible_entity\"].str.upper()\n",
    "merged_df[\"Producer\"] = merged_df[\"Producer\"].str.upper()\n",
    "\n",
    "# Calculate refund amount per unit of medicine and drop obsolete columns\n",
    "merged_df[\"Producer\"] = merged_df[\"Producer\"].str.replace(\"\\n\", \" \")\n",
    "merged_df[\"Refund_per_unit\"] = merged_df[\"Refund_amount\"] / merged_df[\"Package\"]\n",
    "merged_df[\"Mean_refund\"] = merged_df.groupby([\"Form\", \"Responsible_entity\", \"Substance\"])[\"Refund_per_unit\"].transform(\"mean\")\n",
    "merged_df.drop([\"Refund_amount\", \"Refund_per_unit\", \"Package\"], axis=1, inplace=True)\n",
    "\n",
    "# Drop duplicates - drops medicines which are being sold in different sizes\n",
    "merged_df.drop_duplicates([\"Form\", \"Responsible_entity\", \"Substance\", \"Producer\", \"Mean_refund\"], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_groupby_entity = merged_df.groupby(\"Responsible_entity\")\n",
    "non_unique_counter = 0\n",
    "unique_producers_per_entity = []\n",
    "for value, group in merged_groupby_entity:\n",
    "    count = len(group[\"Producer\"].unique())\n",
    "    unique_producers_per_entity.append((group, count))\n",
    "    if count != 1:\n",
    "        non_unique_counter += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Liczba unikalnych podmitów odpowiedzialnych: 183\n",
      "Podmioty odpowiedzialne dla więcej niż jednego producenta: 101\n"
     ]
    }
   ],
   "source": [
    "print(\n",
    "    f\"Liczba unikalnych podmitów odpowiedzialnych: {len(merged_df['Responsible_entity'].unique())}\"\n",
    ")\n",
    "print(\n",
    "    f\"Podmioty odpowiedzialne dla więcej niż jednego producenta: {non_unique_counter}\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "unique_producers_per_entity = sorted(\n",
    "    unique_producers_per_entity, key=lambda x: x[1], reverse=True\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Podmiot odpowiedzialny: ['SANDOZ GMBH'], Stopień słupa: 54\n",
      "['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. ROWA PHARMACEUTICALS LTD. SALUTAS PHARMA GMBH'\n",
      " 'NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH'\n",
      " 'NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH SALUTAS PHARMA'\n",
      " 'SANDOZ GMBH' 'SALUTAS PHARMA GMBH SANDOZ GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK S.A. S.C. SANDOZ S.R.L.' 'LEK S.A.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. SANDOZ GMBH S.C. SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. SANDOZ GMBH SANDOZ S.R.L.'\n",
      " 'AEROPHARM GMBH LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH'\n",
      " 'AEROPHARM GMBH LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.) SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH'\n",
      " 'PENCEF PHARMA GMBH SANDOZ GMBH' 'ACS DOBFAR S.P.A'\n",
      " 'GLAXOSMITHKLINE TRADING SERVICES LIMITED LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.)'\n",
      " 'S.C. SANDOZ S.R.L.' 'LEK PHARMACEUTICALS D.D.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.'\n",
      " 'ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS, D.D.' 'AEROPHARM GMBH'\n",
      " 'NOVARTIS PHARMA GMBH NOVARTIS PHARMACEUTICA SA'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A.'\n",
      " 'HAUPT PHARMA MUENSTER GMBH SALUTAS PHARMA GMBH'\n",
      " 'EBEWE PHARMA GES.M.B.H NFG. KG EVER PHARMA JENA GMBH EVER PHARMA JENA GMBH SANDOZ GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH' nan\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH'\n",
      " 'HEXAL A/S LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH'\n",
      " 'GLAXOSMITHKLINE PHARMACEUTICALS S.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH'\n",
      " 'ASPEN BAD OLDESLOE GMBH NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ S.R.L.'\n",
      " 'PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A. SALUTAS PHARMA GMBH'\n",
      " 'LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.'\n",
      " 'ADAMED PHARMA S.A. LEK PHARMACEUTICALS D.D.'\n",
      " 'ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS D.D.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK S.A.'\n",
      " 'LEK D.D., PE PROIZODNJA LENDAVA LEK S.A.' 'LEK S.A. SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.'\n",
      " 'SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.'\n",
      " 'LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.']\n"
     ]
    }
   ],
   "source": [
    "INDEX = 0\n",
    "\n",
    "print(\n",
    "    f\"Podmiot odpowiedzialny: {unique_producers_per_entity[INDEX][0]['Responsible_entity'].unique()}, Stopień słupa: {unique_producers_per_entity[INDEX][1]}\"\n",
    ")\n",
    "print(unique_producers_per_entity[INDEX][0][\"Producer\"].unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Groupby \n",
    "merged_df_org = merged_df.copy()\n",
    "merged_df['Substance'] = merged_df['Substance'].apply(extract_drug_name)\n",
    "\n",
    "temp_df = merged_df.copy()\n",
    "temp_df['Agg_refund'] = temp_df.groupby([\"Form\", \"Responsible_entity\", \"Substance\"])[\"Mean_refund\"].transform(SUM)\n",
    "\n",
    "temp_df.drop(['Mean_refund'],axis = 1, inplace=True)\n",
    "temp_df.drop_duplicates([\"Form\", \"Responsible_entity\", \"Substance\", \"Producer\", \"Agg_refund\"], inplace=True)\n",
    "merged_df_sum = temp_df.copy()\n",
    "\n",
    "temp_df = merged_df.copy()\n",
    "temp_df['Agg_refund'] = temp_df.groupby([\"Form\", \"Responsible_entity\", \"Substance\"])[\"Mean_refund\"].transform(AVG)\n",
    "\n",
    "temp_df.drop(['Mean_refund'],axis = 1, inplace=True)\n",
    "temp_df.drop_duplicates([\"Form\", \"Responsible_entity\", \"Substance\", \"Producer\", \"Agg_refund\"], inplace=True)\n",
    "merged_df_avg = temp_df.copy()\n",
    "\n",
    "# Change name in original dataframe so it matches the schema\n",
    "merged_df_org = merged_df_org.rename(\n",
    "        columns={\n",
    "            \"Mean_refund\": \"Agg_refund\",\n",
    "        }\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "graph = network_util.create_bipartite_graph(merged_df_org[\"Substance\"], merged_df_org['Responsible_entity'], merged_df_org[\"Agg_refund\"])\n",
    "pos_g = network_util.create_bipartite_layout(merged_df_org[\"Substance\"], merged_df_org['Responsible_entity'])\n",
    "\n",
    "g_sum = network_util.create_bipartite_graph(merged_df_sum[\"Substance\"], merged_df_sum['Responsible_entity'], merged_df_sum[\"Agg_refund\"])\n",
    "pos_sum = network_util.create_bipartite_layout(merged_df_sum[\"Substance\"], merged_df_sum['Responsible_entity'])\n",
    "\n",
    "g_avg = network_util.create_bipartite_graph(merged_df_avg[\"Substance\"], merged_df_avg['Responsible_entity'], merged_df_avg[\"Agg_refund\"])\n",
    "pos_avg = network_util.create_bipartite_layout(merged_df_avg[\"Substance\"], merged_df_avg['Responsible_entity'])\n",
    "\n",
    "g_sum_producer = network_util.create_bipartite_graph(merged_df_sum[\"Substance\"], merged_df_sum['Producer'], merged_df_sum[\"Agg_refund\"])\n",
    "pos_sum_producer = network_util.create_bipartite_layout(merged_df_sum[\"Substance\"], merged_df_sum['Producer'])\n",
    "\n",
    "g_avg_producer  = network_util.create_bipartite_graph(merged_df_avg[\"Substance\"], merged_df_avg['Producer'], merged_df_avg[\"Agg_refund\"])\n",
    "pos_avg_producer  = network_util.create_bipartite_layout(merged_df_avg[\"Substance\"], merged_df_avg['Producer'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "# plt.figure(figsize=(12, 20))\n",
    "# nx.draw(graph, pos=pos_g, with_labels=True, font_weight='bold', node_color='skyblue', font_size=4)\n",
    "# plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "# plt.figure(figsize=(12, 20))\n",
    "# nx.draw(g_sum, pos=pos_sum, with_labels=True, font_weight='bold', node_color='skyblue', font_size=4)\n",
    "# plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [],
   "source": [
    "# plt.figure(figsize=(12, 20))\n",
    "# nx.draw(g_avg, pos=pos_avg, with_labels=True, font_weight='bold', node_color='skyblue', font_size=4)\n",
    "# plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Quinaprilum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 1.0]], 0.212), 'Travoprostum + Timololum': ([['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 1.0]], 28.97), 'Insulinum glarginum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS S.P.A.', 0.247], ['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.753]], 109.85249999999999), 'Pyridostigmini bromidum': ([['ICN POLFA RZESZÓW S.A. LABIANA PHARMACEUTICALS, S.L.', 1.0]], 0.6540666666666667), 'Cenobamate': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA SWISS CAPS GMBH', 1.0]], 17.5725), 'Ergotamini tartras': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.156), 'Fentanylu cytrynian -': ([['ARDENA PAMPLONA S.L. BLUEPHARMA INDUSTRIA FARMACEUTICA S.A.', 1.0]], 15.229642857142858), 'Cefaclorum': ([['ACS DOBFAR S.P.A TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 0.9919523809523808), 'Anastrozolum': ([['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.126], ['IVAX PHARMACEUTICALS, S.R.O. MERCKLE GMBH PHARMACHEMIE B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.127], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES GENERIS FARMACEUTICA, S.A.', 0.118], ['DOPPEL FARMACEUTICI S.R.L. GENEPHARM S.A.', 0.127], ['HAUPT PHARMA MUENSTER GMBH', 0.127], ['VIPHARM S.A.', 0.127], ['EGIS PHARMACEUTICALS PLC SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.127], [nan, 0.119]], 14.83045238095238), 'Azytromycyna dwuwodna': ([['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH SANDOZ S.R.L.', 0.5], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.5]], 15.39333333333333), 'Pancreatinum': ([['ABBOTT LABORATORIES GMBH, WERK NEUSTADT', 1.0]], 1.2598), 'Furaginum (': ([['ADAMED PHARMA S.A.', 1.0]], 0.09033333333333333), 'Paliperidonum': ([['PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.182], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.182], ['ADAMED PHARMA S.A. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.158], ['ACTAVIS GROUP PTC EHF.', 0.182], ['JANSSEN PHARMACEUTICA N.V.', 0.296]], 2892.913333333334), 'Tetrabenazinum': ([['AOP ORPHAN PHARMACEUTICALS GMBH', 1.0]], 3.846964285714286), 'Enalaprili maleas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.09269444444444445), 'Chloroquini phosphas': ([['ADAMED PHARMA S.A.', 1.0]], 0.471), 'Dienogestum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.143], ['ARISTO PHARMA GMBH', 0.143], [nan, 0.143], ['LABORATORIOS LEON FARMA, S.A.', 0.143], ['SYMPHAR SP. Z O.O.', 0.143], ['BAYER WEIMAR GMBH UND CO. KG', 0.143], ['GEDEON RICHTER PLC.', 0.143]], 8.305), 'Amantadini hydrochloridum': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.29540000000000005), 'Enoxaparinum natricum': ([['CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. - CSANYIKVOLGY SITE SANOFI WINTHROP INDUSTRIE SANOFI WINTHROP INDUSTRIE SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.333], ['SANOFI WINTHROP INDUSTRIE SANOFI WINTHROP INDUSTRIE SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.333], [nan, 0.333]], 40.528285714285715), 'Clopidogrelum hydrosulfas': ([['ACTAVIS LTD.', 0.198], ['ADAMED PHARMA S.A.', 0.202], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.202], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.197], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.202]], 3.263571428571429), 'Lansoprazolum': ([['KRKA, D.D., NOVO MESTO', 0.5], ['LABORATORIOS LICONSA, S.A.', 0.5]], 0.33285714285714285), 'Posaconazolum': ([['GENEPHARM S.A. RAFARM S.A.', 0.336], ['GENEPHARM S.A. RAFARM S.A. STADA ARZNEIMITTEL AG STADA ARZNEIMITTEL AG', 0.332], ['GENEPHARM S.A. MERCKLE GMBH RAFARM S.A. TEVA OPERATIONS POLAND SP. Z O.O.', 0.331]], 20.164571428571428), 'Glyceroli trinitras': ([['EGIS PHARMACEUTICALS PLC', 0.897], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.103]], 1.5073939393939393), 'Dornasum alfa': ([[nan, 1.0]], 81.79566666666668), 'Beclometasoni dipropionas': ([['CHIESI PHARMACEUTICALS GMBH CHIESI PHARMACEUTICI S.P.A. CHIESI SAS', 0.319], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI SAS', 0.194], [nan, 0.168], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI S.A.S.', 0.319]], 509.8375), 'Calcipotriolum': ([['ARISTO PHARMA GMBH C.P.M. CONTRACTPHARMA GMBH', 0.195], ['LEO LABORATOIRES LTD. LEO PHARMA A/S', 0.202], ['LEO LABORATOIRES LTD.', 0.135], ['C.P.M. CONTRACTPHARMA GMBH', 0.194], ['COLEP LAUPHEIM GMBH & CO. KG LEO LABORATORIES LTD. LEO PHARMA A/S', 0.004], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.27]], 274.192), 'Tamoxifeni citras': ([['SALUTAS PHARMA GMBH', 0.434], ['EGIS PHARMACEUTICALS PLC', 0.566]], 1.193), 'Ropiniroli hydrochloridum': ([['ACTAVIS LTD.', 0.159], ['VIPHARM S.A.', 0.059], ['ACTAVIS LTD. ADAMED PHARMA S.A.', 0.159], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.159], ['GLAXO WELLCOME S.A.', 0.17], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.136], ['EGIS PHARMACEUTICALS PLC PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.159]], 10.763390476190477), 'Ethambutoli dihydrochloridum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 0.44612), 'Donepezili hydrochloridum monohydricum': ([['BIOFARM SP. Z O.O.', 0.093], ['ACTAVIS GROUP PTC EHF. ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.095], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMAPATH S.A.', 0.126], ['BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A. ICN POLFA RZESZÓW', 0.126], ['CELON PHARMA S.A.', 0.095], ['BLUEFISH PHARMACEUTICALS AB', 0.087], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.095], ['ADAMED PHARMA S.A. GENEPHARM S.A.', 0.095], ['KRKA, D.D., NOVO MESTO', 0.095], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.095]], 7.434208333333334), 'Pyrazinamidum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE FARMAPOL SP. Z O.O.', 1.0]], 0.63844), 'Fentanyli citras': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ETYPHARM', 0.5], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ETHYPHARM', 0.5]], 40.36933333333333), 'Buprenorphinum': ([['G.L. PHARMA GMBH', 0.5], ['GRUENENTHAL GMBH', 0.5]], 32.02066666666667), 'Omeprazolum': ([['LABORATORIOS LICONSA, S.A.', 0.039], ['TOWA PHARMACEUTICALS EUROPE, S.L.', 0.026], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U.', 0.026], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.039], ['S.C. ZENTIVA S.A.', 0.039], ['INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A.', 0.041], ['TEVA PHARMA S.L.U. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.039], ['ADAMED PHARMA S.A.', 0.026], ['TEVA PHARMA, S.L.U.', 0.726]], 8.55853869047619), 'Dabigatranu eteksylan w postaci mezylanu': ([['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 1.501851851851852), 'Duloxetini hydrochloridum': ([['TOWA PHARMACEUTICALS EUROPE, S.L.', 0.373], ['GENERICON PHARMA GES.M.B.H.', 0.371], ['TERAPIA S.A. TOWA PHARMACEUTICALS EUROPE, S.L.', 0.257]], 1.4552261904761905), 'Ezetimibum': ([['ACTAVIS LTD. BALKANPHARMA - DUPNITSA AD', 0.1], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.096], ['ADAMED PHARMA S.A. GENERICON PHARMA GESELLSCHAFT M.B.H.', 0.101], ['ZENTIVA, K.S.', 0.101], ['LABORATORIOS LICONSA S.A.', 0.1], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.1], ['GLENMARK ARZNEIMITTEL GMBH GLENMARK PHARMACEUTICALS EUROPE LIMITED GLENMARK PHARMACEUTICALS S.R.O. ORION CORPORATION PHARMADOX HEALTHCARE LTD.', 0.1], [nan, 0.1], ['HENNIG ARZNEIMITTEL GMBH & CO. KG', 0.1], ['ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS, D.D.', 0.1]], 3.304162698412698), 'Acebutololi hydrochloridum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.11), 'Spironolactonum': ([['ORION CORPORATION ORION CORPORATION', 0.252], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.316], ['GEDEON RICHTER PLC.', 0.32], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.112]], 1.2498416666666665), 'Haloperidoli decanoas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 7.22), 'Acidum zoledronicum': ([['EGIS PHARMACEUTICALS PLC SM FARMACEUTICI SRL', 0.203], [nan, 0.203], ['ACTAVIS ITALY S.P.A.', 0.195], ['DEMO S.A. PHARMACEUTICAL INDUSTRY', 0.196], ['VIPHARM S.A.', 0.203]], 522.025), 'Methylprednisoloni acetas': ([['PFIZER MANUFACTURING BELGIUM NV', 1.0]], 7.61), 'Esomeprazolum magnesicum': ([['KRKA, D.D., NOVO MESTO', 0.332], ['ETHYPHARM ETHYPHARM S.C. ZENTIVA S.A.', 0.334], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.333]], 0.6607093253968254), 'Vortioxetini hydrobromidum': ([['H. LUNDBECK A/S', 1.0]], 1.659732142857143), 'Clarithromycinum': ([['KRKA, D.D., NOVO MESTO', 0.022], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.022], ['ALKALOIDA CHEMICAL CO. ZRT. S.C. TERAPIA S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.507], ['ABBOTT S.R.L.', 0.36], ['ABBVIE S.R.L.', 0.024], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.032], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.032]], 32.96500476190476), 'Fentanylum': ([['JANSSEN PHARMACEUTICA N.V.', 0.016], ['ACTAVIS GROUP PTC EHF. LUYE PHARMA AG', 0.018], ['CURIDA AS', 0.724], ['LTS LOHMANN THERAPIE SYSTEME AG', 0.016], ['LTS LOHMANN TERAPIE-SYSTEME GMBH NYCOMED DANMARK APS NYCOMED GMBH', 0.016], ['LTS LOHMANN TERAPIE-SYSTEME GMBH', 0.016], ['LTS LOHMANN THERAPIE SYSTEME AG NYCOMED GMBH', 0.016], ['L. MOLTENI & C. DEI F.LLI ALITTI SOCIETÀ DI ESERCIZIO SPA', 0.179]], 886.0980833333333), 'Cefuroximum axetilum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.061], [nan, 0.073], ['APL SWIFT SERVICES (MALTA) LTD.', 0.074], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.635], ['ALKALOIDA CHEMICAL CO. ZRT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.075], ['GLAXOSMITHKLINE TRADING SERVICES LIMITED LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.)', 0.081]], 22.446535714285712), 'Budesonidum': ([['GENETIC S.P.A', 0.005], ['GENETIC S.P.A ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.005], ['ORION CORPORATION ORION PHARMA', 0.095], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.001], ['ALL-GEN PHARMACEUTICALS & GENERICS BV CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH', 0.077], ['ADAMED PHARMA S.A. GENETIC S.P.A. ', 0.005], ['COSMO S.P.A.', 0.018], ['ASTREA FONTAINE', 0.006], ['DR. FALK PHARMA GMBH', 0.031], ['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.001], ['MERCKLE GMBH', 0.005], ['ASTRAZENECA AB', 0.088], [nan, 0.005], ['AEROPHARM GMBH LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.07], ['AEROPHARM GMBH LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.) SALUTAS PHARMA GMBH', 0.142], ['ORION CORPORATION', 0.095], ['NORTON (WATERFORD) LIMITED T/A TEVA PHARMACEUTICALS IRELAND TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL EUROPE B.V.', 0.142], ['AEROPHARM GMBH LEK PHARMACEUTICALS, D.D. SALUTAS PHARMA', 0.106], ['ASTRAZENECA DUNKERQUE PRODUCTION', 0.103]], 638.2263888888889), 'Buspironi hydrochloridum': ([[nan, 0.4], ['EGIS PHARMACEUTICALS PLC', 0.3], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.3]], 0.8070000000000002), 'Itraconazolum': ([['JOINT-STOCK COMPANY \"OLAINFARM\"', 0.343], ['JANSSEN-CILAG S.P.A.', 0.303], ['LICONSA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.354]], 4.265357142857143), 'Mercaptopurinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 1.0]], 1.7200000000000002), 'Perindoprili tosilas': ([['TEVA GYOGYSZERGYAR ZRT. TEVA OPERATIONS POLAND SP. Z O.O.', 0.333], ['PHARMACHEMIE B.V. TEVA GYÓGYSZERGYÁR ZRT. (TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.333], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.333]], 0.3575), 'Methotrexatum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O. WESSLING HUNGARY KFT.', 0.401], ['ACTAVIS ITALY S.P.A. S.C. SINDAN-PHARMA S.R.L.', 0.297], ['ORION CORPORATION ORION PHARMA ORION CORPORATION, ORION PHARMA', 0.002], ['BASIC PHARMA MANUFACTURING B.V.', 0.3]], 140.15341666666666), 'Indapamidum': ([['POLFARMEX S.A.', 0.108], ['PHARMACHEMIE B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.095], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.108], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.151], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.093], ['ORION CORPORATION', 0.108], ['KRKA, D.D., NOVO MESTO', 0.092], [nan, 0.096], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 0.108], ['LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 0.04]], 1.9784166666666667), 'Nadroparinum calcicum': ([['ASPEN NOTRE DAME DE BONDEVILLE GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 10.89225), 'Ganirelixum': ([['GEDEON RICHTER PLC.', 1.0]], 48.55), 'Methylphenidati hydrochloridum': ([['JANSSEN PHARMACEUTICA N.V.', 0.491], ['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.509]], 4.313416666666667), 'Acitretinum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.505], ['CENEXI ROCHE POLSKA SP. Z O.O.', 0.495]], 5.454350000000001), 'Ethinylestradiolum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.248], ['BAYER PHARMA AG', 0.251], [nan, 0.251], ['GEDEON RICHTER PLC.', 0.251]], 1.0103174603174603), 'Methylprednisolonum': ([['PFIZER ITALIA S.R.L.', 0.013], ['MIBE GMBH ARZNEIMITTEL', 0.016], ['PFIZER MANUFACTURING BELGIUM NV', 0.971]], 30.98812222222222), 'Fludrocortisoni acetas': ([['ADAMED PHARMA S.A.', 1.0]], 0.5980000000000001), 'Hydrocortisonum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 1.0]], 0.22099999999999997), 'Perindoprilum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 1.0]], 0.0793333333333333), 'Cholecalciferolum koncentrat olejowy (vit. D': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.663), 'Levonorgestrelum': ([['HAUPT PHARMA MUENSTER GMBH PFIZER IRELAND PHARMACEUTICALS', 1.0]], 0.25333333333333335), 'Insulinum degludecum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 21.694), 'Tacrolimus': ([['ASTELLAS IRELAND CO., LTD.', 0.482], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.239], ['LEK PHARMACEUTICALS D.D.', 0.279]], 23.489422222222224), 'Terbinafinum': ([['BAUSCH HEALTH POLAND SP. Z O.O. LABORATORIOS LICONSA S.A.', 1.0]], 0.827857142857143), 'Medroxyprogesteroni acetas': ([['PFIZER ITALIA S.R.L.', 0.5], ['PFIZER ITALIA S.R.L. PFIZER MANUFACTURING BELGIUM NV', 0.5]], 0.5700000000000001), 'Acarbosum': ([['POLFARMEX S.A.', 1.0]], 0.33166666666666667), 'Everolimusum': ([['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY LTD. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S. NOVARTIS S.R.O. NOVARTIS SVERIGE AG SANDOZ S.R.L.', 0.5], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY LTD. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG SANDOZ S.R.L.', 0.5]], 29.600555555555555), 'Icatibanti acetas': ([['UNIVERSAL FARMA, S.L.', 1.0]], 2208.4100000000003), 'Acidum mycophenolicum': ([['ACCORD HEALTHCARE B.V. PHARMADOX HEALTHCARE LTD. STADA ARZNEIMITTEL AG', 1.0]], 1.158625), 'Buprenorphini hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.8780000000000001), 'Clobetasoli propionas': ([[nan, 0.5], ['ASPEN BAD OLDESLOE GMBH', 0.5]], 0.33319999999999994), 'Ipratropii bromidum': ([['LABORATORIO ALDO-UNION S.L. LABORATORIO ECHEVARNE, S.A.', 0.414], ['INSTITUTO DE ANGELI S.R.L.', 0.171], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.414]], 39.78), 'Nimesulidum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA BOEHRINGER INGELHEIM HELLAS S.A. CHINOIN PRIVATE CO. LTD DOVEMA S.R.O. FARMACIA MARTIN A.S. HELSINN BIREX PHARMACEUTICALS LTD. MEDICOM INTERNATIONAL S.R.O. MIPHARM S.P.A.', 0.175], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA DOVEMA S.R.O. FARMACIA MARTIN A.S. HELSINN BIREX PHARMACEUTICALS LTD. MEDICOM INTERNATIONAL S.R.O. MIPHARM S.P.A.', 0.413], ['FINE FOOD & PHARMACEUTICALS NTM S.P.A. LABORATORIOS MENARINI S.A.', 0.413]], 0.7301666666666666), 'Diclofenacum natricum': ([['EXCELVISION', 0.246], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.048], ['LEK PHARMACEUTICALS D.D.', 0.127], ['SWISS CAPS GMBH TEMMLER WERKE GMBH', 0.028], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.223], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.038], ['KRKA, D.D., NOVO MESTO', 0.131], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.028], ['MEPHA PHARMA GMBH MEPHA POLSKA SP. Z O.O. MERCKLE GMBH', 0.131]], 6.740166666666667), 'Denosumabum': ([['AMGEN EUROPE B.V. AMGEN NV AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY', 1.0]], 441.46), 'Methadoni hydrochloridum': ([['L.MOLTENI & C. DEI F.LII ALITTI SOCIETA DI ESERCIZIO S.P.A.', 1.0]], 0.06899999999999999), 'Natrii alendronas trihydricus': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 1.0]], 2.1675), 'Terbinafini hydrochloridum': ([['POLFARMEX S.A.', 0.5], ['ACTAVIS LTD. ', 0.5]], 1.6557142857142857), 'Mometasoni furoas monohydricum': ([['FARMEA', 0.5], ['ADAMED PHARMA S.A. FARMEA', 0.5]], 15.0), 'Quetiapini fumaras': ([['GENEPHARM S.A.', 0.06], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.06], ['MCDERMOTT LABORATORIES LTD T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.06], ['EGIS PHARMACEUTICALS PLC', 0.088], ['CELON PHARMA S.A.', 0.06], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A. SALUTAS PHARMA GMBH', 0.104], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.126], ['ADAMED PHARMA S.A. MERCKLE GMBH TEVA PHARMA S.L.U.', 0.126], ['ADAMED PHARMA S.A. MERCKLE GMBH PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.126], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.088], ['ELPEN PHARMACEUTICAL CO.INC. LABORATORI FUNDACIÓ DAU SYMPHAR SP. Z O.O. TERAPIA S.A.', 0.103]], 12.273505555555555), 'Tiagabinum': ([['ALMAC PHARMA SERVICES (IRELAND) LIMITED ALMAC PHARMA SERVICES LTD. BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['ALMAC PHARMA SERVICES (IRLANDIA) LIMITED ALMAC PHARMA SERVICES LTD. BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5]], 7.406933333333334), 'Finasteridum': ([['ADAMED PHARMA S.A. APL SWIFT SERVICES (MALTA) LTD.', 0.068], ['HAUPT PHARMA MUENSTER GMBH SIEGFRIED MALTA LTD.', 0.068], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.068], ['ACTAVIS GROUP PTC EHF. ZENTIVA, K.S.', 0.068], [nan, 0.067], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.068], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.068], ['BLUEFISH PHARMACEUTICALS AB PHARMADOX HEALTHCARE LTD.', 0.051], ['ACTAVIS EHF. KRKA, D.D., NOVO MESTO', 0.068], ['ACTAVIS GROUP PTC EHF. GENERICON PHARMA GMBH G.L. PHARMA GMBH', 0.068], ['ZENTIVA, K.S.', 0.068], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.068], ['QUINTA-ANALYTICA S.R.O. SYMPHAR SP. Z O.O. ZENTIVA K.S.', 0.065], ['HEUMANN PHARMA GMBH PHARMADOX HEALTHCARE LTD.', 0.068], ['GEDEON RICHTER PLC.', 0.068]], 11.475165343915345), 'Insulinum glargine': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 1.0]], 21.694000000000003), 'Bimatoprostum': ([['RAFARM S.A.', 1.0]], 32.935), 'Donepezili hydrochloridum': ([[nan, 0.588], ['ORION CORPORATION ORION PHARMA ORION CORPORATION ORION PHARMA', 0.412]], 1.5937500000000002), 'Leflunomidum': ([['OPELLA HEALTHCARE INTERNATIONAL SAS', 0.178], ['BLUEFISH PHARMACEUTICALS AB HAUPT PHARMA MUENSTER GMBH', 0.176], ['HAUPT PHARMA MUENSTER GMBH MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.182], ['ORION CORPORATION PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.218], ['HAUPT PHARMA MUENSTER GMBH SALUTAS PHARMA GMBH', 0.245]], 15.197888888888889), 'Fenoksymetyolpenicylina potasowa': ([[nan, 1.0]], 24.884999999999998), 'Corifollitropin alfa': ([['N.V. ORGANON', 1.0]], 1359.44), 'Levocetirizini dihydrochloridum -': ([['ADAMED PHARMA S.A. MEDANA PHARMA S.A.', 1.0]], 15.950000000000001), 'sól sodowa atorwastatyny': ([['BIOFARM SP. Z O.O.', 1.0]], 0.40235185185185185), 'Flutamidum': ([[nan, 0.515], ['EGIS PHARMACEUTICALS PRIVATE LIMITED COMPANY', 0.485]], 1.4175111111111112), 'Triamcinolonum': ([['ADAMED PHARMA S.A.', 1.0]], 0.7729999999999999), 'Pojedyncze alergoidy pyłków roślin': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Betaxololi hydrochloridum': ([['ALCON-COUVREUR', 1.0]], 0.7714999999999999), 'Ramiprilum': ([[nan, 0.046], ['KRKA, D.D., NOVO MESTO', 0.035], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.06], ['ACTAVIS (BALKANPHARMA) DUPNISTA AD ACTAVIS LTD. ADAMED PHARMA S.A. EXTRACTUM PHARMA LTD.', 0.05], ['LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH', 0.048], ['ACTAVIS EHF. ACTAVIS LTD. BALKANPHARMA DUPNITSA AD ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.049], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.076], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.027], ['DELPHARM DIJON SANOFI AVENTIS DEUTSCHLAND GMBH SANOFI S.R.L. S.C. ZENTIVA S.A', 0.042], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD ORFICE MEDICAL AB', 0.045], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.045], ['BALKANPHARMA-DUPNITSA AD ORFICE MEDICAL AB', 0.045], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.082], ['EGIS PHARMACEUTICALS PLC', 0.082], ['ADAMED PHARMA S.A. IASIS PHARMACEUTICALS HELLAS S.A.', 0.08], ['LEK PHARMACEUTICALS D.D. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.082], ['CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. (CHINOIN PRIVATE CO. LTD.) - CSANYIKVOLGY SITE CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. (CHINOIN PRIVATE CO. LTD.) - UJPEST SITE OPELLA HUNGARY LIMITED LIABILITY COMAPNY (OPELLA HEALTHCARE HUNGARY LTD.)', 0.031], ['OPELLA HUNGARY LIMITED LIABILITY COMAPNY (OPELLA HEALTHCARE HUNGARY LTD.)', 0.031], ['SANOFI AVENTIS DEUTSCHLAND GMBH SANOFI S.R.L. S.C. ZENTIVA S.A.', 0.042]], 3.6977976190476194), 'Timololi maleas': ([['SIEGFRIED EL MASNOU, S.A.', 0.833], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.167]], 4.632), 'Felodipinum': ([['ASTRAZENECA AB ASTRAZENECA GMBH ASTRAZENECA REIMS PRODUCTION', 1.0]], 0.3032142857142857), 'Amiloridi hydrochloridum': ([['IPCA LABORATORIES LIMITED ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.2388), 'Phenytoinum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.2076666666666667), 'Tapentadolum': ([['GRUENENTHAL GMBH', 1.0]], 5.054366666666667), 'Benazeprili hydrochloridum': ([['MADAUS GMBH', 1.0]], 0.13508928571428572), 'Amoxicillinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.018], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACEUTICA, S.A.', 0.017], ['SANDOZ GMBH', 0.019], ['SALUTAS PHARMA GMBH SANDOZ GMBH', 0.268], [nan, 0.023], ['PANCEF PHARMA GMBH', 0.016], ['PENCEF PHARMA GMBH', 0.025], ['HAUPT PHARMA LATINA S.R.L.', 0.252], ['HAUPT PHARMA LATINA S.R.L. PENCEF PHARMA GMBH', 0.17], ['GLAXO WELLCOME PRODUCTION', 0.171], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.022]], 47.03283452380952), 'Cetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.014], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.014], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.014], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.343], ['KRKA, D.D., NOVO MESTO', 0.014], ['AESICA PHARMACEUTICALS S.R.L.', 0.014], [nan, 0.561], ['AESICA PHARMACEUTICALS S.R.L. PHOENIX PHARMA POLSKA SP. Z O.O.', 0.028]], 23.212000000000003), 'Estradioli valeras': ([['DELPHARM LILLE S.A.S. ORION CORPORATION', 0.545], ['DR. KADE PHARMAZEUTISCHE FABRIK GMBH HAUPT PHARMA MUENSTER GMBH', 0.455]], 0.891904761904762), 'Sulfamethoxazolum': ([['EUMEDICA PHARMACEUTICALS GMBH', 0.559], [nan, 0.05], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.363], ['ADAMED PHARMA S.A.', 0.028]], 21.019333333333336), 'Travoprostum': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.199], ['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.199], ['JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.201], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.199], ['ADAMED PHARMA S.A. BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.202]], 145.46833333333333), 'Aprepitantum': ([['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.255], ['ETHYPHARM ETHYPHARM', 0.255], ['LEK PHARMACEUTICALS D.D. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.255], ['CENTRAFARM SERVICES B.V. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. STADA ARZNEIMITTEL AG', 0.236]], 101.70333333333335), 'Olodaterolum': ([['BOEHRINGER INGELHEIM ESPANA S.A. BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 48.577000000000005), 'Atorvastatinum calcicum trihydricum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.172], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.264], ['LEK S.A.', 0.196], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.196], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.172]], 1.992416666666667), 'Simvastatinum': ([['APOTEX NEDERLAND B.V. FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.057], ['APOTEX NEDERLAND B.V. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.057], ['BALKANPHARMA-DUPNITSA AD', 0.075], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.059], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.059], ['ZENTIVA, K.S.', 0.059], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.038], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.075], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.059], ['APL SWIFT SERVICES (MALTA) LTD. FAREVA AMBOISE', 0.057], ['BLUEFISH PHARMACEUTICALS AB', 0.059], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.059], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.059], ['KRKA, D.D., NOVO MESTO', 0.059], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.038], ['ROTTENDORF PHARMA GMBH SYNTHON HISPANIA S.L.', 0.075], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.059]], 2.7561603174603166), 'Ziprasidonum': ([['KRKA, D.D., NOVO MESTO', 1.0]], 3.7164285714285716), 'Midazolamum': ([['LABORATORIOS LESVI S.L. NEURAXPHARM ARZNEIMITTEL GMBH SHIRE PHARMACEUTICALS IRELAND LIMITED', 1.0]], 67.86749999999999), 'Losartanum kalicum': ([['BIOFARM SP. Z O.O.', 0.082], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.123], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.123], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.123], ['LABORATORIOS LICONSA S.A.', 0.069], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.123], ['PLIVA CROATIA LTD. (PLIVA HRVATSKA D.O.O.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.082], ['ZENTIVA, K.S.', 0.082], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMAPATH S.A.', 0.109], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.082]], 3.257057539682539), 'Fenofibratum (zmikronizowany)': ([[\"ASTREA FONTAINE DELPHARM L'AIGLE FAMAR L'AIGLE\", 1.0]], 0.44333333333333336), 'Ondansetroni hydrochloridum dihydricum': ([['EGIS PHARMACEUTICALS PLC', 0.366], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.366], ['GLAXOSMITHKLINE PHARMACEUTICALS S.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.268]], 11.508500000000002), 'Fluticasoni propionas': ([['TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.024], ['GLAXO WELLCOME S.A.', 0.002], ['GLAXO WELLCOME PRODUCTION GLAXO WELLCOME S.A.', 0.197], ['GLAXO WELLCOME PRODUCTION', 0.197], [nan, 0.001], ['ADAMED PHARMA S.A.', 0.003], ['POLFARMEX S.A.', 0.287], ['CELON PHARMA SP. Z O.O.', 0.289]], 270.7302847222222), 'Sertralinum': ([['BIOFARM SP. Z O.O.', 0.218], [nan, 0.169], ['KRKA, D.D., NOVO MESTO', 0.218], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.191], ['ACTAVIS LTD.', 0.204]], 2.266111111111111), 'Amoksycylina trójwodna': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.1118), 'Gliclazidum': ([['BALKANPHARMA-DUPNITSA AD', 0.092], ['L.MOLTENI & C. DEI F.LLI ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.047], ['MCDERMOTT LABORATORIES LIMITED (T.A. GERARD LABORATORIES) MYLAN HUNGARY KFT.', 0.123], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.062], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.062], ['KRKA, D.D., NOVO MESTO', 0.092], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.184], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.123], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.123], ['SYMPHAR SP. Z O.O.', 0.092]], 1.7960694444444445), 'Azithromycinum': ([['KRKA POLSKA SP. Z O.O.', 0.12], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.09], ['PSI SUPPLY N.V. SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.117], ['LEK PHARMACEUTICALS D.D. SANDOZ GMBH S.C. SANDOZ S.R.L.', 0.09], ['LEK PHARMACEUTICALS D.D. SANDOZ GMBH SANDOZ S.R.L.', 0.09], ['ZENTIVA, K.S.', 0.12], ['ADAMED PHARMA S.A. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.027], ['ADAMED PHARMA S.A.', 0.09], ['ICN POLFA RZESZÓW', 0.12], ['PLIVA CROATIA LTD. (PLIVA HRVATSKA D.O.O.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.075], ['PLIVA CROATIA LTD. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.06]], 14.693833333333334), 'Diltiazemi hydrochloridum': ([['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 1.0]], 0.3144444444444444), 'Leuprorelini acetas': ([['RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A', 0.477], ['EBEWE PHARMA GES.M.B.H NFG. KG EVER PHARMA JENA GMBH EVER PHARMA JENA GMBH SANDOZ GMBH', 0.212], ['AMW GMBH', 0.311]], 1747.4050000000002), 'Theophyllinum': ([['BIOFARM SP. Z O.O.', 0.51], ['TAKEDA GMBH', 0.49]], 0.3514333333333334), 'Sirolimusum': ([['PFIZER IRELAND PHARMACEUTICALS  PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.503], ['PFIZER SERVICE COMPANY BVBA', 0.497]], 33.586), 'Paroxetinum': ([['FARMACEUTISCH ANALYTISCH LABORATORIUM DUIVEN BV MEDOCHEMIE LTD. (FACTORY A) SANICO N.V.', 0.286], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.286], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.429]], 1.1524166666666666), 'Mometasoni furoas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.011], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.011], ['LEK PHARMACEUTICALS D.D.', 0.495], ['MERCKLE GMBH TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V.', 0.483]], 15.1457), 'Venlafaxinum': ([['KRKA, D.D., NOVO MESTO', 0.094], [nan, 0.078], ['LABORATORIOS LICONSA, S.A.', 0.098], ['BIOCHEM LABOR FUER BIOLOGISCHE UND CHEMISCHE ANALYTIK GMBH EUROPHARTECH MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. PHARMA-PACK KFT. PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.042], ['ADAMED PHARMA S.A. MYLAN HUNGARY KFT. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.099], ['ADAMED PHARMA S.A. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.099], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON', 0.096], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS', 0.096], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.099], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.099], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.099]], 6.5997063492063495), 'Pantoprazolum -': ([['ACTAVIS DEUTSCHLAND GMBH & CO. KG ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 1.0]], 0.11098214285714286), 'Melphalanum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 4.7976), 'Insulina ludzka biosyntetyczna wysokooczyszczona': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 18.744), 'Flupentixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.3898), 'Venlafaxini hydrochloridum': ([['PFIZER IRELAND PHARMACEUTICALS PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.179], ['BALKANPHARMA-DUPNITSA AD', 0.139], ['BIOCHEM LABOR FUER BIOLOGISCHE UND CHEMISCHE ANALYTIK GMBH EUROPHARTECH MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. PHARMA-PACK KFT. PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.157], ['ORION CORPORATION ORION CORPORATION', 0.127], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.127], ['PHARMATHEN INTERNATIONAL S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.14], [nan, 0.131]], 4.681662414965986), 'Amlodipini besilas': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.107], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 0.136], ['POLFARMEX S.A.', 0.153], ['ADAMED PHARMA S.A.', 0.216], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.149], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 0.238]], 1.8701666666666668), 'stiripentolum': ([['BIOCODEX', 1.0]], 18.41383333333333), 'Desloratadinum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.013], ['BALKANPHARMA-TROYAN AD WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA', 0.4], ['PHARMAPATH S.A. WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA', 0.013], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.013], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.011], ['FAMAR A.V.E. FAMAR S.A. GENEPHARM S.A. GLENMARK PHARMACEUTICALS S.R.O.', 0.003], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.013], ['ADAMED PHARMA S.A. FAMAR A.V.E. GENEPHARM S.A.', 0.499], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.01], [nan, 0.012], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.013]], 23.944731481481483), 'Kalii chloridum': ([['DELPHARM POZNAŃ S.A.', 1.0]], 0.09266666666666666), 'Mianserini hydrochloridum': ([['ADAMED PHARMA S.A.', 0.235], ['BAUSCH HEALTH POLAND SP. Z O.O. PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.148], ['GERARD LABORATOIRES LTD. MYLAN HUNGARY KFT./MYLAN HUNGARY LTD', 0.234], ['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT./MYLAN HUNGARY LTD', 0.234], ['ORGANON HEIST BV', 0.148]], 2.8298101851851856), 'Tizanidinum': ([[nan, 1.0]], 1.0539999999999998), 'Collagenasum N (o aktywności klostrydiopeptydazy A nie mniej niż': ([['NORDMARK PHARMA GMBH', 1.0]], 1.038), 'Valganciclovirum': ([['PRESTIGE PROMOTION VERKAUFSFÖRDERUNG & WERBESERVICE GMBH PRESTIGE PROMOTION VERKAUFSFÖRDERUNG & WERBESERVICE GMBH', 0.99], ['ACCORD HEALTHCARE POLSKA SP. Z O.O. PHARMADOX HEALTHCARE LTD.', 0.01]], 793.2343333333332), 'Nitrendipinum': ([['EGIS PHARMACEUTICALS PLC, SITE 3', 1.0]], 0.12008333333333335), 'Wirus grypy (inaktywowany, rozszczepiony) Szczepy:  A/Victoria/': ([['SANOFI PASTEUR SANOFI PASTEUR SANOFI-AVENTIS ZRT.', 1.0]], 26.6), 'Olanzapinum': ([[nan, 0.003], ['ORION CORPORATION', 0.003], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.002], ['MCDERMOTT LABORATORIES LIMITED (T.A. GERARD LABORATORIES) MYLAN HUNGARY KFT.', 0.003], ['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.003], ['ADAMED PHARMA S.A.', 0.004], ['ADAMED PHARMA S.A. ADAMED SP. Z O.O.', 0.002], ['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.002], ['BASICS GMBH CEMELOG BRS KFT. RANBAXY IRELAND LIMITED TERAPIA S.A.', 0.004], ['CEMELOG BRS LTD. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.002], ['CEMELOG BRS KFT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.003], ['ACTAVIS GROUP PTC EHF. ACTAVIS LTD. BALKANPHARMA DUPNITSA AD', 0.002], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.004], ['VIPHARM S.A.', 0.002], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.004], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\"', 0.002], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.002], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.004], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A.', 0.004], ['LILLY S.A.', 0.94]], 932.3587535430838), 'Fluoxetini hydrochloridum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.286], ['EGIS PHARMACEUTICALS LTD. EGIS PHARMACEUTICALS PLC', 0.286], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.286], ['ORION CORPORATION', 0.143]], 1.1525857142857143), 'Octreotidi acetas': ([['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARIA KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.002], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.002], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.498], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.498]], 2449.4286666666667), 'Natrii alendronas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.504], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.496]], 4.34375), 'Thymolum': ([['ALLERGAN PHARMACEUTICALS IRELAND', 1.0]], 23.29), 'Atorvastatin calcium trihydrate': ([['LABORATORIOS LICONSA S.A.', 1.0]], 0.27399999999999997), 'Flupentixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 13.740000000000002), 'Indakaterol': ([['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.5], ['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 0.5]], 5.490166666666666), 'Tianeptinum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.333], [nan, 0.333], ['ADAMED PHARMA S.A. LABORATORIOS LICONSA, S.A.', 0.333]], 0.7470000000000001), 'Pregabalinum': ([['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.276], ['VIPHARM S.A.', 0.279], ['NEURAXPHARM PHARMACEUTICALS, S.L.', 0.159], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.287]], 4.612741071428571), 'Quinaprili hydrochloridum': ([['BIOFARM SP. Z O.O.', 0.632], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.368]], 0.16766666666666666), 'Dulaglutidum': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE', 1.0]], 68.965), 'Dorzolamidum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.314], ['ADAMED PHARMA S.A. RAFARM S.A.', 0.314], ['EXCELVISION PHARMATHEN S.A.', 0.372]], 59.63333333333334), 'Lisinoprilum dihydricum': ([['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.14], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.14], ['GEDEON RICHTER PLC.', 0.15], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.135], ['FARMACOL S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.135], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.15], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.15]], 0.8541636904761905), 'Telmisartanum': ([['BIOFARM SP. Z O.O. DELORBIS PHARMACEUTICALS LTD.', 0.038], ['ACTAVIS EHF. ACTAVIS LTD.', 0.041], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DELPHARM REIMS S.A.S. ROTTENDORF PHARMA GMBH', 0.047], ['ACTAVIS LTD.', 0.041], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.035], ['LABORATORIOS LICONSA, S.A. ', 0.035], ['EGIS PHARMACEUTICALS PLC GLENMARK PHARMACEUTICALS S.R.O.', 0.035], [nan, 0.038], ['LABORATORIOS LICONSA, S.A. SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.038], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.035], ['ACTAVIS LTD. ADAMED PHARMA S.A.', 0.038], ['ZENTIVA, K.S. ZENTIVA S.A.', 0.041], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.036], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.035], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW LABORATORIOS LICONSA, S.A. PHARMASWISS D.O.O.', 0.038], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.037], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.036], ['ACTAVIS LTD. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.047], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 0.047], ['ACTAVIS LTD. EGIS PHARMACEUTICALS PLC', 0.039], ['S.C. ZENTIVA S.A. ZENTIVA, A.S.', 0.023], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.041], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.036], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.039], ['LABORATORIOS LICONSA, S.A.', 0.038], ['PRO.MED.CS PRAHA A.S.', 0.047]], 11.391940854119428), 'Duloxetine hydrochloride': ([['ADAMED PHARMA S.A.', 1.0]], 0.5603125), 'Oxcarbazepinum': ([['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.202], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.202], ['ADAMED PHARMA S.A. ATLANTIC PHARMA - PRODUCOES FARMACEUTICAS SA FARMALABOR - PRODUTOS FARMACEUTICOS, S.A.', 0.264], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.264], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS POLAND SP. Z O.O.', 0.068]], 4.78744), 'Furazidinum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['ADAMED PHARMA S.A.', 0.5]], 0.36133333333333334), 'Travoprostum + Timololi maleas': ([['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 1.0]], 28.970000000000002), 'Ciprofibratum': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE SANOFI WINTHROP INDUSTRIE', 1.0]], 0.44333333333333336), 'Salmeterolu ksynafonian': ([['AEROPHARM GMBH', 0.234], ['ADAMED PHARMA S.A. GENETIC S.P.A', 0.221], ['ELPEN PHARMACEUTICAL CO.INC.', 0.234], ['POLFARMEX S.A.', 0.155], ['GLAXO WELLCOME PRODUCTION', 0.155]], 354.0433333333334), 'Ganirelixi acetas': ([['N.V. ORGANON', 1.0]], 48.55000000000001), 'Famotidinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.32399999999999995), 'Sotaloli hydrochloridum': ([['LEK S.A. SALUTAS PHARMA GMBH', 1.0]], 0.39075), 'Insulinum detemirum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 21.694), 'Trazodoni hydrochloridum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ISTITUTO DE ANGELI S.R.L', 0.25], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. INSTITUTO DE ANGELI S.R.L.', 0.25], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.', 0.5]], 1.1205), 'Pancreatinum o aktywności: Lipazy': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.6854166666666668), 'Sitagliptin hydrochloride monohydrate': ([['LABORATORIOS LICONSA S.A.', 0.136], ['GALENICUM HEALTH, S.L. SAG MANUFACTURING S.L.U.', 0.273], ['CENTRAFARM SERVICES B.V. LABORATORIOS LICONSA S.A. STADA ARZNEIMITTEL AG STADA ARZNEIMITTEL GMBH', 0.273], ['ADAMED PHARMA S.A.', 0.182], ['ADAMED PHARMA S.A. MERCKLE GMBH MERCKLE GMBH', 0.136]], 2.8181904761904764), 'Thiethylperazini dimaleas': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4046), 'Tacrolimusum monohydricum': ([['ASTELLAS IRELAND CO., LTD.', 0.527], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH ROTTENDORF PHARMA GMBH', 0.473]], 21.546370370370372), 'Chlorambucilum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 3.6395999999999997), 'Topiramatum': ([['APL SWIFT SERVICES (MALTA) LTD. LACHIFARMA S.R.L. LABORATORIO CHIMICO FARMACEUTICO SALENTINO', 0.016], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.016], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.016], ['ORION CORPORATION, ORION PHARMA', 0.01], ['JANSSEN CILAG S.P.A JANSSEN PHARMACEUTICA N.V. LUSOMEDICAMENTA - SOCIEDADE TECNICA FARMACEUTICA S.A.', 0.462], ['JANSSEN PHARMACEUTICA N.V. JANSSEN-CILAG S.P.A. LUSOMEDICAMENTA - SOCIEDADE TECNICA FARMACEUTICA S.A.', 0.462], ['GLENMARK ARZNEIMITTEL GMBH GLENMARK PHARMACEUTICALS S.R.O.', 0.016]], 63.039593253968256), 'Fenoteroli hydrobromidum': ([['BOEHRINGER INGELHEIM PHARMA KG', 0.493], ['INSTITUTO DE ANGELI S.R.L.', 0.014], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.493]], 24.961000000000006), 'Lisinoprilum': ([[nan, 1.0]], 0.15899999999999997), 'Letrozolum': ([['CELON PHARMA SP. Z O.O.', 0.17], ['S.C. SINDAN-PHARMA S.R.L.', 0.17], ['ROTTENDORF PHARMA GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.163], ['VIPHARM S.A.', 0.17], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.161], ['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.167]], 11.139958333333333), 'Fluticasoni furoas': ([['GLAXO WELLCOME PRODUCTION', 1.0]], 143.69), 'Amoxicillin trihydrate': ([[nan, 0.334], ['PENCEF PHARMA GMBH', 0.325], ['ALKALOIDA CHEMICAL CO. ZRT. ECOPHARM EOOD SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.342]], 2.9190714285714288), 'Duloxetinum': ([['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.1], ['MCDERMOTT LABORATORIES LIMITED T/A GERARD LABORATORIES T/A MYLAN DUBLIN MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.101], ['S.C. ZENTIVA S.A', 0.095], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.132], [nan, 0.124], ['NEURAXPHARM PHARMACEUTICALS, S.L.', 0.156], ['LABORATORIOS LESVI S.L.', 0.156], ['TERAPIA S.A. TOWA PHARMACEUTICALS EUROPE, S.L.', 0.134]], 5.5298738977072315), 'Montelukastum natricum': ([['POLFARMEX S.A.', 0.063], ['ADAMED PHARMA S.A.', 0.063], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.063], ['BLUEFISH PHARMACEUTICALS AB', 0.139], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.14], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.063], [nan, 0.14], ['ORION CORPORATION ORION CORPORATION, ORION PHARMA', 0.063], ['HBM PHARMA S.R.O. SANECA PHARMACEUTICALS A.S.', 0.063], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.14], ['SUN PHARMACEUTICALS INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.063]], 4.151297619047618), 'Diazepamum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 1.0]], 4.45), 'Amlodipini besilas -': ([['ADAMED PHARMA S.A.', 1.0]], 0.2023333333333333), 'Cyclophosphamidum': ([['BAXTER ONCOLOGY GMBH', 1.0]], 1.7624), 'Filgrastimum': ([['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE LIMITED ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.495], ['SANDOZ GMBH', 0.505]], 83.65942857142858), 'Mieszanki alergoidów pyłku roślin (zgodnie z załącznikeim I)': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Insulini injectio neutralis aspartum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 19.356), 'Clindamycinum': ([['HAUPT PHARMA WÜLFING GMBH', 0.667], ['FAREVA AMBOISE', 0.333]], 1.9402083333333335), 'Oxybutynini hydrochloridum': ([['ASTREA FONTAINE', 0.5], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.5]], 0.4095), 'Carvedilolum': ([['ZENTIVA, K.S.', 0.135], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.135], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.135], ['MERCKLE GMBH TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICAL WORKS PVT. LTD.', 0.135], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.108], ['KRKA, D.D., NOVO MESTO', 0.108], ['KRKA, D.D., NOVO MESTO SCANPHARM A/S', 0.108], ['EGIS PHARMACEUTICALS PLC', 0.135]], 0.8752777777777777), 'Nebivololi hydrochloridum': ([['LABORATORI FUNDACIO DAU SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.12], ['GENERICON PHARMA GMBH PHARMAPATH S.A.', 0.127], ['ACTAVIS HF. ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.123], ['PHARMAPATH S.A.', 0.126], ['BERLIN-CHEMIE AG (MENARINI GROUP)', 0.127], ['SPECIFAR S.A.', 0.127], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.124], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.127]], 2.5202916666666666), 'Fluvoxamini maleas': ([['MYLAN LABORATOIRES SAS', 1.0]], 0.247), 'Naldemedinum': ([['SHIONOGI B.V.', 1.0]], 8.73857142857143), 'Levocetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.006], ['MEDIS INTERNATIONAL A.S. PHARMADOX HEALTHCARE LTD.', 0.006], ['KRKA, D.D., NOVO MESTO', 0.006], [nan, 0.319], ['ADAMED PHARMA S.A.', 0.006], ['ADAMED PHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.319], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.006], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.006], ['AESICA PHARMACEUTICALS S.R.L.', 0.319], ['ZENTIVA, K.S.', 0.006]], 50.04762499999999), 'Isosorbidi mononitras': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE', 1.0]], 0.45766666666666667), 'Fluconazolum': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.314], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE', 0.042], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.365], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.042], ['GENERIS FARMACÊUTICA, S.A.,', 0.025], ['POLFARMEX S.A.', 0.002], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.034], ['PHARMAPATH S.A.', 0.042], [nan, 0.042], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.025], ['GEDEON RICHTER PLC.', 0.067]], 44.23977202380952), 'Tafluprostum': ([['SANTEN OY TUBILUX PHARMA S.P.A.', 0.5], ['SANTEN OY', 0.5]], 26.120666666666665), 'Candesartanum cilexetilum + Amlodipinum': ([['ZENTIVA, K.S.', 1.0]], 0.5349999999999999), 'Glucagoni hydrochloridum': ([['NOVO NORDISK A/S', 1.0]], 62.53999999999999), 'Nebivololum': ([['BIOFARM SP. Z O.O.', 0.182], ['BIOFARM SP. Z O.O. PHARMAPATH S.A.', 0.182], ['ADAMED PHARMA S.A.', 0.128], ['PHARMAPATH S.A.', 0.128], ['KRKA, D.D., NOVO MESTO', 0.128], ['ORION CORPORATION', 0.125], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.128]], 2.500894047619048), 'Amlodipini maleas': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 1.0]], 0.2798333333333334), 'Gentamicini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 4.55), 'Verapamili hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.20124999999999998), 'Naproxenum': ([['ADAMED PHARMA S.A.', 0.128], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.128], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.444], ['SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.128], ['POLFARMEX S.A.', 0.171]], 1.493527777777778), 'Busulfanum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 8.5168), 'Sertralini hydrochloridum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.128], ['ORION CORPORATION ORION CORPORATION', 0.149], ['KRKA, D.D., NOVO MESTO SPECIFAR ABEE TAD PHARMA GMBH', 0.136], ['TEVA PHARMA, S.L.U.', 0.16], ['EGIS PHARMACEUTICALS PLC', 0.107], ['HAUPT PHARMA LATINA S.R.L. PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.16], ['ACTAVIS LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.16]], 3.081857142857143), 'Methylprednisoloni natrii succinas': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.992], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.008]], 63.87499999999999), 'Icatibantum': ([['SHIRE PHARMACEUTICALS IRELAND LIMITED TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH', 0.208], ['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.208], ['FRESENIUS KABI AUSTRIA GMBH', 0.189], ['EUROFINS PROXY LABORATORIES BV PHARMADOX HEALTHCARE LTD.', 0.204], ['EUROFINS PROXY LABORATORIES BV PHARMADOX HEALTHCARE LTD. TERAPIA S.A.', 0.191]], 11696.760000000002), 'Nabumetonum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.12758333333333327), 'Zuclopenthixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.39005), 'Lithii carbonas': ([['DELPHARM POZNAŃ S.A.', 1.0]], 0.261), 'Menotropina': ([[nan, 0.888], ['IBSA FARMACEUTICI ITALIA S.R.L.', 0.112]], 1142.79), 'Montelukastum': ([['HBM PHARMA S.R.O. NYCOMED PHARMA SP. Z O.O. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.258], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.258], ['MEDIS INTERNATIONAL A.S.', 0.249], [nan, 0.235]], 2.2525476190476192), 'Brinzolamidum': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.332], ['BALKANPHARMA-RAZGRAD AD FAMAR S.A., PLANT A HEUMANN PHARMA GMBH & CO. GENERICA KG PHARMATEN S.A.', 0.332], ['LUSOMEDICAMENTA SOCIEDADE TECNICA FARMACEUTICA, S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.336]], 70.13666666666666), 'Follitropinum alfa': ([['GEDEON RICHTER PLC.', 0.268], ['MERCK SERONO S.P.A.', 0.088], ['MERCKLE GMBH TEVA BIOTECH GMBH TEVA PHARMACEUTICALS EUROPE B.V.', 0.644]], 954.0450000000001), 'Ivabradini hydrochloridum': ([['KRKA, D.D., NOVO MESTO', 0.342], ['REMEDICA LTD', 0.314], ['GENEPHARM S.A.', 0.344]], 4.613973214285714), 'Alfuzosini hydrochloridum': ([['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.363], ['ORION CORPORATION ORION CORPORATION', 0.275], ['SANOFI WINTHROP INDUSTRIE', 0.363]], 1.9610000000000003), 'Vigabatrinum': ([['PATHEON FRANCE S.A.', 1.0]], 2.7886), 'Conestatum alfa': ([['PHARMING TECHNOLOGIES B.V.', 1.0]], 3943.96), 'Wyciągi alergenowe roztoczy kurzu domowego -': ([['ALLERGOPHARMA GMBH & CO. KG', 1.0]], 263.37833333333333), 'Colistimethatum natricum': ([['LYOCONTRACT GMBH TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 19.896), 'Danazolum': ([['POLFARMEX S.A.', 1.0]], 2.3287999999999998), 'Spiramycinum': ([['SANOFI S.R.L.', 1.0]], 0.795), 'Ciprofloxacini hydrochloridum': ([['ZENTIVA, A.S. ZENTIVA, K.S.', 0.23], ['KRKA, D.D., NOVO MESTO', 0.177], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.178], ['GEDEON RICHTER POLSKA SP. Z O.O. GEDEON RICHTER ROMANIA S.A.', 0.238], ['S.C. LABORMED-PHARMA S.A. WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE', 0.177]], 2.4815), 'Insulinum lisprum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.202], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 0.298], ['LILLY FRANCE S.A.S.', 0.202], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 0.298]], 95.653), 'Sulpiridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.368], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.632]], 0.5003611111111111), 'Glipizidum': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY „GALENA”', 1.0]], 0.05699999999999997), 'Calcitriolum': ([['MIBE GMBH ARZNEIMITTEL', 1.0]], 0.5593888888888889), 'Clozapinum': ([['LABORATORI FUNDACIÓ DAU', 0.268], ['EGIS PHARMACEUTICALS PLC', 0.268], ['SYMPHAR SP. Z O.O.', 0.464]], 0.9832416666666666), 'Apixaban': ([['CATALENT ANAGNI S.R.L. PFIZER IRELAND PHARMACEUTICALS PFIZER MANUFACTURING DEUTSCHLAND GMBH SWORDS LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS, EXTERNAL MANUFACTURING', 1.0]], 1.803839285714286), 'Rivastigmini hydrogenotartras': ([['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A.', 0.312], ['GENEPHARM S.A. NEURAXPHARM ARZNEIMITTEL GMBH', 0.313], ['ORION CORPORATION', 0.375]], 0.9392633928571428), 'Febuxostatum hemihydricum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACEUTICA, S.A.', 1.0]], 0.5772321428571427), 'Glimepiridum': ([['SANOFI S.R.L. SANOFI WINTHROP INDUSTRIE', 0.187], ['BIOFARM SP. Z O.O. PHARMAPATH S.A.', 0.183], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.223], ['PHARMAPATH S.A.', 0.208]], 1.3151333333333333), 'Allopurinol': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.40866666666666673), 'Riluzolum': ([['PRO.MED.CS. PRAHA A.S. PRO.MED.CS. PRAHA A.S.', 1.0]], 3.22), 'tert-Butylamini perindoprilum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.204], ['GEDEON RICHTER PLC. GRODZISKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" SP. Z O.O.', 0.194], ['KRKA, D.D., NOVO MESTO LEK PHARMACEUTICALS D.D. TAD PHARMA GMBH', 0.204], ['ADAMED PHARMA S.A. LEK PHARMACEUTICALS D.D.', 0.194], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.204]], 0.6129940476190476), 'Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum A/Victoria/': ([['ABBOTT BIOLOGICALS B.V.', 1.0]], 26.37), 'Atomoxetinum': ([['G.L. PHARMA GMBH LANNACHER HEILMITTEL GMBH PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.46], [nan, 0.54]], 6.3589761904761914), 'Clopidogrelum': ([[nan, 0.332], ['ORIFARM GENERICS A/S PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.34], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O.', 0.327]], 1.6846428571428573), 'Terazosini dihydricum hydrochloridum': ([['AESICA PHARMACEUTICALS S.R.L. FAMAR ITALIA S.P.A.', 0.624], ['LEK PHARMACEUTICALS D.D.', 0.376]], 0.8708809523809522), 'Hydroxycarbamidum': ([['PLIVA KRAKÓW ZAKŁADY FARMACEUTYCZNE S.A. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['MEDAC GESELLSCHAFT FUR KLINISCHE SPECIALPRAPARATE MBH', 0.5]], 2.1038), 'Empagliflozinum': ([['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 1.0]], 3.7353571428571435), 'Agomelatinum': ([['MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.167], ['GENERICON PHARMA GESELLSCHAFT M.B.H. MEDIS INTERNATIONAL A.S.', 0.165], ['G.L. PHARMA GMBH MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.165], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LABORATORIOS SERVIER S.L. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER IRELAND INDUSTRIES LTD.', 0.167], ['BIOFARM SP. Z O.O. MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.167], ['MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE SYMPHAR SP. Z O.O.', 0.167]], 9.39847619047619), 'Ibuprofenum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.03183333333333332), 'Dermatophagoides pteronyssinus': ([['ALK-ABELLO S.A.', 1.0]], 9.438666666666666), 'Warfarinum natricum': ([['ORION CORPORATION ORION CORPORATION', 1.0]], 0.10485), 'Meloxicamum': ([['BIOFARM SP. Z O.O.', 0.139], ['ZENTIVA, K.S.', 0.145], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.14], ['CHANELLE MEDICAL UNLIMITED COMPANY STADA ARZNEIMITTEL AG', 0.145], ['BOEHRINGER INGELHEIM HELLAS SINGLE MEMBER S.A. BOEHRINGER INGELHEIM INTERNATIONAL GMBH ROTTENDORF PHARMA GMBH', 0.145], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.141], [nan, 0.145]], 1.7601666666666669), 'Cyanocobalaminum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.8039999999999998), 'Ticlopidini hydrochloridum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.4181666666666667), 'Mesalazinum': ([['SEVER PHARMA SOLUTIONS AB', 0.043], ['TEMMLER ITALIA S.R.L.', 0.078], ['FARMINA SP. Z O.O.', 0.124], ['FERRING GMBH', 0.088], ['FERRING LEČIVA A.S.', 0.388], ['FAES FARMA, S.A.', 0.058], ['LABORATORIOS VITÓRIA S.A.', 0.165], ['DR. FALK PHARMA GMBH', 0.056]], 12.215089285714285), 'Mycophenolas mofetil': ([['ROCHE PHARMA AG', 0.2], [nan, 0.1], ['LABORATORI FUNDACIO DAU', 0.2], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH', 0.099], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.2], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.2]], 7.5763), 'Tianeptinum': ([['LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 1.0]], 0.24900000000000003), 'Azathioprinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 0.488], ['ASPEN BAD OLDESLOE GMBH EXCELLA GMBH & CO. KG', 0.512]], 1.0514333333333332), 'Estradioli valeras tabletki białe -': ([['BAYER AG BAYER WEIMAR GMBH UND CO. KG', 1.0]], 0.3347619047619048), 'mikonazol': ([['GEDEON RICHTER PLC.', 1.0]], 0.8079999999999999), 'Urofollitropinum': ([['IMED POLAND SP. Z O.O. LABORATOIRES GENEVRIER S.A.', 1.0]], 73.00999999999999), 'Triptorelini pamoas': ([['IPSEN PHARMA BIOTECH SAS', 1.0]], 555.95), 'Ciclosporinum': ([['MEDIS INTERNATIONAL AS, PRODUCTION PLANT BOLATICE MONTERESEARCH S.R.L.', 0.081], ['TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.163], [nan, 0.159], ['EXCELVISION SANTEN OY', 0.24], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.064], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD INTERNATIONAL SERVICE LABORATORY BRANCH IRELAND NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.064], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S. NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.163], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.064]], 38.110083333333336), 'Carbamazepinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.147], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.228], ['GEROT PHARMAZEUTIKA GMBH', 0.346], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.056], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.224]], 1.3293299999999997), 'Insulinum aspartum': ([['NOVO NORDISK A/S', 0.333], ['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.333], ['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.333]], 58.052), 'Ketoprofenum': ([['FAMAR LYON OPELLA HEALTHCARE INTERNATIONAL SAS', 0.1], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.1], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.1], ['LEK PHARMACEUTICALS D.D.', 0.15], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A.', 0.1], ['MIBE GMBH ARZNEIMITTEL', 0.1], ['HAUPT PHARMA LIVRON UNITHER LIQUID MANUFACTURING', 0.348]], 1.6966666666666668), 'Loratadinum': ([['LEK PHARMACEUTICALS D.D.', 0.444], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY GALENA - ZAKŁAD NR 2', 0.444], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.113]], 0.7077600000000002), 'Levothyroxinum natricum': ([[nan, 0.38], ['CORDEN PHARMA GMBH FAMAR HEALTH CARE SERVICES MADRID SAU MERCK HEALTHCARE KGAA', 0.34], ['BERLIN-CHEMIE AG', 0.28]], 0.3012001515151515), 'Cariprazine': ([['GEDEON RICHTER PLC.', 1.0]], 8.436428571428571), 'Clopamidum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.3295), 'Lurasidonum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA MILLMOUNT HEALTHCARE LTD.', 1.0]], 8.241428571428571), 'Benzathini phenoxymethylpenicillinum': ([['SANDOZ GMBH', 1.0]], 0.2733333333333333), 'Tizanidini hydrochloridum': ([['ORION CORPORATION', 1.0]], 0.7026666666666667), 'Furosemidum': ([['MEDIS INTERNATIONAL A.S.', 0.191], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.259], ['POLFARMEX S.A.', 0.275], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.275]], 0.777), 'Glycopyrronii bromidum': ([['NOVARTIS FARMACÉUTICA S.A NOVARTIS PHARMA GMBH', 1.0]], 2.227), 'Zuclopenthixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 15.36), 'Betamethasoni dipropionas': ([['MIBE GMBH ARZNEIMITTEL', 0.332], ['ORGANON HEIST BV', 0.22], ['BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.448]], 31.075000000000003), 'Hydrochlorothiazidum': ([['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.143], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.571], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 0.286]], 1.8725), 'Estradiolum': ([['ORION CORPORATION', 0.06], [nan, 0.08], ['NOVO NORDISK A/S', 0.049], ['BESINS MANUFACTURING BELGIUM S.A. LABORATOIRES BESINS INTERNATIONAL', 0.048], ['AESICA PHARMACEUTICALS GMBH LTS LOHMANN TERAPIE-SYSTEME AG', 0.373], ['BAYER AG', 0.055], ['ABBOTT BIOLOGICALS B.V.', 0.055], ['AESICA PHARMACEUTICALS GMBH', 0.28]], 7.315101190476191), 'Latanoprostum': ([['PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH', 0.097], ['S.C. ROMPHARM COMPANY S.R.L.', 0.051], ['RAFARM S.A.', 0.1], ['EXCEL VISION LABORATOIRES THEA LABORATOIRES UNITHER', 0.004], ['ADAMED PHARMA S.A. RAFARM S.A.', 0.068], ['ADAMED PHARMA S.A. GENETIC S.P.A', 0.068], ['PFIZER MANUFACTURING BELGIUM NV', 0.074], ['LOMAPHARM GMBH', 0.099], ['FAMAR S.A. FARMIGEA S.P.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.099], ['GENETIC S.P.A', 0.099], ['ADAMED PHARMA S.A. S.C. ROMPHARM COMPANY S.R.L.', 0.068], ['PFIZER MANUFACTURING BELGIUM N.V.', 0.074], ['JADRAN-GALENSKI LABORATORIJ D.D. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.099]], 282.90144444444445), 'Clomipramini hydrochloridum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 1.205), 'Fluoxetinum': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE', 0.333], ['APL SWIFT SERVICES (MALTA) LTD.', 0.333], ['PRO.MED.CS PRAHA A.S.', 0.333]], 0.988), 'Insulinum lisprum injectio neutralis': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 1.0]], 19.356), 'Thioguaninum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 18.0212), 'Amlodipine besilate': ([['ZENTIVA, K.S.', 1.0]], 0.24620833333333333), 'all-rac-Fitomenadion (witamina K': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 1.7853333333333332), 'Insulinum humanum isophanum': ([['BIOTON S.A.', 0.5], ['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.5]], 37.144000000000005), 'Atorvastatinum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O., DPC JASTREBARSKO', 0.073], ['KRKA, D.D., NOVO MESTO', 0.073], ['HAUPT PHARMA LATINA S.R.L.', 0.088], ['MEDIS INTERNATIONAL A.S.', 0.078], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.057], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.057], [nan, 0.085], ['BIOFARM SP. Z O.O.', 0.196], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A. SUPROBION SP. Z O.O. SPÓŁKA KOMANDYTOWA', 0.056], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. SUPROBION SP. Z O.O. SPÓŁKA KOMANDYTOWA', 0.056], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.066], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.057], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, A.S.', 0.057]], 4.253064814814815), 'Cloxacillinum natrium': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 1.25625), 'Natrii risedronas': ([['ZENTIVA, K.S.', 1.0]], 2.1875), 'Progesteronum': ([['ADAMED PHARMA S.A.', 0.039], ['CYNDEA PHARMA S.L.', 0.961]], 2.7263333333333337), 'Goserelini acetas': ([['AMW GMBH ARZNEIMITTELWERK WARNGAU', 0.336], ['AMW GMBH ARZNEIMITTELWERK WARNGAU MERCKLE GMBH', 0.327], [nan, 0.337]], 1025.915), 'Kalii citras': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.476], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 0.524]], 0.42986363636363634), 'Clopidogrelum besilate': ([['DOCPHARMA NV PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. SGS LABORATORIES SIMON S.A.', 0.487], ['PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.513]], 1.117142857142857), 'Prednisolonum': ([['ADAMED PHARMA S.A.', 0.155], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.845]], 1.8929999999999998), 'Salmeterolum': ([[nan, 0.271], ['GENETIC S.P.A ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.271], ['GENETIC S.P.A', 0.264], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.003], ['GLAXO WELLCOME GMBH & CO. KG GLAXO WELLCOME PRODUCTION', 0.191]], 288.47933333333333), 'Sertindolum': ([['H. LUNDBECK A/S', 1.0]], 8.46563492063492), 'Fentanylu cytrynian': ([['MERCKLE GMBH TEVA PHARMACEUTICAL EUROPE B.V.', 1.0]], 20.177142857142854), 'Pantoprazolum natricum sesquihydricum': ([['NYCOMED GMBH', 0.118], [nan, 0.176], ['LOGITERS, LOGISTICA, PORTUGAL, S.A. MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.176], ['BLUEFISH PHARMACEUTICALS AB TEVA PHARMA, S.L.U.', 0.176], ['CEMELOG BRF KFT. IMED POLAND SP. Z O.O. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.176], ['ALKALOIDA CHEMICAL CO. ZRT. CEMELOG BRF KFT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.176]], 0.9430357142857142), 'Sulfasalazinum w postaci granulatu z powidonem -': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4455), 'Ethosuximidum': ([['G.L. PHARMA GMBH', 1.0]], 0.5944999999999999), 'Acidum alendronicum': ([['CEMELOG BRS KFT. FARMACOL S.A. RANBAXY IRELAND LTD.', 0.38], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.328], ['BLUEFISH PHARMACEUTICALS AB', 0.292]], 5.665000000000001), 'Aciclovirum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.308], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.344], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.348]], 1.4142222222222223), 'Relugolixum': ([['MILLMOUNT HEALTHCARE LIMITED', 1.0]], 14.965333333333332), 'Tramadoli hydrochloridum': ([['MEDANA PHARMA S.A.', 0.869], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.007], ['MEDOCHEMIE LTD., FACILITY A-Z ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.019], ['APL SWIFT SERVICES (MALTA) LTD.', 0.006], ['KRKA, D.D., NOVO MESTO', 0.006], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.006], ['STADA ARZNEIMITTEL AG', 0.016], [nan, 0.019], ['GRUENENTHAL GMBH STADA ARZNEIMITTEL AG', 0.016], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.007], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 0.005], ['PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.) PLIVA LJUBLJANA D.O.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.005], ['ZENTIVA, K.S.', 0.009], ['MEDIS INTERNATIONAL A.S.', 0.005], ['POLFARMEX S.A.', 0.005]], 42.30231249999999), 'Propranololi hydrochloridum': ([[nan, 0.5], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.5]], 0.24400000000000002), 'Clindamycini hydrochloridum': ([['CHEPHASAAR, CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH', 0.53], ['FAREVA AMBOISE', 0.136], ['S.C. SANDOZ S.R.L.', 0.334]], 1.7876597222222221), 'Indacateroli maleas': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 1.0]], 3.1340000000000003), 'Rivaroxaban': ([['BAYER AG BAYER BITTERFELD GMBH BAYER HEALTHCARE MANUFACTURING S.R.L.', 1.0]], 3.8448571428571428), 'Haloperidolum': ([['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.487], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.026], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.487]], 10.4950625), 'Etaksylan dabigatranu': ([['BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 1.2343333333333335), 'Cefuroximum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.046], ['ACS DOBFAR S.P.A', 0.954]], 5.955294117647059), 'Risperidonum': ([['ORION CORPORATION ORION CORPORATION', 0.002], ['ORION CORPORATION', 0.087], ['PHARMAPATH S.A.', 0.002], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.)', 0.45], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['JANSSEN-CILAG S.P.A.', 0.002], ['JANSSEN PHARMACEUTICA N.V.', 0.001], ['CAP PHARMACY LINE JANSSEN PHARMACEUTICA N.V.', 0.451], ['ACTAVIS LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.002], ['KRKA, D.D., NOVO MESTO', 0.001]], 388.3620833333334), 'Clonazepamum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.2793333333333333), 'Folitropinum delta': ([['FERRING GMBH', 1.0]], 916.71), 'Esomeprazolum (esomeprazol magnezowy, amorficzny)': ([['PHARMACHEMIE B.V. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.5], ['PHARMACHEMIE B.V. TERAPIA S.A. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PVT. LTD.', 0.5]], 0.44392857142857145), 'Sitagliptini hydrochloridum monohydricum': ([['PHARMADOX HEALTHCARE LTD. SYMPHAR SP. Z O.O.', 0.667], ['GALENICUM HEALTH S.L. SAG MANUFACTURING S.L.U.', 0.333]], 1.152857142857143), 'Bisoprololi fumaras': ([['BIOFARM SP. Z O.O.', 0.155], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.181], ['ICN POLFA RZESZÓW S.A.', 0.147], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.166], ['SANECA PHARMACEUTICALS A.S. S.C. ZENTIVA S.A.', 0.16], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.192]], 1.201625), 'Ofloxacinum': ([['OPELLA HEALTHCARE INTERNATIONAL SAS', 1.0]], 0.8849999999999999), 'Lamotriginum': ([['ACTAVIS GROUP PTC EHF. BALKANPHARMA-DUPNITSA AD SPECIFAR S.A. TJOAPACK NETHERLANDS BV', 0.157], [nan, 0.114], ['BALKANPHARMA DUPNITSA AD MERCKLE GMBH PHARMACHEMIE B.V. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICALS LTD.', 0.22], ['DELPHARM POZNAŃ S.A.', 0.39], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.118]], 3.1809074074074077), 'Rywastygmina': ([['LUYE PHARMA AG ZENTIVA SA', 1.0]], 0.9863333333333334), 'Tamsulosini hydrochloridum': ([['A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.R.L. ADAMED PHARMA S.A. MENARINI-VON HEYDEN GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['ADAMED PHARMA S.A.', 0.053], ['APL SWIFT SERVICES (MALTA) LTD.', 0.053], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.053], [nan, 0.04], ['ZENTIVA, K.S.', 0.053], ['GEDEON RICHTER PLC.', 0.053], ['QUINTA-ANALYTICA S.R.O. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.053], ['SYMPHAR SP. Z O.O.', 0.049], ['ORION CORPORATION ORION CORPORATION', 0.044], ['LABORATOIROS NORMON S.A. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. ROWA PHARMACEUTICALS LTD. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.051], ['GENERICON PHARMA GESELLSCHAFT M.B.H. G.L. PHARMA GMBH INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.043], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. SYNTHON HISPANIA S.L.', 0.049], ['MEDIS INTERNATIONAL A.S. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.039], ['KRKA, D.D., NOVO MESTO QUINTA-ANALYTICA S.R.O. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['KRKA, D.D., NOVO MESTO SYNTHON HISPANIA S.L. TAD PHARMA GMBH', 0.053], ['ASTELLAS PHARMA EUROPE B.V.', 0.053]], 10.126296296296298), 'Brimonidini tartras': ([['ALLERGAN PHARMACEUTICALS IRELAND', 0.066], ['ADAMED PHARMA S.A. PHARMA STULLN GMBH UAB SANTONIKA', 0.296], ['RAFARM S.A.', 0.276], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.066], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMA STULLN GMBH UAB SANTONIKA', 0.296]], 70.88033333333334), 'Rupatadini fumaras': ([['MARTIN DOW PHARMACEUTICALS MEIJI PHARMA SPAIN S.A.', 1.0]], 0.2463), 'Exemestanum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['SYMPHAR SP. Z O.O.', 0.5]], 3.7813333333333334), 'Doxazosini mesilas': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.065], ['ADAMED PHARMA S.A. APL SWIFT SERVICES (MALTA) LTD.', 0.08], ['GENERICS FARMACEUTICA, S.A.', 0.065], ['GENERIS FARMACEUTICA, S.A.', 0.065], ['PFIZER MANUFACTURING DEUTSCHLAND GMBH R-PHARM GERMANY GMBH', 0.196], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.07], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.069], ['ACTAVIS GROUP PTC EHF.', 0.131], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.058], ['KRKA, D.D., NOVO MESTO', 0.131], ['ZENTIVA, K.S.', 0.07]], 3.756001157407407), 'Methotrexatum natricum': ([['EBEWE PHARMA GES.M.B.H NFG. KG FAREVA UNTERACH GMBH SALUTAS PHARMA GMBH', 0.476], ['MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.524]], 94.22452380952382), 'Tiotropium': ([['ACTAVIS LTD.  LABORATORIOS LICONSA S.A. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMA B.V.', 0.523], ['HELM AG', 0.477]], 5.552666666666666), 'Atomoxetini hydrochloridum': ([['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.385], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.308], ['GLENMARK PHARMACEUTICALS S.R.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.306]], 7.586339285714285), 'Metformini hydrochloridum': ([['BIOTON S.A.', 0.055], [nan, 0.052], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.096], ['DRAGENOPHARM APOTHEKER PUESCHL GMBH & CO. KG ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.064], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L. N.PETSIAVAS S.A. PETSIAVAS S.A.', 0.048], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L. N.PETSIAVAS S.A. PETSIAVAS S.A. PHARMA-PACH GYOGYSZERGYARTO ES SZOLGALTATO KFT', 0.048], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L.', 0.022], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. CENTRE DE PRODUCTION DE SEMOY MERCK S.L.', 0.073], ['MERCK HEALTHCARE KGAA MERCK SANTÉ S.A.S MERCK S.L.', 0.073], ['SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.029], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.029], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.05], ['BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLAND SP. Z O.O.', 0.067], ['BLUEFISH PHARMACEUTICALS AB', 0.04], ['BERLIN-CHEMIE AG MENARINI-VON HEYDEN GMBH', 0.052], ['BERLIN-CHEMIE AG', 0.055], ['SYMPHAR SP. Z O.O.', 0.052], ['LEK D.D., PE PROIZODNJA LENDAVA LEK S.A.', 0.096]], 2.2113740299823634), 'Acidum valproicum': ([['G.L. PHARMA GMBH', 0.5], ['G.L. PHARMA GMBH G.L. PHARMA GMBH', 0.5]], 0.5461333333333332), 'Moclobemidum': ([['MEDA PHARMA GMBH & CO. KG MYLAN HUNGARY KFT.', 0.333], ['BAUSCH HEALTH POLAND SP. Z O.O. PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.333], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.333]], 1.1470000000000002), 'Candesartanum cilexetili': ([[nan, 0.142], ['ZENTIVA, A.S. ZENTIVA, K.S.', 0.102], ['ORION CORPORATION ORION CORPORATION', 0.066], ['KRKA, D.D., NOVO MESTO', 0.093], ['BASICS GMBH CEMELOG BRF KFT RANBAXY PHARMACIE GENERIGUES SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.066], ['CEMELOG BRF KFT RANBAXY PHARMACIE GENERIGUES SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.066], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.093], ['ADAMED PHARMA S.A. ADAMED PHARMA S.A.', 0.066], ['ZENTIVA, K.S.', 0.102], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.102], ['DELORBIS PHARMACEUTICALS LTD. HBM PHARMA S.R.O. S.C. ZENTIVA S.A.', 0.102]], 6.106473462301587), 'Cilazaprilum': ([['KRKA, D.D., NOVO MESTO', 0.492], ['POLFARMEX S.A.', 0.508]], 0.23470238095238094), 'Insulinum lisprum zinci protaminati injectio': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 0.5], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 0.5]], 38.711999999999996), 'Ivabradinum': ([[nan, 0.127], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LABORATORIOS SERVIER, S.L. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 0.131], ['LABORATORIOS LICONSA S.A.', 0.104], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.131], ['PHARMATHEN FARMAKEFTIKI S.A. PHARMATHEN INTERNATIONAL S.A.', 0.131], ['DELORBIS PHARMACEUTICALS LTD. HBM PHARMA S.R.O.', 0.131], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.12], ['GEDEON RICHTER ROMANIA S.A.', 0.126]], 12.083750000000002), 'Allopurinolum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 0.18], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.396], ['EGIS PHARMACEUTICALS PLC', 0.424]], 0.6230666666666667), 'Pramipexolum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 1.0]], 1.6667738095238096), 'Tiotropii bromidum monohydricum': ([['BOEHRINGER INGELHEIM ESPANA S.A. BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.962], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.038]], 75.91183333333332), 'Gabapentinum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.125], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.366], [nan, 0.14], ['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.369]], 3.090233333333333), 'Insulina ludzka rekombinowana': ([['BIOTON S.A.', 1.0]], 18.568), 'Perindoprilum argininum': ([['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 1.0]], 0.1590000000000001), 'Desmopressinum': ([['FERRING GMBH', 1.0]], 6.033944444444445), 'Levetiracetamum': ([['REMEDICA LTD', 0.001], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.003], ['REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.003], ['NEXTPHARMA SAS', 0.389], ['G.L. PHARMA GMBH', 0.004], ['WESSLING HUNGARY KFT.', 0.384], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.003], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.003], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.003], ['ZENTIVA, K.S.', 0.003], ['PHAROS MT LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.003], ['GLENMARK PHARMACEUTICALS S.R.O. PHAROS MT LTD REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.003], ['ADAMED PHARMA S.A. REMEDICA LTD', 0.195], ['ADAMED PHARMA S.A. PHAROS MT LTD REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.003]], 183.11753630952384), 'Lacidipinum': ([['BIOFARM SP. Z O.O.', 0.235], ['DELPHARM POZNAŃ S.A. GLAXO WELLCOME S.A.', 0.235], ['GLAXO WELLCOME S.A.', 0.235], [nan, 0.294]], 0.8591071428571427), 'Lovastatinum': ([['BIOFARM SP. Z O.O.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.185), 'Furaginum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 0.09033333333333333), 'Hydrocortisoni acetas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 1.0]], 3.7800000000000002), 'Paroxetini hydrochloridum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.318], ['GEDEON RICHTER PLC.', 0.341], ['ACTAVIS EHF. ACTAVIS LTD. ACTAVIS NORDIC A/S BALKANPHARMA-DUPNITSA AD', 0.341]], 0.966), 'Perazinum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.639], ['LABOR PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE SP. Z O.O.', 0.361]], 0.7150416666666667), 'Tropicamidum': ([['JADRAN-GALENSKI LABORATORIJ D.D.', 1.0]], 1.1584999999999999), 'Salbutamoli sulfas': ([['ORION CORPORATION', 0.004], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.496], ['GLAXO WELLCOME PRODUCTION GLAXO WELLCOME S.A.', 0.5]], 14.82825), 'Solifenacini succinas': ([['ADAMED PHARMA S.A. S.C. ZENTIVA S.A.', 0.075], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.075], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.074], ['BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.059], ['ALKALOIDA CHEMICAL CO. ZRT. S.C. TERAPIA S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.073], ['SANECA PHARMACEUTICALS A.S.', 0.1], ['AFLOFARM FARMACJA POLSKA SP. Z O.O. GENEPHARM S.A.', 0.1], ['GENERICON PHARMA GESELLSCHAFT M.B.H. S.C. ZENTIVA S.A.', 0.075], ['LABORATORIOS LESVI S.L.', 0.074], ['ORION CORPORATION ORION CORPORATION', 0.075], ['G.L. PHARMA GMBH PRO.MED.CS. PRAHA A.S.', 0.075], ['S.C. ZENTIVA S.A.', 0.075], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.071]], 8.251594444444445), 'Pantoprazolum natricum sesquihydricum -': ([[nan, 1.0]], 0.10794642857142858), 'Rosuvastatinum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.154], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.151], [nan, 0.153], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.136], ['ADAMED PHARMA S.A. BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.136], ['ELPEN PHARMACEUTICAL CO.INC.', 0.136], ['ADAMED PHARMA S.A. LEK PHARMACEUTICALS D.D.', 0.136]], 2.446257936507936), 'Sitagliptinum': ([['MERCK SHARP & DOHME B.V.', 0.095], ['GEDEON RICHTER PLC. GEDEON RICHTER ROMANIA S.A.', 0.084], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.084], ['PHARMACARE PREMIUM LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA SA', 0.084], ['LEK PHARMACEUTICALS D.D. LEK S.A.', 0.126], ['ADAMED PHARMA S.A.', 0.095], ['LABORATORIOS LICONSA S.A.', 0.126], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.095], ['GALENICUM HEALTH, S.L. SAG MANUFACTURING S.L.U.', 0.063], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.084], ['PHARMADOX HEALTHCARE LTD. SYMPHAR SP. Z O.O.', 0.063]], 6.0849126984126976), 'Vildagliptinum': ([['ADIPHARM EAD COMBINO PHARM (MALTA) LTD GENEPHARM S.A. VIPHARM S.A.', 0.143], ['LEK D.D. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.143], ['PHARMADOX HEALTHCARE LTD. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.143], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.143], ['STADA ARZNEIMITTEL AG', 0.143], [nan, 0.143], ['ADIPHARM EAD GENEPHARM S.A.', 0.143]], 2.6908095238095235), 'Miconazoli nitras': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.9013333333333334), 'Atropini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 2.722), 'Rivastigminum': ([['LUYE PHARMA AG ZENTIVA SA', 0.232], [nan, 0.312], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.3], ['ADAMED PHARMA S.A.', 0.156]], 2.256454365079365), 'Dihydrocodeini tartras': ([['FIDELIO HEALTHCARE LIMBURG GMBH', 1.0]], 0.7771666666666668), 'Beclometasoni dipropionas anhydricus (': ([['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI SAS', 1.0]], 136.18), 'Amiodaroni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.4348333333333334), 'Perazini dimaleas': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.24038333333333334), 'Mebendazolum': ([[nan, 0.425], ['GEDEON RICHTER PLC.', 0.575]], 2.6616666666666666), 'Naproxenum natricum': ([['ADAMED PHARMA S.A.', 0.429], ['KRKA, D.D., NOVO MESTO', 0.571]], 0.49175), 'Cefuroximum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.002], [nan, 0.03], ['ALKALOIDA CHEMICAL CO. ZRT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.016], ['RANBAXY LABORATORIES LTD. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.477], ['KRKA, D.D., NOVO MESTO', 0.031], ['SANDOZ GMBH', 0.025], ['PENCEF PHARMA GMBH SANDOZ GMBH', 0.025], ['ARISTO PHARMA GMBH MERCKLE GMBH TEVA OPERATIONS POLAND SP. Z O.O.', 0.025], ['ARISTO PHARMA GMBH MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.025], ['GLAXOSMITHKLINE TRADING SERVICES LIMITED LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.)', 0.319], ['POLFARMEX S.A.', 0.024]], 55.1807318802521), 'Piribedilum': ([['LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 1.0]], 0.5486666666666667), 'Acenocoumarolum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.15733333333333335), 'Morphini hydrochloridum': ([['G.L. PHARMA GMBH', 1.0]], 1.575), 'Adrenalinum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 28.49), 'Atorvastatinum calcicum': ([['BIOFARM SP. Z O.O.', 0.036], ['APL SWIFT SERVICES (MALTA) LTD.', 0.055], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O., DPC JASTREBARSKO', 0.143], ['KRKA, D.D., NOVO MESTO', 0.143], ['LOGITERS, LOGISTICA, PORTUGAL, S.A. MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.071], ['PHARMACHEMIE B.V. SYNOPTIS INDUSTRIAL SP. Z O.O. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY TEVA PHARMACEUTICAL WORKS PVT. LTD. TEVA SANTE SA', 0.083], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.19], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.089], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.19]], 4.375703703703705), 'Ropinirolum': ([['KRKA, D.D., NOVO MESTO MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.134], ['KRKA, D.D., NOVO MESTO TEVA OPERATIONS POLSKA SP. Z O.O.', 0.134], ['ORION CORPORATION ORION CORPORATION PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.14], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.14], ['GLAXO WELLCOME S.A.', 0.14], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.15], [nan, 0.162]], 12.214196428571428), 'Salmeterolum + Fluticasoni propionas': ([['ORION CORPORATION', 1.0]], 82.955), 'Levothyroxine sodium': ([['ARISTO PHARMA GMBH LINDOPHARM GMBH', 1.0]], 0.060050000000000006), 'Dorzolamidi hydrochloridum': ([['RAFARM S.A.', 0.199], [nan, 0.248], ['EXCELVISION PHARMATHEN S.A.', 0.13], ['FAMAR S.A., PLANT A PHARMATHEN S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.293], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. FAMAR S.A. PHARMATHEN S.A.', 0.13]], 76.16466666666666), 'Phenobarbitalum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.5]], 0.7420000000000001), 'Phenoxymethylpenicillinum kalicum': ([['SANDOZ GMBH', 1.0]], 1.0400416666666668), 'Clindamycini phosphas': ([['LEK PHARMACEUTICALS D.D.', 1.0]], 6.086), 'Penicillaminum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 2.590333333333333), 'Semaglutidum': ([['NOVO NORDISK A/S', 1.0]], 275.86), 'Triptorelini acetas': ([['IPSEN PHARMA BIOTECH SAS', 0.877], ['FERRING GMBH', 0.123]], 196.92142857142855), 'Cyproteroni acetas': ([['BAYER WEIMAR GMBH UND CO. KG', 0.628], ['MIBE GMBH ARZNEIMITTEL', 0.124], ['BAYER AG BAYER PHARMA AG', 0.124], ['SYMPHAR SP. Z O.O.', 0.124]], 2.04395873015873), 'Dinatrii pamidronas': ([['VIPHARM S.A.', 1.0]], 205.9333333333333), 'Estradiolum (zmikronizowany)': ([['AESICA PHARMACEUTICALS GMBH', 1.0]], 2.04625), 'Levodopum': ([[nan, 0.607], ['LEK PHARMACEUTICALS D.D.', 0.393]], 1.58125), 'Lacosamidum': ([['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O. LABORATORI FUNDACIÓ DAU', 0.235], ['COMBINO PHARM (MALTA) LTD GALENICA PHARMACEUTICAL INDUSTRY S.A. GLENMARK PHARMACEUTICALS S.R.O. SVUS PHARMA A.S.', 0.23], ['MERCKLE GMBH TEVA GYOGYSZERGYAR ZRT. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.23], ['DELORBIS PHARMACEUTICALS LTD. G.L. PHARMA GMBH', 0.22], ['AESICA PHARMACEUTICALS GMBH UCB PHARMA S.A.', 0.084]], 7.503200892857143), 'Acidum ursodeoxycholicum': ([['POLFARMEX S.A.', 0.312], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.375], ['AS GRINDEKS', 0.312]], 1.8688000000000002), 'Roxithromycinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.4414999999999999), 'Propafenoni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.2725), 'Formoteroli fumaras dihydricus': ([['ASTRAZENECA DUNKERQUE PRODUCTION', 1.0]], 143.69), 'Finerenonum': ([['BAYER AG', 1.0]], 7.185714285714285), 'Midazolamu chlorowodorek': ([['LABORATORIOS LICONSA S.A.', 1.0]], 67.8675), 'Sulfasalazinum (w postaci mieszaniny z powidonem)': ([['RECIPHARM, UPPSALA AB', 1.0]], 0.453525), 'Inhibitor C': ([['CSL BEHRING GMBH', 1.0]], 2303.74), 'Olanzapiny dichlorowodorek trójwodny': ([['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 1.0]], 2.2617410714285713), 'Amlodipinum': ([[nan, 0.103], ['KRKA, D.D., NOVO MESTO', 0.081], ['BLUEFISH PHARMACEUTICALS AB', 0.065], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.067], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. ROWA PHARMACEUTICALS LTD. SALUTAS PHARMA GMBH', 0.091], ['EGIS PHARMACEUTICALS PLC', 0.064], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.073], ['BALKANPHARMA - DUPNITSA AD POLFARMEX S.A.', 0.134], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH SALUTAS PHARMA', 0.161], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.161]], 3.324638888888889), 'Aripiprazolum': ([['ELAIAPHARM ZAMBON S.P.A.', 0.004], ['ELAIAPHARM H. LUNDBECK A/S', 0.946], ['PHARMADOX HEALTHCARE, LTD. ', 0.003], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.004], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.004], ['GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.004], ['GE PHARMACEUTICALS LTD G.L. PHARMA GMBH', 0.003], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.004], ['GENERICON PHARMA GESELLSCHAFT M.B.H. SYNTHON HISPANIA S.L. SYNTHON S.R.O.', 0.004], ['BETAPHARM ARZNEIMITTEL GMBH SYNTHON HISPANIA S.L. SYNTHON S.R.O.', 0.004], ['ORION CORPORATION ORION CORPORATION, ORION PHARMA', 0.003], ['LEK PHARMACEUTICALS D.D. LEK S.A. S.C. SANDOZ S.R.L.', 0.003], ['LABORATORIOS LESVI S.L.', 0.003], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.004], ['VIPHARM S.A.', 0.003], ['EGIS PHARMACEUTICALS PLC', 0.004]], 988.8158043320107), 'Loperamidi hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.134), 'Ondansetronum': ([['BLUEFISH PHARMACEUTICALS AB SOFARIMEX INDUSTRIA QUIMICA E FARMACEUTICA S.A.', 0.394], ['ASPEN BAD OLDESLOE GMBH NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.606]], 6.9515), 'Amisulpridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.11], ['PRO.MED.CS PRAHA A.S.', 0.188], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON', 0.188], ['DELPHARM DIJON', 0.19], [nan, 0.183], ['MEDOCHEMIE LTD.', 0.142]], 19.567888888888888), 'Natrii valproas': ([['SANOFI AVENTIS S.A. SANOFI WINTHROP INDUSTRIE', 0.144], [nan, 0.174], ['SANOFI WINTHROP INDUSTRIE', 0.192], ['ORION CORPORATION ORION CORPORATION', 0.139], ['G.L. PHARMA GMBH', 0.344], ['UNITHER LIQUID MANUFACTURING', 0.008]], 3.986166666666668), 'Tiotropium bromide monohydrate': ([['BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 2.9018333333333333), 'Quetiapinum': ([['GENEPHARM S.A.', 0.092], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.134], ['EGIS PHARMACEUTICALS PLC PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.103], ['ORION CORPORATION ORION PHARMA ORION CORPORATION ORION PHARMA', 0.073], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.073], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A. SALUTAS PHARMA GMBH', 0.188], ['KRKA, D.D., NOVO MESTO KRKA-FARMA D.O.O.', 0.072], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.1], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.072], ['ACTAVIS LTD.', 0.094]], 15.054486111111109), 'Bromocriptini mesylas': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.52), 'Amoxicillinum trihydricum': ([['KRKA, D.D., NOVO MESTO', 0.301], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.699]], 1.2882142857142858), 'Degarelix': ([['FERRING GMBH', 1.0]], 682.98), 'Umeclidini bromidum': ([['GLAXO WELLCOME PRODUCTION', 1.0]], 94.02000000000001), 'Formoteroli fumaras': ([['CHIESI PHARMACEUTICALS GMBH CHIESI PHARMACEUTICI S.P.A. CHIESI SAS', 0.21], ['NOVARTIS PHARMA GMBH NOVARTIS PHARMACEUTICA SA', 0.003], ['ADAMED PHARMA S.A.', 0.003], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH', 0.21], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. SMB TECHNOLOGY S.A.', 0.003], ['ORION CORPORATION', 0.418], ['ASTRAZENECA AB', 0.147], ['SMB TECHNOLOGY S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.003]], 262.9897129629629), 'Doxazosinum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.182], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SANDOZ A/S SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.182], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.233], ['TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.233], ['KRKA, D.D., NOVO MESTO', 0.169]], 2.1033055555555555), 'Acidum undecylenicum': ([['PRO.MED.CS PRAHA A.S.', 1.0]], 0.584), 'Bimatoprost': ([['S.C. ROMPHARM COMPANY S.R.L. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['ALLERGAN PHARMACEUTICALS IRELAND', 0.199], ['EXCELVISION PHARMATHEN S.A.', 0.2], ['ADAMED PHARMA S.A. S.C. ROMPHARM COMPANY S.R.L.', 0.2], ['RAFARM S.A.', 0.2]], 164.57), 'Voriconazolum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.498], ['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O. PHARMADOX HEALTHCARE LTD.', 0.502]], 13.535333333333334), 'Pilocarpini hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 1.347), 'Dexamethasonum': ([['CYNDEA PHARMA S.L. FORMULA PHARMAZEUTISCHE UND CHEMISCHE ENTWICKLUNGS GMBH', 0.074], [nan, 0.235], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.5], ['ADAMED PHARMA S.A.', 0.192]], 23.311425), 'Selegilini hydrochloridum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.2766), 'Insulinum humanum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.249], ['BIOTON S.A.', 0.249], ['NOVO NORDISK A/S', 0.249], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.252]], 74.464), 'Tolterodini tartras': ([['MERCKLE GMBH PHARMACARE PREMIUM LTD. PHARMACHEMIE B.V. PHARMADOX HEALTHCARE, LTD.  PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.267], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.2], ['PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.267], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.267]], 1.5439841269841268), 'Rifampicinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 2.3798500000000002), 'Ipatropii bromidum momonydricum': ([['GLENMARK PHARMACEUTICALS S.R.O.', 1.0]], 16.290000000000003), 'Fenofibratum': ([['BIOFARM SP. Z O.O. LABORATOIRES BTT', 0.141], ['BIOFARM SP. Z O.O.', 0.141], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. SMB TECHNOLOGY S.A.', 0.141], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.135], [\"ASTREA FONTAINE DELPHARM L'AIGLE FAMAR L'AIGLE\", 0.161], ['ASTREA FONTAINE FAMAR L’AIGLE', 0.141], [\"ASTREA FONTAINE DELPHARM L'AIGLE\", 0.141]], 3.6769444444444446), 'Candesartanum cilexetilum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.375], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.625]], 1.4266666666666667), 'Pantoprazolum': ([['ADAMED PHARMA S.A.', 0.078], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.076], ['DELPHARM NOVARA S.R.L. NYCOMED GMBH', 0.103], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ S.R.L.', 0.078], ['EGIS PHARMACEUTICALS PLC PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.078], ['KRKA, D.D., NOVO MESTO', 0.078], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.078], [nan, 0.097], ['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE ROTTENDORF PHARMA GMBH SC ZENTIVA SA', 0.078], ['TEVA PHARMA, S.L.U.', 0.078], ['ACTAVIS DEUTSCHLAND GMBH & CO. KG ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.103], ['FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. LACHIFARMA S.R.L. LAMP SAN PROSPERO S.P.A SOFARIMEX INDUSTRIA QUIMICA E FARMACEUTICA S.A.', 0.078]], 2.1468333333333334), 'Ciclesonidum': ([[nan, 1.0]], 100.195), 'Paroxetini hydrochloridum (semihydricum)': ([['ORION CORPORATION, ORION PHARMA', 1.0]], 0.3216666666666666), 'Doxycyclinum': ([['POLFARMEX S.A.', 0.5], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.5]], 1.084), 'Silodosinum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.492], ['LABIRATOIRES BOUCHARA-RECORDATI RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A', 0.508]], 0.6626666666666667), 'Rosuvastatinum calicum': ([['ADAMED PHARMA S.A.', 0.117], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.128], ['BIOFARM SP. Z O.O.', 0.118], ['KRKA, D.D., NOVO MESTO', 0.125], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.112], ['ADAMED SP. Z O.O. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁAD FARMACEUTYCZNY ADAMED PHARMA S.A.', 0.142], ['GEDEON RICHTER PLC.', 0.145], ['ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS D.D.', 0.112]], 3.140517096560847), 'Levomepromazini maleas': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.2394), 'Chlorprothixeni hydrochloridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZENTIVA, K.S.', 0.5]], 0.39590000000000003), 'Rosuvastatin calcium': ([['LABORATORIOS LICONSA S.A.', 1.0]], 0.29410714285714284), 'Insulinum glulisinum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 1.0]], 34.234), 'Salbutamolum': ([['LABORATORIO ALDO-UNION S.A.', 1.0]], 7.410000000000001), 'Megestroli acetas': ([['POLFARMEX S.A.', 0.25], ['BAUSCH HEALTH POLAND SP. Z O.O.', 0.25], ['VIPHARM S.A.', 0.25], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.25]], 2.212833333333333), 'Dapagliflozinum': ([['ASTRAZENECA AB ASTRAZENECA UK LTD.', 1.0]], 3.7353333333333336), 'Dutasteridum': ([['ADAMED PHARMA S.A. GENERICON PHARMA GESELLSCHAFT M.B.H. LABORATORIOS LEON FARMA, S.A.', 0.263], ['CYNDEA PHARMA S.L. GALENICUM HEALTH, S.L.U. PHARMADOX HEALTHCARE LTD. SAG MANUFACTURING, S.L.U.', 0.236], ['APL SWIFT SERVICES (MALTA) LTD.', 0.223], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACÊUTICA, S.A.,', 0.278]], 2.3721666666666668), 'Oxycodoni hydrochloridum': ([[nan, 0.156], ['FIDELIO HEALTHCARE LIMBURG GMBH MUNDIPHARMA DC B.V.', 0.158], ['G.L. PHARMA GMBH', 0.153], ['BALKANPHARMA-DUPNITSA AD', 0.128], ['DEVELCO PHARMA GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.202], ['DEVELCO PHARMA GMBH PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.202]], 13.735918518518519), 'Lanreotidi acetas': ([['IPSEN PHARMA BIOTECH SAS', 1.0]], 5209.405), 'Febuxostatum': ([['MENARINI-VON HEYDEN GMBH PATHEON FRANCE S.A.', 0.205], ['PHAROS MT LTD PHAROS MT LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.205], ['RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.205], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.205], ['HEUMANN PHARMA GMBH & CO. GENERICA KG PHARMADOX HEALTHCARE LTD. PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.179]], 2.813928571428571), 'Metoprololi tartras': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.377], ['MEDIS INTERNATIONAL A.S.', 0.623]], 0.2925), 'Prednisonum': ([['ADAMED PHARMA S.A.', 1.0]], 0.6162562499999998), 'Tolterodini hydrogenotartras': ([['ZENTIVA, K.S.', 1.0]], 0.2057142857142857), 'Morphini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.077], ['FIDELIO HEALTHCARE LIMBURG GMBH', 0.05], ['L. MOLTENI & C. DEI F.LLI ALITTI SOCIETÀ DI ESERCIZIO SPA', 0.872]], 23.003333333333334), 'Acidum valproicum + Natrii valproas': ([['HEXAL A/S LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 1.0]], 0.5578333333333334), 'Brivaracetamum': ([['UCB PHARMA S.A.', 1.0]], 6.400535714285715), 'Valsartanum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.032], ['POLFARMEX S.A.', 0.035], ['MERCKLE GMBH PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.038], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH', 0.047], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH', 0.058], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH', 0.058], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.058], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.041], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.059], [nan, 0.047], ['LABORATORIOS CINFA, S.A. LABORATORIOS LICONSA, S.A. ZENTIVA, K.S.', 0.03], ['ZENTIVA, K.S.', 0.035], ['CELON PHARMA S.A.', 0.035], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.038], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.038], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.038], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.038], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.058], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.058], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.058], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.059], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD EGIS PHARMACEUTICALS PLC', 0.041]], 11.402839332955406), 'Biperideni hydrochloridum': ([['LABORATORIO FARMACEUTICO S.I.T. SRL', 0.667], [nan, 0.333]], 0.5945333333333334)}\n",
      "--------------------------------------\n",
      "Monopolists: 207\n",
      "Podmiot odpowiedzialny: nan, Liczba wygranych: 18\n",
      "Podmiot odpowiedzialny: BIOFARM SP. Z O.O., Liczba wygranych: 6\n",
      "Podmiot odpowiedzialny: PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A., Liczba wygranych: 6\n",
      "Podmiot odpowiedzialny: MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O., Liczba wygranych: 5\n",
      "Podmiot odpowiedzialny: GEDEON RICHTER PLC., Liczba wygranych: 5\n"
     ]
    }
   ],
   "source": [
    "entity_nodes_g_avg_producer = {n for n, d in g_avg_producer.nodes(data=True) if d['bipartite'] == 1}\n",
    "substance_nodes_g_avg_producer = {n for n, d in g_avg_producer.nodes(data=True) if d['bipartite'] == 0}\n",
    "\n",
    "entity_share = network_util.get_entity_share(g_avg_producer, substance_nodes_g_avg_producer)\n",
    "print(entity_share)\n",
    "print(\"--------------------------------------\")\n",
    "\n",
    "favored_producers, n_monopolists = network_util.get_favored_producer(entity_share)\n",
    "print(f\"Monopolists: {n_monopolists}\")\n",
    "for elem in sorted(list(favored_producers.items()), key=lambda x : x[1], reverse=True)[:5]:\n",
    "    print(f\"Podmiot odpowiedzialny: {elem[0]}, Liczba wygranych: {elem[1]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Quinaprilum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.212), 'Travoprostum + Timololum': ([['MEDICAL VALLEY INVEST AB', 1.0]], 28.97), 'Insulinum glarginum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.247], ['SANOFI WINTHROP INDUSTRIE', 0.753]], 109.85249999999999), 'Pyridostigmini bromidum': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 0.6540666666666667), 'Cenobamate': ([['ANGELINI PHARMA S.P.A.', 1.0]], 17.5725), 'Ergotamini tartras': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.156), 'Fentanylu cytrynian -': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 1.0]], 15.229642857142858), 'Cefaclorum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 0.9919523809523808), 'Anastrozolum': ([['BLUEFISH PHARMACEUTICALS AB', 0.126], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.127], ['EUGIA PHARMA (MALTA) LTD.', 0.118], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.127], ['LABORATOIRES JUVISE PHARMACEUTICALS', 0.127], ['VIPHARM S.A.', 0.127], ['EGIS PHARMACEUTICALS PLC', 0.127], ['DELFARMA SP. Z O.O.', 0.119]], 14.83045238095238), 'Azytromycyna dwuwodna': ([['SANDOZ GMBH', 1.0]], 7.696666666666665), 'Pancreatinum': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 1.2598), 'Furaginum (': ([['ADAMED PHARMA S.A.', 1.0]], 0.09033333333333333), 'Paliperidonum': ([['EGIS PHARMACEUTICALS PLC', 0.223], ['ADAMED PHARMA S.A.', 0.193], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.223], ['JANSSEN-CILAG INTERNATIONAL N.V.', 0.362]], 2366.376666666667), 'Tetrabenazinum': ([['AOP ORPHAN PHARMACEUTICALS GMBH', 1.0]], 3.846964285714286), 'Enalaprili maleas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.09269444444444445), 'Chloroquini phosphas': ([['ADAMED PHARMA S.A.', 1.0]], 0.471), 'Dienogestum': ([['SUN-FARM SP. Z O.O.', 0.111], ['ARISTO PHARMA SP. Z O.O.', 0.111], ['INPHARM SP. Z O.O.', 0.111], ['DELFARMA SP. Z O.O.', 0.111], ['EXELTIS POLAND SP. Z O.O.', 0.111], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.111], ['SYMPHAR SP. Z O.O.', 0.111], ['BAYER AG', 0.111], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.111]], 10.681607142857143), 'Amantadini hydrochloridum': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.29540000000000005), 'Enoxaparinum natricum': ([['SANOFI WINTHROP INDUSTRIE', 0.5], ['SCIENCEPHARMA SP. Z O.O.', 0.5]], 27.018857142857144), 'Clopidogrelum hydrosulfas': ([['ACTAVIS GROUP PTC EHF.', 0.198], ['ADAMED PHARMA S.A.', 0.202], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.202], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.197], ['SANDOZ GMBH', 0.202]], 3.263571428571429), 'Lansoprazolum': ([['KRKA, D.D., NOVO MESTO', 0.5], ['EXELTIS POLAND SP. Z O.O.', 0.5]], 0.33285714285714285), 'Posaconazolum': ([['GLENMARK PHARMACEUTICALS S.R.O.', 0.249], ['MYLAN IRELAND LIMITED', 0.253], ['STADA ARZNEIMITTEL AG', 0.25], ['TEVA B.V.', 0.249]], 26.844285714285714), 'Glyceroli trinitras': ([['PROTERAPIA SP. Z O.O.', 0.897], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.103]], 1.5073939393939393), 'Dornasum alfa': ([['ROCHE POLSKA SP. Z O.O.', 1.0]], 81.79566666666668), 'Beclometasoni dipropionas': ([['CHIESI FARMACEUTICI S.P.A.', 0.535], ['ZENTIVA, K.S.', 0.465]], 184.5775), 'Calcipotriolum': ([['ARISTO PHARMA SP. Z O.O.', 0.294], ['LEO PHARMA A/S', 0.007], ['BAUSCH HEALTH IRELAND LTD.', 0.293], ['SUN-FARM SP. Z O.O.', 0.407]], 181.792), 'Tamoxifeni citras': ([['SANDOZ GMBH', 0.434], ['EGIS PHARMACEUTICALS PLC', 0.566]], 1.193), 'Ropiniroli hydrochloridum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.144], ['VIPHARM S.A.', 0.144], ['ADAMED PHARMA S.A.', 0.144], ['BAUSCH HEALTH IRELAND LTD.', 0.144], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.155], ['KRKA, D.D., NOVO MESTO', 0.124], ['EGIS PHARMACEUTICALS PLC', 0.144]], 11.830595238095238), 'Ethambutoli dihydrochloridum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 0.44612), 'Donepezili hydrochloridum monohydricum': ([['BIOFARM SP. Z O.O.', 0.103], ['ACTAVIS GROUP PTC EHF.', 0.105], ['BAUSCH HEALTH IRELAND LTD.', 0.139], ['PHARMASWISS ČESKÁ REPUBLIKA S.R.O.', 0.14], ['CELON PHARMA S.A.', 0.105], ['BLUEFISH PHARMACEUTICALS AB', 0.096], ['VIPHARM S.A.', 0.105], ['ADAMED PHARMA S.A.', 0.105], ['KRKA, D.D., NOVO MESTO', 0.105]], 6.729744047619048), 'Pyrazinamidum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE FARMAPOL SP. Z O.O.', 1.0]], 0.63844), 'Fentanyli citras': ([['ANGELINI PHARMA POLSKA SP. Z O.O.', 1.0]], 20.184666666666665), 'Buprenorphinum': ([['G.L. PHARMA GMBH', 0.5], ['GRUENENTHAL GMBH', 0.5]], 32.02066666666667), 'Omeprazolum': ([['EXELTIS POLAND SP. Z O.O.', 0.023], ['BIOFARM SP. Z O.O.', 0.034], ['TEVA B.V.', 0.024], ['S-LAB SP. Z O.O.', 0.024], ['ZENTIVA, K.S.', 0.036], ['VIATRIS LTD', 0.026], ['SYNOPTIS PHARMA SP. Z O.O.', 0.038], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.036], ['ADAMED PHARMA S.A.', 0.024], ['MERCAPHARM SP. Z O.O.', 0.024], ['RECORDATI IRELAND LIMITED', 0.674], ['KRKA, D.D., NOVO MESTO', 0.036]], 9.215720238095239), 'Dabigatranu eteksylan w postaci mezylanu': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 1.501851851851852), 'Duloxetini hydrochloridum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.373], ['PHARMA ARZNEIMITTEL GMBH', 0.371], ['SYMPHAR SP. Z O.O.', 0.257]], 1.4552261904761905), 'Ezetimibum': ([['S-LAB SP. Z O.O.', 0.1], ['RANBAXY (POLAND) SP. Z O.O.', 0.096], ['ADAMED PHARMA S.A.', 0.101], ['ZENTIVA, K.S.', 0.101], ['SYNOPTIS PHARMA SP. Z O.O.', 0.1], ['KRKA, D.D., NOVO MESTO', 0.1], ['ORION CORPORATION', 0.1], ['EGIS PHARMACEUTICALS PLC', 0.1], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.1], ['SANDOZ GMBH', 0.1]], 3.304162698412698), 'Acebutololi hydrochloridum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.11), 'Spironolactonum': ([['ORION CORPORATION', 0.371], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.465], ['GEDEON RICHTER PLC.', 0.165]], 0.8498416666666667), 'Haloperidoli decanoas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 7.22), 'Acidum zoledronicum': ([['EGIS PHARMACEUTICALS PLC', 0.255], ['ACTAVIS GROUP PTC EHF.', 0.245], ['NORIDEM ENTERPRISES LTD.', 0.246], ['VIPHARM S.A.', 0.255]], 416.105), 'Methylprednisoloni acetas': ([['PFIZER EUROPE MA EEIG', 1.0]], 7.61), 'Esomeprazolum magnesicum': ([['KRKA, D.D., NOVO MESTO', 0.332], ['ZENTIVA, K.S.', 0.334], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.333]], 0.6607093253968254), 'Vortioxetini hydrobromidum': ([['H. LUNDBECK A/S', 1.0]], 1.659732142857143), 'Clarithromycinum': ([['KRKA, D.D., NOVO MESTO', 0.036], ['RANBAXY (POLAND) SP. Z O.O.', 0.821], ['MYLAN HEALTHCARE SP. Z O.O.', 0.039], ['BAUSCH HEALTH IRELAND LTD.', 0.052], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.052]], 20.36785714285714), 'Fentanylum': ([['JANSSEN-CILAG INTERNATIONAL N.V.', 0.016], ['ACTAVIS GROUP PTC EHF.', 0.019], ['TAKEDA PHARMA A/S', 0.76], ['TAKEDA PHARMA SP. Z O.O.', 0.017], ['KYOWA KIRIN HOLDINGS B.V.', 0.188]], 843.6060833333333), 'Cefuroximum axetilum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.151], ['S-LAB SP. Z O.O.', 0.101], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.183], ['SYNOPTIS PHARMA SP. Z O.O.', 0.179], ['RANBAXY (POLAND) SP. Z O.O.', 0.185], ['SANDOZ GMBH', 0.201]], 9.102392857142858), 'Budesonidum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.006], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.142], ['ORION CORPORATION', 0.128], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.001], ['CHIESI FARMACEUTICI S.P.A.', 0.103], ['ADAMED PHARMA S.A.', 0.006], ['FERRING GMBH', 0.024], ['TILLOTTS PHARMA GMBH', 0.008], ['DR. FALK PHARMA GMBH', 0.042], ['NOVARTIS POLAND SP. Z O.O.', 0.001], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.006], ['ASTRAZENECA AB', 0.138], ['DELFARMA SP. Z O.O.', 0.007], ['INPHARM SP. Z O.O.', 0.007], ['SANDOZ GMBH', 0.19], ['TEVA PHARMA B.V.', 0.19]], 476.8458888888889), 'Buspironi hydrochloridum': ([['INPHARM SP. Z O.O.', 0.571], ['EGIS POLSKA SP. Z O.O.', 0.429]], 0.5647500000000001), 'Itraconazolum': ([['ARISTO PHARMA SP. Z O.O.', 0.343], ['JANSSEN-CILAG INTERNATIONAL N.V.', 0.303], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.354]], 4.265357142857143), 'Mercaptopurinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 1.0]], 1.7200000000000002), 'Perindoprili tosilas': ([['TEVA B.V.', 0.5], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.5]], 0.2383333333333333), 'Methotrexatum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.401], ['ACTAVIS GROUP PTC EHF.', 0.297], ['ORION CORPORATION', 0.002], ['EGIS PHARMACEUTICALS PLC', 0.3]], 140.15341666666666), 'Indapamidum': ([['POLFARMEX S.A.', 0.108], ['SYNOPTIS PHARMA SP. Z O.O.', 0.095], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.108], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.151], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.093], ['ORION CORPORATION', 0.108], ['KRKA, D.D., NOVO MESTO', 0.092], ['SYMPHAR SP. Z O.O.', 0.096], ['LES LABORATOIRES SERVIER', 0.108], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.04]], 1.9784166666666667), 'Nadroparinum calcicum': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 10.89225), 'Ganirelixum': ([['GEDEON RICHTER PLC.', 1.0]], 48.55), 'Methylphenidati hydrochloridum': ([['JANSSEN-CILAG INTERNATIONAL N.V.', 0.491], ['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.509]], 4.313416666666667), 'Acitretinum': ([['SUN-FARM SP. Z O.O.', 0.505], ['ACTAVIS GROUP PTC EHF.', 0.495]], 5.454350000000001), 'Ethinylestradiolum': ([['SUN-FARM SP. Z O.O.', 0.248], ['BAYER AG', 0.251], ['DELFARMA SP. Z O.O.', 0.251], ['GEDEON RICHTER PLC.', 0.251]], 1.0103174603174603), 'Methylprednisolonum': ([['PFIZER EUROPE MA EEIG', 0.984], ['SUN-FARM SP. Z O.O.', 0.016]], 30.576555555555554), 'Fludrocortisoni acetas': ([['ADAMED PHARMA S.A.', 1.0]], 0.5980000000000001), 'Hydrocortisonum': ([['SUN-FARM SP. Z O.O.', 1.0]], 0.22099999999999997), 'Perindoprilum': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.0793333333333333), 'Cholecalciferolum koncentrat olejowy (vit. D': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.663), 'Levonorgestrelum': ([['PFIZER EUROPE MA EEIG', 1.0]], 0.25333333333333335), 'Insulinum degludecum': ([['NOVO NORDISK A/S', 1.0]], 21.694), 'Tacrolimus': ([['ASTELLAS PHARMA EUROPE B.V.', 0.313], ['SANDOZ GMBH', 0.252], ['ASTELLAS PHARMA SP. Z O.O.', 0.435]], 26.015644444444444), 'Terbinafinum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.827857142857143), 'Medroxyprogesteroni acetas': ([['PFIZER EUROPE MA EEIG', 1.0]], 0.28500000000000003), 'Acarbosum': ([['POLFARMEX S.A.', 1.0]], 0.33166666666666667), 'Everolimusum': ([['NOVARTIS POLAND SP. Z O.O.', 1.0]], 14.800277777777778), 'Icatibanti acetas': ([['MEDICAL VALLEY INVEST AB', 1.0]], 2208.4100000000003), 'Acidum mycophenolicum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 1.0]], 1.158625), 'Buprenorphini hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.8780000000000001), 'Clobetasoli propionas': ([['DELFARMA SP. Z O.O.', 0.5], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.5]], 0.33319999999999994), 'Ipratropii bromidum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5], ['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 0.5]], 32.96), 'Nimesulidum': ([['ANGELINI PHARMA ČESKÁ REPUBLIKA S.R.O.', 0.5], ['LABORATORI GUIDOTTI S.P.A.', 0.5]], 0.6026666666666667), 'Diclofenacum natricum': ([['LABORATOIRES THEA', 0.253], ['RATIOPHARM GMBH', 0.05], ['SANDOZ GMBH', 0.131], ['BAUSCH HEALTH IRELAND LTD.', 0.029], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.229], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.039], ['KRKA, D.D., NOVO MESTO', 0.134], ['TEVA B.V.', 0.134]], 6.548500000000001), 'Denosumabum': ([['AMGEN EUROPE B.V.', 1.0]], 441.46), 'Methadoni hydrochloridum': ([['L.MOLTENI & C. DEI F.LII ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.74], ['L.MOLTENI & C. DEI F.LLI ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.26]], 0.2658), 'Natrii alendronas trihydricus': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 1.0]], 2.1675), 'Terbinafini hydrochloridum': ([['POLFARMEX S.A.', 0.5], ['ARISTO PHARMA SP. Z O.O.', 0.5]], 1.6557142857142857), 'Mometasoni furoas monohydricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5], ['ADAMED PHARMA S.A.', 0.5]], 15.0), 'Quetiapini fumaras': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.068], ['MYLAN IRELAND LIMITED', 0.068], ['PROTERAPIA SP. Z O.O.', 0.101], ['CELON PHARMA S.A.', 0.068], ['SANDOZ GMBH', 0.119], ['KRKA, D.D., NOVO MESTO', 0.144], ['ADAMED PHARMA S.A.', 0.144], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.068], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.101], ['SYMPHAR SP. Z O.O.', 0.118]], 10.725238888888889), 'Tiagabinum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 3.703466666666667), 'Finasteridum': ([['ADAMED PHARMA S.A.', 0.06], ['ACTAVIS GROUP PTC EHF.', 0.06], ['ORION CORPORATION', 0.06], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.06], ['DELFARMA SP. Z O.O.', 0.059], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.06], ['RANBAXY (POLAND) SP. Z O.O.', 0.06], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.06], ['BLUEFISH PHARMACEUTICALS AB', 0.045], ['KRKA, D.D., NOVO MESTO', 0.06], ['RECORDATI POLSKA SP. Z O.O.', 0.06], ['+PHARMA ARZNEIMITTEL GMBH', 0.06], ['ZENTIVA, K.S.', 0.06], ['ORGANON POLSKA SP. Z O.O.', 0.06], ['SYMPHAR SP. Z O.O.', 0.057], ['ARISTO PHARMA SP. Z O.O.', 0.06], ['GEDEON RICHTER PLC.', 0.06]], 13.04310978835979), 'Insulinum glargine': ([['ELI LILLY NEDERLAND B.V.', 1.0]], 21.694000000000003), 'Bimatoprostum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 32.935), 'Donepezili hydrochloridum': ([['DELFARMA SP. Z O.O.', 0.588], ['ORION CORPORATION', 0.412]], 1.5937500000000002), 'Leflunomidum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.178], ['BLUEFISH PHARMACEUTICALS AB', 0.176], ['MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.182], ['ORION CORPORATION', 0.218], ['SANDOZ GMBH', 0.245]], 15.197888888888889), 'Fenoksymetyolpenicylina potasowa': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 24.884999999999998), 'Corifollitropin alfa': ([['N.V. ORGANON', 1.0]], 1359.44), 'Levocetirizini dihydrochloridum -': ([['ADAMED PHARMA S.A.', 1.0]], 15.950000000000001), 'sól sodowa atorwastatyny': ([['BIOFARM SP. Z O.O.', 1.0]], 0.40235185185185185), 'Flutamidum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.515], ['EGIS PHARMACEUTICALS PLC', 0.485]], 1.4175111111111112), 'Triamcinolonum': ([['ADAMED PHARMA S.A.', 1.0]], 0.7729999999999999), 'Pojedyncze alergoidy pyłków roślin': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Betaxololi hydrochloridum': ([['IMMEDICA PHARMA AB', 1.0]], 0.7714999999999999), 'Ramiprilum': ([['DELFARMA SP. Z O.O.', 0.073], ['INPHARM SP. Z O.O.', 0.068], ['KRKA, D.D., NOVO MESTO', 0.048], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.083], ['ADAMED PHARMA S.A.', 0.111], ['SANDOZ GMBH', 0.113], ['MEDEZIN SP. Z O.O.', 0.064], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.105], ['RANBAXY (POLAND) SP. Z O.O.', 0.038], ['SYNOPTIS PHARMA SP. Z O.O.', 0.063], ['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.058], ['ACTAVIS GROUP PTC EHF.', 0.062], ['PROTERAPIA SP. Z O.O.', 0.113]], 2.677438416477702), 'Timololi maleas': ([['IMMEDICA PHARMA AB', 0.833], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.167]], 4.632), 'Felodipinum': ([['GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE', 1.0]], 0.3032142857142857), 'Amiloridi hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.1194), 'Phenytoinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.2076666666666667), 'Tapentadolum': ([['GRUENENTHAL GMBH', 1.0]], 5.054366666666667), 'Benazeprili hydrochloridum': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 0.13508928571428572), 'Amoxicillinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.029], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.027], ['SANDOZ GMBH', 0.031], ['INPHARM SP. Z O.O.', 0.035], ['DELFARMA SP. Z O.O.', 0.034], ['MYLAN IRELAND LIMITED', 0.025], ['VIATRIS LTD', 0.402], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.039], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.272], ['PHARMAVITAE SP. Z O.O. SP. K.', 0.035], ['KRKA, D.D., NOVO MESTO', 0.035], ['POLFARMEX S.A.', 0.036]], 29.5169119047619), 'Cetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.009], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.009], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.229], ['KRKA, D.D., NOVO MESTO', 0.009], ['VEDIM SP. Z O.O.', 0.009], ['INPHARM SP. Z O.O.', 0.361], ['DELFARMA SP. Z O.O.', 0.374]], 34.79600000000001), 'Estradioli valeras': ([['ORION CORPORATION', 0.545], ['DR. KADE PHARMAZEUTISCHE FABRIK GMBH', 0.455]], 0.891904761904762), 'Sulfamethoxazolum': ([['EUMEDICA PHARMACEUTICALS GMBH', 0.082], ['INPHARM SP. Z O.O.', 0.104], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.756], ['ADAMED PHARMA S.A.', 0.059]], 10.083583333333333), 'Travoprostum': ([['NOVARTIS EUROPHARM LIMITED', 0.249], ['SYNOPTIS PHARMA SP. Z O.O.', 0.249], ['BAUSCH+LOMB IRELAND LTD.', 0.251], ['ADAMED PHARMA S.A.', 0.252]], 116.49833333333333), 'Aprepitantum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.255], ['VIATRIS LTD', 0.255], ['SANDOZ GMBH', 0.255], ['STADA ARZNEIMITTEL AG', 0.236]], 101.70333333333335), 'Olodaterolum': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 48.577000000000005), 'Atorvastatinum calcicum trihydricum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.273], ['RANBAXY (POLAND) SP. Z O.O.', 0.417], ['SANDOZ GMBH', 0.31]], 1.2588750000000002), 'Simvastatinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.074], ['ACTAVIS GROUP PTC EHF.', 0.098], ['RATIOPHARM GMBH', 0.076], ['ZENTIVA, K.S.', 0.076], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.049], ['MYLAN IRELAND LIMITED', 0.098], ['SANDOZ GMBH', 0.076], ['BLUEFISH PHARMACEUTICALS AB', 0.076], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.076], ['KRKA, D.D., NOVO MESTO', 0.076], ['BAUSCH HEALTH IRELAND LTD.', 0.049], ['RECORDATI POLSKA SP. Z O.O.', 0.098], ['ORGANON POLSKA SP. Z O.O.', 0.076]], 2.119836507936508), 'Ziprasidonum': ([['KRKA, D.D., NOVO MESTO', 1.0]], 3.7164285714285716), 'Midazolamum': ([['LABORATORIOS LESVI, S.L.', 1.0]], 67.86749999999999), 'Losartanum kalicum': ([['BIOFARM SP. Z O.O.', 0.098], ['ORGANON POLSKA SP. Z O.O.', 0.147], ['KRKA, D.D., NOVO MESTO', 0.147], ['SYNOPTIS PHARMA SP. Z O.O.', 0.083], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.098], ['ZENTIVA, A.S.', 0.098], ['BAUSCH HEALTH IRELAND LTD.', 0.131], ['ADAMED PHARMA S.A.', 0.098], ['ZENTIVA, K.S.', 0.098]], 2.721937169312169), 'Fenofibratum (zmikronizowany)': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 0.44333333333333336), 'Ondansetroni hydrochloridum dihydricum': ([['EGIS PHARMACEUTICALS PLC', 0.366], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.366], ['SANDOZ GMBH', 0.268]], 11.508500000000002), 'Fluticasoni propionas': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.03], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.246], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.002], ['ADAMED PHARMA S.A.', 0.003], ['POLFARMEX S.A.', 0.359], ['CELON PHARMA S.A.', 0.361]], 216.75746527777778), 'Sertralinum': ([['BIOFARM SP. Z O.O.', 0.177], ['DELFARMA SP. Z O.O.', 0.185], ['KRKA, D.D., NOVO MESTO', 0.178], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.138], ['MYLAN IRELAND LIMITED', 0.155], ['+PHARMA ARZNEIMITTEL GMBH', 0.166]], 2.7821825396825397), 'Amoksycylina trójwodna': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.1118), 'Gliclazidum': ([['SYNOPTIS PHARMA SP. Z O.O.', 0.102], ['L.MOLTENI & C. DEI F.LLI ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.051], ['MYLAN IRELAND LIMITED', 0.136], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.068], ['BAUSCH HEALTH IRELAND LTD.', 0.068], ['KRKA, D.D., NOVO MESTO', 0.203], ['RANBAXY (POLAND) SP. Z O.O.', 0.136], ['SANDOZ GMBH', 0.136], ['SYMPHAR SP. Z O.O.', 0.102]], 1.630375), 'Azithromycinum': ([['KRKA, D.D., NOVO MESTO', 0.149], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.112], ['SYNOPTIS PHARMA SP. Z O.O.', 0.144], ['SANDOZ GMBH', 0.112], ['ZENTIVA, K.S.', 0.149], ['ADAMED PHARMA S.A.', 0.112], ['BAUSCH HEALTH IRELAND LTD.', 0.149], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.074]], 11.871666666666666), 'Diltiazemi hydrochloridum': ([['PFIZER EUROPE MA EEIG', 1.0]], 0.3144444444444444), 'Leuprorelini acetas': ([['RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A', 0.477], ['SANDOZ GMBH', 0.212], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.311]], 1747.4050000000002), 'Theophyllinum': ([['BIOFARM SP. Z O.O.', 0.51], ['PHARMAAND GMBH', 0.49]], 0.3514333333333334), 'Sirolimusum': ([['PFIZER EUROPE MA EEIG', 1.0]], 16.691333333333333), 'Paroxetinum': ([['VIPHARM S.A.', 0.286], ['MYLAN IRELAND LIMITED', 0.286], ['SANDOZ GMBH', 0.429]], 1.1524166666666666), 'Mometasoni furoas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.011], ['SUN-FARM SP. Z O.O.', 0.011], ['SANDOZ GMBH', 0.495], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.483]], 15.1457), 'Venlafaxinum': ([['KRKA, D.D., NOVO MESTO', 0.096], ['MEDEZIN SP. Z O.O.', 0.1], ['DELFARMA SP. Z O.O.', 0.09], ['INPHARM SP. Z O.O.', 0.09], ['ARISTO PHARMA SP. Z O.O.', 0.1], ['MYLAN IRELAND LIMITED', 0.043], ['ADAMED PHARMA S.A.', 0.101], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.098], ['SYMPHAR SP. Z O.O.', 0.08], ['PROTERAPIA SP. Z O.O.', 0.101], ['BAUSCH HEALTH IRELAND LTD.', 0.101]], 6.471420634920635), 'Pantoprazolum -': ([['ACTAVIS GROUP PTC EHF.', 1.0]], 0.11098214285714286), 'Melphalanum': ([['ASPEN PHARMA TRADING LTD.', 1.0]], 4.7976), 'Insulina ludzka biosyntetyczna wysokooczyszczona': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 18.744), 'Flupentixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.3898), 'Venlafaxini hydrochloridum': ([['UPJOHN EESV', 0.206], ['ACTAVIS GROUP PTC EHF.', 0.159], ['MYLAN IRELAND LIMITED', 0.18], ['ORION CORPORATION', 0.145], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.16], ['BLUEFISH PHARMACEUTICALS AB', 0.151]], 4.088212159863946), 'Amlodipini besilas': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.107], ['BAUSCH HEALTH IRELAND LTD.', 0.136], ['POLFARMEX S.A.', 0.153], ['ADAMED PHARMA S.A.', 0.216], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.149], ['SANDOZ GMBH', 0.238]], 1.8701666666666668), 'stiripentolum': ([['BIOCODEX', 1.0]], 18.41383333333333), 'Desloratadinum': ([['KRKA, D.D., NOVO MESTO', 0.119], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.114], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.119], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.101], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.116], ['ADAMED PHARMA S.A.', 0.089], ['INPHARM SP. Z O.O.', 0.112], ['DELFARMA SP. Z O.O.', 0.113], ['SANDOZ GMBH', 0.115]], 2.6318425925925926), 'Kalii chloridum': ([['GSK PSC POLAND SP. Z O.O.', 1.0]], 0.09266666666666666), 'Mianserini hydrochloridum': ([['ADAMED PHARMA S.A.', 0.307], ['PHARMASWISS ČESKÁ REPUBLIKA S.R.O.', 0.194], ['MYLAN IRELAND LIMITED', 0.305], ['ORGANON POLSKA SP. Z O.O.', 0.194]], 2.1679212962962966), 'Tizanidinum': ([['SANDOZ GMBH', 1.0]], 1.0539999999999998), 'Collagenasum N (o aktywności klostrydiopeptydazy A nie mniej niż': ([['SMITH & NEPHEW GMBH', 1.0]], 1.038), 'Valganciclovirum': ([['CHEPLAPHARM ARZNEIMITTEL GMBH', 0.99], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.01]], 793.2343333333332), 'Nitrendipinum': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.12008333333333335), 'Wirus grypy (inaktywowany, rozszczepiony) Szczepy:  A/Victoria/': ([['SANOFI PASTEUR', 1.0]], 26.6), 'Olanzapinum': ([['DELFARMA SP. Z O.O.', 0.002], ['ORION CORPORATION', 0.003], ['INPHARM SP. Z O.O.', 0.003], ['MYLAN PHARMACEUTICALS LTD', 0.002], ['VIATRIS LTD', 0.003], ['+PHARMA ARZNEIMITTEL GMBH', 0.002], ['BLUEFISH PHARMACEUTICALS AB', 0.002], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['ARISTO PHARMA SP. Z O.O.', 0.003], ['ACTAVIS GROUP PTC EHF.', 0.002], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.004], ['VIPHARM S.A.', 0.002], ['ADAMED PHARMA S.A.', 0.004], ['KRKA, D.D., NOVO MESTO', 0.004], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.004], ['BAUSCH HEALTH IRELAND LTD.', 0.004], ['ELI LILLY NEDERLAND B.V.', 0.952]], 920.9856464002268), 'Fluoxetini hydrochloridum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.286], ['EGIS PHARMACEUTICALS PLC', 0.286], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.286], ['ORION CORPORATION', 0.143]], 1.1525857142857143), 'Octreotidi acetas': ([['NOVARTIS POLAND SP. Z O.O.', 1.0]], 1220.7633333333333), 'Natrii alendronas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.504], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.496]], 4.34375), 'Thymolum': ([['ABBVIE SP. Z O.O.', 1.0]], 23.29), 'Atorvastatin calcium trihydrate': ([['MEDICAL VALLEY INVEST AB', 1.0]], 0.27399999999999997), 'Flupentixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 13.740000000000002), 'Indakaterol': ([['NOVARTIS EUROPHARM LIMITED', 1.0]], 2.745083333333333), 'Tianeptinum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.25], ['DELFARMA SP. Z O.O.', 0.25], ['INPHARM SP. Z O.O.', 0.25], ['ADAMED PHARMA S.A.', 0.25]], 0.996), 'Pregabalinum': ([['UPJOHN EESV', 0.276], ['VIPHARM S.A.', 0.279], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.159], ['SANDOZ GMBH', 0.287]], 4.612741071428571), 'Quinaprili hydrochloridum': ([['BIOFARM SP. Z O.O.', 0.632], ['BAUSCH HEALTH IRELAND LTD.', 0.368]], 0.16766666666666666), 'Dulaglutidum': ([['ELI LILLY NEDERLAND B.V.', 1.0]], 68.965), 'Dorzolamidum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.314], ['ADAMED PHARMA S.A.', 0.314], ['BAUSCH+LOMB IRELAND LTD.', 0.372]], 59.63333333333334), 'Lisinoprilum dihydricum': ([['SANDOZ GMBH', 0.247], ['RATIOPHARM GMBH', 0.247], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.266], ['RANBAXY (POLAND) SP. Z O.O.', 0.24]], 0.4821220238095238), 'Telmisartanum': ([['BIOFARM SP. Z O.O.', 0.052], ['ACTAVIS GROUP PTC EHF.', 0.057], ['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 0.065], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.051], ['RANBAXY (POLAND) SP. Z O.O.', 0.049], ['BLUEFISH PHARMACEUTICALS AB', 0.049], ['EGIS PHARMACEUTICALS PLC', 0.054], ['DELFARMA SP. Z O.O.', 0.048], ['INPHARM SP. Z O.O.', 0.048], ['SYNOPTIS PHARMA SP. Z O.O.', 0.052], ['VIATRIS LTD', 0.049], ['ADAMED PHARMA S.A.', 0.052], ['ZENTIVA, K.S.', 0.057], ['KRKA, D.D., NOVO MESTO', 0.05], ['SANDOZ GMBH', 0.054], ['PHARMASWISS ČESKÁ REPUBLIKA S.R.O.', 0.052], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.065], ['ZENTIVA, A.S.', 0.032], ['PRO.MED.CS PRAHA A.S.', 0.065]], 8.232219041320231), 'Duloxetine hydrochloride': ([['ADAMED PHARMA S.A.', 1.0]], 0.5603125), 'Oxcarbazepinum': ([['VIATRIS LTD', 0.379], ['ADAMED PHARMA S.A.', 0.494], ['NOVARTIS POLAND SP. Z O.O.', 0.127]], 2.55614), 'Furazidinum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.5], ['ADAMED PHARMA S.A.', 0.5]], 0.36133333333333334), 'Travoprostum + Timololi maleas': ([['SYNOPTIS PHARMA SP. Z O.O.', 1.0]], 28.970000000000002), 'Ciprofibratum': ([['SANOFI WINTHROP INDUSTRIE', 1.0]], 0.44333333333333336), 'Salmeterolu ksynafonian': ([['SANDOZ GMBH', 0.234], ['ADAMED PHARMA S.A.', 0.221], ['SYMPHAR SP. Z O.O.', 0.234], ['POLFARMEX S.A.', 0.155], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.155]], 354.0433333333334), 'Ganirelixi acetas': ([['N.V. ORGANON', 1.0]], 48.55000000000001), 'Famotidinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.32399999999999995), 'Sotaloli hydrochloridum': ([['SANDOZ GMBH', 1.0]], 0.39075), 'Insulinum detemirum': ([['NOVO NORDISK A/S', 1.0]], 21.694), 'Trazodoni hydrochloridum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.', 1.0]], 0.5603333333333333), 'Pancreatinum o aktywności: Lipazy': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.6854166666666668), 'Sitagliptin hydrochloride monohydrate': ([['ZENTIVA, K.S.', 0.138], ['EGIS PHARMACEUTICALS PLC', 0.207], ['BIOTON S.A.', 0.207], ['STADA ARZNEIMITTEL AG', 0.207], ['ADAMED PHARMA S.A.', 0.138], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.103]], 3.7149880952380956), 'Thiethylperazini dimaleas': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4046), 'Tacrolimusum monohydricum': ([['ASTELLAS PHARMA EUROPE B.V.', 0.527], ['CHIESI FARMACEUTICI S.P.A.', 0.473]], 21.546370370370372), 'Chlorambucilum': ([['ASPEN PHARMA TRADING LTD.', 1.0]], 3.6395999999999997), 'Topiramatum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.032], ['BAUSCH HEALTH IRELAND LTD.', 0.032], ['ORION CORPORATION', 0.02], ['JANSSEN-CILAG INTERNATIONAL N.V.', 0.886], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.031]], 32.88218253968254), 'Fenoteroli hydrobromidum': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 12.310000000000002), 'Lisinoprilum': ([['DELFARMA SP. Z O.O.', 0.333], ['PHARMAVITAE SP. Z O.O. SP. K.', 0.333], ['INPHARM SP. Z O.O.', 0.333]], 0.4769999999999999), 'Letrozolum': ([['CELON PHARMA S.A.', 0.17], ['ACTAVIS GROUP PTC EHF.', 0.17], ['EGIS PHARMACEUTICALS PLC', 0.163], ['VIPHARM S.A.', 0.17], ['EUGIA PHARMA (MALTA) LTD.', 0.161], ['BLUEFISH PHARMACEUTICALS AB', 0.167]], 11.139958333333333), 'Fluticasoni furoas': ([['GLAXOSMITHKLINE TRADING SERVICES LIMITED', 1.0]], 143.69), 'Amoxicillin trihydrate': ([['BLUEFISH PHARMACEUTICALS AB', 0.334], ['ZENTIVA, K.S.', 0.325], ['RANBAXY (POLAND) SP. Z O.O.', 0.342]], 2.9190714285714288), 'Duloxetinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.119], ['MYLAN PHARMACEUTICALS LTD', 0.12], ['ZENTIVA, K.S.', 0.113], ['KRKA, D.D., NOVO MESTO', 0.156], ['DELFARMA SP. Z O.O.', 0.147], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.185], ['SYMPHAR SP. Z O.O.', 0.159]], 4.66532032627866), 'Montelukastum natricum': ([['POLFARMEX S.A.', 0.109], ['ADAMED PHARMA S.A.', 0.109], ['KRKA, D.D., NOVO MESTO', 0.109], ['BLUEFISH PHARMACEUTICALS AB', 0.24], ['SANDOZ GMBH', 0.109], ['ORION CORPORATION', 0.109], ['BAUSCH HEALTH IRELAND LTD.', 0.109], ['RANBAXY (POLAND) SP. Z O.O.', 0.109]], 2.408035714285714), 'Diazepamum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 4.45), 'Amlodipini besilas -': ([['ADAMED PHARMA S.A.', 1.0]], 0.2023333333333333), 'Cyclophosphamidum': ([['BAXTER POLSKA SP. Z O.O.', 1.0]], 1.7624), 'Filgrastimum': ([['ACCORD HEALTHCARE S.L.U.', 0.495], ['SANDOZ GMBH', 0.505]], 83.65942857142858), 'Mieszanki alergoidów pyłku roślin (zgodnie z załącznikeim I)': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Insulini injectio neutralis aspartum': ([['NOVO NORDISK A/S', 1.0]], 19.356), 'Clindamycinum': ([['SOLINEA SP. Z O.O. SP.K.', 0.667], ['PFIZER EUROPE MA EEIG', 0.333]], 1.9402083333333335), 'Oxybutynini hydrochloridum': ([['MYLAN HEALTHCARE SP. Z O.O.', 0.5], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.5]], 0.4095), 'Carvedilolum': ([['ZENTIVA, K.S.', 0.178], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.178], ['RATIOPHARM GMBH', 0.178], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.143], ['KRKA, D.D., NOVO MESTO', 0.143], ['PROTERAPIA SP. Z O.O.', 0.178]], 0.66225), 'Nebivololi hydrochloridum': ([['SYNOPTIS PHARMA SP. Z O.O.', 0.12], ['S-LAB SP. Z O.O.', 0.127], ['ACTAVIS GROUP PTC EHF.', 0.123], ['BIOTON S.A.', 0.126], ['BERLIN-CHEMIE AG (MENARINI GROUP)', 0.127], ['RECORDATI POLSKA SP. Z O.O.', 0.127], ['SANDOZ GMBH', 0.124], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.127]], 2.5202916666666666), 'Fluvoxamini maleas': ([['MYLAN HEALTHCARE SP. Z O.O.', 1.0]], 0.247), 'Naldemedinum': ([['SHIONOGI B.V.', 1.0]], 8.73857142857143), 'Levocetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.009], ['MEDREG S.R.O.', 0.009], ['KRKA, D.D., NOVO MESTO', 0.009], ['DELFARMA SP. Z O.O.', 0.464], ['INPHARM SP. Z O.O.', 0.009], ['ADAMED PHARMA S.A.', 0.009], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.009], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.009], ['VEDIM SP. Z O.O.', 0.464], ['ZENTIVA, K.S.', 0.009]], 34.411625), 'Isosorbidi mononitras': ([['SANOFI-AVENTIS SP. Z O.O.', 1.0]], 0.45766666666666667), 'Fluconazolum': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.05], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.062], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.532], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.062], ['SYNOPTIS PHARMA SP. Z O.O.', 0.036], ['POLFARMEX S.A.', 0.004], ['ACTAVIS GROUP PTC EHF.', 0.06], ['ARISTO PHARMA SP. Z O.O.', 0.061], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.037], ['GEDEON RICHTER PLC.', 0.097]], 30.369772023809524), 'Tafluprostum': ([['SANTEN OY', 1.0]], 13.060333333333332), 'Candesartanum cilexetilum + Amlodipinum': ([['ZENTIVA, K.S.', 1.0]], 0.5349999999999999), 'Glucagoni hydrochloridum': ([['NOVO NORDISK A/S', 1.0]], 62.53999999999999), 'Nebivololum': ([['BIOFARM SP. Z O.O.', 0.222], ['ADAMED PHARMA S.A.', 0.156], ['BAUSCH HEALTH IRELAND LTD.', 0.156], ['KRKA, D.D., NOVO MESTO', 0.157], ['ORION CORPORATION', 0.153], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.156]], 2.046117261904762), 'Amlodipini maleas': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.2798333333333334), 'Gentamicini sulfas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 4.55), 'Verapamili hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.20124999999999998), 'Naproxenum': ([['ADAMED PHARMA S.A.', 0.128], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.128], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.444], ['SYNOPTIS PHARMA SP. Z O.O.', 0.128], ['POLFARMEX S.A.', 0.171]], 1.493527777777778), 'Busulfanum': ([['ASPEN PHARMA TRADING LTD.', 1.0]], 8.5168), 'Sertralini hydrochloridum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.128], ['ORION CORPORATION', 0.149], ['KRKA, D.D., NOVO MESTO', 0.136], ['ACTAVIS GROUP PTC EHF.', 0.16], ['PROTERAPIA SP. Z O.O.', 0.107], ['UPJOHN EESV', 0.16], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.16]], 3.081857142857143), 'Methylprednisoloni natrii succinas': ([['SUN-FARM SP. Z O.O.', 0.992], ['ORION CORPORATION', 0.008]], 63.87499999999999), 'Icatibantum': ([['TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH', 0.208], ['ACCORD HEALTHCARE S.L.U.', 0.208], ['FRESENIUS KABI POLSKA SP. Z O.O.', 0.189], ['ZENTIVA, K.S.', 0.204], ['RANBAXY (POLAND) SP. Z O.O.', 0.191]], 11696.760000000002), 'Nabumetonum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.12758333333333327), 'Zuclopenthixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.39005), 'Lithii carbonas': ([['GSK PSC POLAND SP. Z O.O.', 1.0]], 0.261), 'Menotropina': ([['FERRING GMBH', 0.888], ['IBSA FARMACEUTICI ITALIA S.R.L.', 0.112]], 1142.79), 'Montelukastum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.21], ['KRKA, D.D., NOVO MESTO', 0.21], ['MEDREG S.R.O.', 0.203], ['INPHARM SP. Z O.O.', 0.185], ['DELFARMA SP. Z O.O.', 0.192]], 2.7627976190476193), 'Brinzolamidum': ([['NOVARTIS EUROPHARM LIMITED', 0.332], ['SYNOPTIS PHARMA SP. Z O.O.', 0.332], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.336]], 70.13666666666666), 'Follitropinum alfa': ([['GEDEON RICHTER PLC.', 0.268], ['MERCK EUROPE B.V.', 0.088], ['THERAMEX IRELAND LIMITED', 0.644]], 954.0450000000001), 'Ivabradini hydrochloridum': ([['KRKA, D.D., NOVO MESTO', 0.342], ['RANBAXY (POLAND) SP. Z O.O.', 0.314], ['BAUSCH HEALTH IRELAND LTD.', 0.344]], 4.613973214285714), 'Alfuzosini hydrochloridum': ([['RANBAXY (POLAND) SP. Z O.O.', 0.363], ['ORION CORPORATION', 0.275], ['SANOFI WINTHROP INDUSTRIE', 0.363]], 1.9610000000000003), 'Vigabatrinum': ([['SANOFI WINTHROP INDUSTRIE', 1.0]], 2.7886), 'Conestatum alfa': ([['PHARMING GROUP N.V.', 1.0]], 3943.96), 'Wyciągi alergenowe roztoczy kurzu domowego -': ([['ALLERGOPHARMA GMBH & CO. KG', 1.0]], 263.37833333333333), 'Colistimethatum natricum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 19.896), 'Danazolum': ([['POLFARMEX S.A.', 1.0]], 2.3287999999999998), 'Spiramycinum': ([['SANOFI WINTHROP INDUSTRIE', 1.0]], 0.795), 'Ciprofloxacini hydrochloridum': ([['ZENTIVA, A.S.', 0.23], ['KRKA, D.D., NOVO MESTO', 0.177], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.178], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.238], ['ZENTIVA, K.S.', 0.177]], 2.4815), 'Insulinum lisprum': ([['SANOFI WINTHROP INDUSTRIE', 0.404], ['ELI LILLY NEDERLAND B.V.', 0.596]], 47.806), 'Sulpiridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.368], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.632]], 0.5003611111111111), 'Glipizidum': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY GALENA', 1.0]], 0.05699999999999997), 'Calcitriolum': ([['SUN-FARM SP. Z O.O.', 1.0]], 0.5593888888888889), 'Clozapinum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.268], ['EGIS PHARMACEUTICALS PLC', 0.268], ['SYMPHAR SP. Z O.O.', 0.464]], 0.9832416666666666), 'Apixaban': ([['BRISTOL-MYERS SQUIBB/PFIZER EEIG', 1.0]], 1.803839285714286), 'Rivastigmini hydrogenotartras': ([['BAUSCH HEALTH IRELAND LTD.', 0.312], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.313], ['ORION CORPORATION', 0.375]], 0.9392633928571428), 'Febuxostatum hemihydricum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 1.0]], 0.5772321428571427), 'Glimepiridum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.187], ['BIOFARM SP. Z O.O.', 0.183], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['SANDOZ GMBH', 0.223], ['SYMPHAR SP. Z O.O.', 0.208]], 1.3151333333333333), 'Allopurinol': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.40866666666666673), 'Riluzolum': ([['PRO.MED.CS PRAHA A.S.', 1.0]], 3.22), 'tert-Butylamini perindoprilum': ([['KRKA, D.D., NOVO MESTO', 0.344], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.328], ['ADAMED PHARMA S.A.', 0.328]], 0.3632480158730158), 'Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum A/Victoria/': ([['VIATRIS HEALTHCARE LIMITED', 1.0]], 26.37), 'Atomoxetinum': ([['G.L. PHARMA GMBH', 0.46], ['INPHARM SP. Z O.O.', 0.54]], 6.3589761904761914), 'Clopidogrelum': ([['MEDEZIN SP. Z O.O.', 0.195], ['DELFARMA SP. Z O.O.', 0.2], ['INPHARM SP. Z O.O.', 0.201], ['PHARMATHEN S.A.', 0.206], ['KRKA, D.D., NOVO MESTO', 0.198]], 2.7885714285714287), 'Terazosini dihydricum hydrochloridum': ([['AMDIPHARM LIMITED', 0.624], ['SANDOZ GMBH', 0.376]], 0.8708809523809522), 'Hydroxycarbamidum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.5], ['MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.5]], 2.1038), 'Empagliflozinum': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 3.7353571428571435), 'Agomelatinum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.143], ['+PHARMA ARZNEIMITTEL GMBH', 0.141], ['G.L. PHARMA GMBH', 0.142], ['EGIS PHARMACEUTICALS PLC', 0.143], ['KRKA, D.D., NOVO MESTO', 0.143], ['BIOFARM SP. Z O.O.', 0.143], ['SYMPHAR SP. Z O.O.', 0.143]], 10.972047619047618), 'Ibuprofenum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.03183333333333332), 'Dermatophagoides pteronyssinus': ([['ALK-ABELLO A/S', 1.0]], 9.438666666666666), 'Warfarinum natricum': ([['ORION CORPORATION', 1.0]], 0.10485), 'Meloxicamum': ([['BIOFARM SP. Z O.O.', 0.122], ['ZENTIVA, K.S.', 0.127], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.123], ['STADA ARZNEIMITTEL AG', 0.127], ['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 0.127], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.123], ['FARMAK INTERNATIONAL SP. Z O.O.', 0.122], ['ALPEX PHARMA (IRL) LIMITED', 0.127]], 2.005666666666667), 'Cyanocobalaminum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.8039999999999998), 'Ticlopidini hydrochloridum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.4181666666666667), 'Mesalazinum': ([['ASTELLAS PHARMA SP. Z O.O.', 0.095], ['FARMINA SP. Z O.O.', 0.152], ['FERRING GMBH', 0.472], ['FAES FARMA S.A.', 0.142], ['FAES FARMA, S.A.', 0.071], ['DR. FALK PHARMA GMBH', 0.068]], 10.03355595238095), 'Mycophenolas mofetil': ([['ROCHE REGISTRATION GMBH', 0.25], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.25], ['SANDOZ GMBH', 0.25], ['TEVA B.V.', 0.25]], 6.0656), 'Tianeptinum': ([['LES LABORATOIRES SERVIER', 1.0]], 0.24900000000000003), 'Azathioprinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 0.488], ['ASPEN PHARMA TRADING LTD.', 0.512]], 1.0514333333333332), 'Estradioli valeras tabletki białe -': ([['BAYER AG', 1.0]], 0.3347619047619048), 'mikonazol': ([['GEDEON RICHTER PLC.', 1.0]], 0.8079999999999999), 'Urofollitropinum': ([['IBSA FARMACEUTICI ITALIA S.R.L.', 1.0]], 73.00999999999999), 'Triptorelini pamoas': ([['IPSEN PHARMA', 1.0]], 555.95), 'Ciclosporinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.094], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.189], ['DELFARMA SP. Z O.O.', 0.183], ['INPHARM SP. Z O.O.', 0.183], ['SANTEN OY', 0.277], ['NOVARTIS POLAND SP. Z O.O.', 0.074]], 33.01991666666667), 'Carbamazepinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.155], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.241], ['G.L. PHARMA GMBH', 0.366], ['NOVARTIS POLAND SP. Z O.O.', 0.237]], 1.25495), 'Insulinum aspartum': ([['NOVO NORDISK A/S', 0.5], ['SANOFI WINTHROP INDUSTRIE', 0.5]], 38.696), 'Ketoprofenum': ([['SANOFI WINTHROP INDUSTRIE', 0.2], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.2], ['SANDOZ GMBH', 0.2], ['SUN-FARM SP. Z O.O.', 0.2]], 0.8513333333333333), 'Loratadinum': ([['SANDOZ GMBH', 0.444], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY GALENA', 0.444], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.113]], 0.7077600000000002), 'Levothyroxinum natricum': ([['ZENTIVA, K.S.', 0.38], ['MERCK SP. Z O.O.', 0.34], ['BERLIN-CHEMIE AG', 0.28]], 0.3012001515151515), 'Cariprazine': ([['GEDEON RICHTER PLC.', 1.0]], 8.436428571428571), 'Clopamidum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.3295), 'Lurasidonum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.', 1.0]], 8.241428571428571), 'Benzathini phenoxymethylpenicillinum': ([['SANDOZ GMBH', 1.0]], 0.2733333333333333), 'Tizanidini hydrochloridum': ([['ORION CORPORATION', 1.0]], 0.7026666666666667), 'Furosemidum': ([['MEDREG S.R.O.', 0.191], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.259], ['POLFARMEX S.A.', 0.275], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.275]], 0.777), 'Glycopyrronii bromidum': ([['NOVARTIS EUROPHARM LIMITED', 1.0]], 2.227), 'Zuclopenthixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 15.36), 'Betamethasoni dipropionas': ([['SUN-FARM SP. Z O.O.', 0.332], ['ORGANON POLSKA SP. Z O.O.', 0.22], ['BELUPO S.R.O.', 0.448]], 31.075000000000003), 'Hydrochlorothiazidum': ([['SANDOZ GMBH', 0.143], ['KRKA, D.D., NOVO MESTO', 0.571], ['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 0.286]], 1.8725), 'Estradiolum': ([['ORION CORPORATION', 0.096], ['INPHARM SP. Z O.O.', 0.127], ['NOVO NORDISK A/S', 0.077], ['BESINS HEALTHCARE S.A.', 0.076], ['THERAMEX IRELAND LIMITED', 0.446], ['BAYER AG', 0.088], ['MYLAN HEALTHCARE SP. Z O.O.', 0.088]], 4.586767857142856), 'Latanoprostum': ([['PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH', 0.163], ['BAUSCH+LOMB IRELAND LTD.', 0.172], ['SYNOPTIS PHARMA SP. Z O.O.', 0.168], ['LABORATOIRES THEA', 0.007], ['ADAMED PHARMA S.A.', 0.114], ['UPJOHN EESV', 0.125], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.166], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.086]], 168.51456944444445), 'Clomipramini hydrochloridum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 1.205), 'Fluoxetinum': ([['NEURAXPHARM ARZNEIMITTEL GMBH', 0.333], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.333], ['PRO.MED.CS PRAHA A.S.', 0.333]], 0.988), 'Insulinum lisprum injectio neutralis': ([['ELI LILLY NEDERLAND B.V.', 1.0]], 19.356), 'Thioguaninum': ([['ASPEN PHARMA TRADING LTD.', 1.0]], 18.0212), 'Amlodipine besilate': ([['ZENTIVA, K.S.', 1.0]], 0.24620833333333333), 'all-rac-Fitomenadion (witamina K': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.7853333333333332), 'Insulinum humanum isophanum': ([['BIOTON S.A.', 0.5], ['NOVO NORDISK A/S', 0.5]], 37.144000000000005), 'Atorvastatinum': ([['KRKA, D.D., NOVO MESTO', 0.09], ['BLUEFISH PHARMACEUTICALS AB', 0.108], ['MEDREG S.R.O.', 0.096], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.07], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.07], ['DELFARMA SP. Z O.O.', 0.105], ['BIOFARM SP. Z O.O.', 0.24], ['S-LAB SP. Z O.O.', 0.069], ['RANBAXY (POLAND) SP. Z O.O.', 0.081], ['ZENTIVA, K.S.', 0.07]], 3.459768518518519), 'Cloxacillinum natrium': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 1.25625), 'Natrii risedronas': ([['ZENTIVA, K.S.', 1.0]], 2.1875), 'Progesteronum': ([['ADAMED PHARMA S.A.', 0.039], ['BESINS HEALTHCARE IRELAND LIMITED', 0.961]], 2.7263333333333337), 'Goserelini acetas': ([['ZENTIVA, K.S.', 0.336], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.327], ['ASTRAZENECA AB', 0.337]], 1025.915), 'Kalii citras': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.476], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 0.524]], 0.42986363636363634), 'Clopidogrelum besilate': ([['BLUEFISH PHARMACEUTICALS AB', 0.487], ['S-LAB SP. Z O.O.', 0.513]], 1.117142857142857), 'Prednisolonum': ([['ADAMED PHARMA S.A.', 0.155], ['SUN-FARM SP. Z O.O.', 0.845]], 1.8929999999999998), 'Salmeterolum': ([['INPHARM SP. Z O.O.', 0.145], ['DELFARMA SP. Z O.O.', 0.145], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.151], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['ADAMED PHARMA S.A.', 0.151], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.151], ['ZENTIVA, K.S.', 0.147], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.106]], 516.9026666666666), 'Sertindolum': ([['H. LUNDBECK A/S', 1.0]], 8.46563492063492), 'Fentanylu cytrynian': ([['TEVA B.V.', 1.0]], 20.177142857142854), 'Pantoprazolum natricum sesquihydricum': ([['TAKEDA PHARMA SP. Z O.O.', 0.143], ['S-LAB SP. Z O.O.', 0.214], ['VIATRIS LTD', 0.214], ['BLUEFISH PHARMACEUTICALS AB', 0.214], ['RANBAXY (POLAND) SP. Z O.O.', 0.214]], 0.7766071428571428), 'Sulfasalazinum w postaci granulatu z powidonem -': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4455), 'Ethosuximidum': ([['G.L. PHARMA GMBH', 1.0]], 0.5944999999999999), 'Acidum alendronicum': ([['RANBAXY (POLAND) SP. Z O.O.', 0.38], ['MYLAN IRELAND LIMITED', 0.328], ['BLUEFISH PHARMACEUTICALS AB', 0.292]], 5.665000000000001), 'Aciclovirum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.308], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.344], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.348]], 1.4142222222222223), 'Relugolixum': ([['ACCORD HEALTHCARE S.L.U.', 1.0]], 14.965333333333332), 'Tramadoli hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.079], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.07], ['KRKA, D.D., NOVO MESTO', 0.079], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.07], ['STADA ARZNEIMITTEL AG', 0.175], ['DELFARMA SP. Z O.O.', 0.211], ['BAUSCH HEALTH IRELAND LTD.', 0.053], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.053], ['ZENTIVA, K.S.', 0.105], ['MEDREG S.R.O.', 0.053], ['POLFARMEX S.A.', 0.053]], 3.819369907407407), 'Propranololi hydrochloridum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.24400000000000002), 'Clindamycini hydrochloridum': ([['MIP PHARMA POLSKA SP. Z O.O.', 0.53], ['PFIZER EUROPE MA EEIG', 0.136], ['SANDOZ GMBH', 0.334]], 1.7876597222222221), 'Indacateroli maleas': ([['NOVARTIS EUROPHARM LIMITED', 1.0]], 3.1340000000000003), 'Rivaroxaban': ([['BAYER AG', 1.0]], 3.8448571428571428), 'Haloperidolum': ([['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 10.219999999999999), 'Etaksylan dabigatranu': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 1.2343333333333335), 'Cefuroximum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.046], ['SANDOZ GMBH', 0.954]], 5.955294117647059), 'Risperidonum': ([['ORION CORPORATION', 0.088], ['VIPHARM S.A.', 0.002], ['TEVA B.V.', 0.452], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['JANSSEN-CILAG INTERNATIONAL N.V.', 0.453], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.002], ['KRKA, D.D., NOVO MESTO', 0.001]], 386.4775458333334), 'Clonazepamum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.2793333333333333), 'Folitropinum delta': ([['FERRING PHARMACEUTICALS A/S', 1.0]], 916.71), 'Esomeprazolum (esomeprazol magnezowy, amorficzny)': ([['RANBAXY (POLAND) SP. Z O.O.', 1.0]], 0.22196428571428573), 'Sitagliptini hydrochloridum monohydricum': ([['SYMPHAR SP. Z O.O.', 0.667], ['BIOTON S.A.', 0.333]], 1.152857142857143), 'Bisoprololi fumaras': ([['BIOFARM SP. Z O.O.', 0.155], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.181], ['BAUSCH HEALTH IRELAND LTD.', 0.147], ['TEVA B.V.', 0.166], ['ZENTIVA, A.S.', 0.16], ['KRKA, D.D., NOVO MESTO', 0.192]], 1.201625), 'Ofloxacinum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 1.0]], 0.8849999999999999), 'Lamotriginum': ([['+PHARMA ARZNEIMITTEL GMBH', 0.128], ['DELFARMA SP. Z O.O.', 0.18], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.18], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.32], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.097], ['SYMPHAR SP. Z O.O.', 0.094]], 3.881240740740741), 'Rywastygmina': ([['ZENTIVA, K.S.', 1.0]], 0.9863333333333334), 'Tamsulosini hydrochloridum': ([['ADAMED PHARMA S.A.', 0.056], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.056], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.056], ['DELFARMA SP. Z O.O.', 0.043], ['INPHARM SP. Z O.O.', 0.043], ['ZENTIVA, K.S.', 0.056], ['GEDEON RICHTER PLC.', 0.056], ['+PHARMA ARZNEIMITTEL GMBH', 0.056], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.056], ['SYMPHAR SP. Z O.O.', 0.052], ['ORION CORPORATION', 0.047], ['SYNOPTIS PHARMA SP. Z O.O.', 0.055], ['G.L. PHARMA GMBH', 0.046], ['ACTAVIS GROUP PTC EHF.', 0.056], ['MYLAN IRELAND LIMITED', 0.052], ['MEDREG S.R.O.', 0.041], ['KRKA, D.D., NOVO MESTO', 0.056], ['RECORDATI POLSKA SP. Z O.O.', 0.056], ['ASTELLAS PHARMA SP. Z O.O.', 0.056]], 9.465574074074075), 'Brimonidini tartras': ([['ABBVIE SP. Z O.O.', 0.066], ['ADAMED PHARMA S.A.', 0.296], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.276], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.066], ['BAUSCH+LOMB IRELAND LTD.', 0.296]], 70.88033333333334), 'Rupatadini fumaras': ([['FARMAK INTERNATIONAL SP. Z O.O.', 1.0]], 0.2463), 'Exemestanum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['SYMPHAR SP. Z O.O.', 0.5]], 3.7813333333333334), 'Doxazosini mesilas': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.075], ['ADAMED PHARMA S.A.', 0.092], ['UPJOHN EESV', 0.225], ['BAUSCH HEALTH IRELAND LTD.', 0.081], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.079], ['ACTAVIS GROUP PTC EHF.', 0.15], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.067], ['KRKA, D.D., NOVO MESTO', 0.15], ['ZENTIVA, K.S.', 0.081]], 3.2683553240740735), 'Methotrexatum natricum': ([['EBEWE PHARMA GES.M.B.H NFG. KG', 0.476], ['MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.524]], 94.22452380952382), 'Tiotropium': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.523], ['ZENTIVA, K.S.', 0.477]], 5.552666666666666), 'Atomoxetini hydrochloridum': ([['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.385], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.308], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.306]], 7.586339285714285), 'Metformini hydrochloridum': ([['BIOTON S.A.', 0.062], ['FARMAK INTERNATIONAL SP. Z O.O.', 0.071], ['SANDOZ GMBH', 0.106], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.071], ['MERCK SANTE S.A.S.', 0.08], ['MERCK SANTÉ S.A.S', 0.025], ['SYNOPTIS PHARMA SP. Z O.O.', 0.032], ['DELFARMA SP. Z O.O.', 0.097], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.032], ['TEVA B.V.', 0.074], ['BLUEFISH PHARMACEUTICALS AB', 0.045], ['RANBAXY (POLAND) SP. Z O.O.', 0.071], ['BERLIN-CHEMIE AG', 0.061], ['BERLIN-CHEMIE AG (MENARINI GROUP)', 0.058], ['SYMPHAR SP. Z O.O.', 0.058], ['ZENTIVA, K.S.', 0.058]], 1.9934769841269844), 'Acidum valproicum': ([['G.L. PHARMA GMBH', 1.0]], 0.2730666666666666), 'Moclobemidum': ([['MYLAN HEALTHCARE SP. Z O.O.', 0.333], ['BAUSCH HEALTH IRELAND LTD.', 0.333], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.333]], 1.1470000000000002), 'Candesartanum cilexetili': ([['DELFARMA SP. Z O.O.', 0.173], ['INPHARM SP. Z O.O.', 0.185], ['ZENTIVA, K.S.', 0.133], ['ORION CORPORATION', 0.085], ['KRKA, D.D., NOVO MESTO', 0.121], ['RANBAXY (POLAND) SP. Z O.O.', 0.085], ['ADAMED PHARMA S.A.', 0.085], ['SANDOZ GMBH', 0.133]], 4.703377232142857), 'Cilazaprilum': ([['KRKA, D.D., NOVO MESTO', 0.492], ['POLFARMEX S.A.', 0.508]], 0.23470238095238094), 'Insulinum lisprum zinci protaminati injectio': ([['ELI LILLY NEDERLAND B.V.', 1.0]], 19.355999999999998), 'Ivabradinum': ([['INPHARM SP. Z O.O.', 0.127], ['DELFARMA SP. Z O.O.', 0.128], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.131], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.104], ['SYNOPTIS PHARMA SP. Z O.O.', 0.131], ['VIATRIS LTD', 0.131], ['ZENTIVA, K.S.', 0.12], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.127]], 12.033080357142858), 'Allopurinolum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 0.18], ['SANDOZ GMBH', 0.396], ['PROTERAPIA SP. Z O.O.', 0.424]], 0.6230666666666667), 'Pramipexolum': ([['KRKA, D.D., NOVO MESTO', 1.0]], 1.6667738095238096), 'Tiotropii bromidum monohydricum': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 2.9018333333333333), 'Gabapentinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.125], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.366], ['DELFARMA SP. Z O.O.', 0.14], ['UPJOHN EESV', 0.369]], 3.090233333333333), 'Insulina ludzka rekombinowana': ([['BIOTON S.A.', 1.0]], 18.568), 'Perindoprilum argininum': ([['LES LABORATOIRES SERVIER', 0.428], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.572]], 0.2781666666666669), 'Desmopressinum': ([['FERRING LEČIVA A.S.', 1.0]], 6.033944444444445), 'Levetiracetamum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.004], ['UCB PHARMA S.A.', 0.488], ['G.L. PHARMA GMBH', 0.005], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.481], ['ACCORD HEALTHCARE S.L.U.', 0.004], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.004], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.004], ['ZENTIVA, K.S.', 0.004], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.004], ['ADAMED PHARMA S.A.', 0.004]], 146.01270773809526), 'Lacidipinum': ([['BIOFARM SP. Z O.O.', 0.308], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.308], ['HOLSTEN PHARMA GMBH', 0.385]], 0.6569642857142857), 'Lovastatinum': ([['BIOFARM SP. Z O.O.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.185), 'Furaginum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 0.09033333333333333), 'Hydrocortisoni acetas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 1.0]], 3.7800000000000002), 'Paroxetini hydrochloridum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.318], ['GEDEON RICHTER PLC.', 0.341], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.341]], 0.966), 'Perazinum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.639], ['LABOR PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE SP. Z O.O.', 0.361]], 0.7150416666666667), 'Tropicamidum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.1584999999999999), 'Salbutamoli sulfas': ([['ORION CORPORATION', 0.004], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.496], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.5]], 14.82825), 'Solifenacini succinas': ([['ADAMED PHARMA S.A.', 0.075], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.075], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.074], ['BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.059], ['RANBAXY (POLAND) SP. Z O.O.', 0.073], ['MEDREG S.R.O.', 0.1], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.1], ['+PHARMA ARZNEIMITTEL GMBH', 0.075], ['RECORDATI POLSKA SP. Z O.O.', 0.074], ['ORION CORPORATION', 0.075], ['G.L. PHARMA GMBH', 0.075], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.075], ['ZENTIVA, K.S.', 0.071]], 8.251594444444445), 'Pantoprazolum natricum sesquihydricum -': ([['SYNOPTIS PHARMA SP. Z O.O.', 1.0]], 0.10794642857142858), 'Rosuvastatinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.137], ['RANBAXY (POLAND) SP. Z O.O.', 0.135], ['DELFARMA SP. Z O.O.', 0.106], ['INPHARM SP. Z O.O.', 0.136], ['KRKA, D.D., NOVO MESTO', 0.121], ['ADAMED PHARMA S.A.', 0.121], ['ZENTIVA, K.S.', 0.121], ['SANDOZ GMBH', 0.121]], 2.736119047619047), 'Sitagliptinum': ([['MERCK SHARP & DOHME B.V.', 0.103], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.092], ['KRKA, D.D., NOVO MESTO', 0.092], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.092], ['SANDOZ GMBH', 0.138], ['ADAMED PHARMA S.A.', 0.103], ['MEDICAL VALLEY INVEST AB', 0.138], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.103], ['EGIS PHARMACEUTICALS PLC', 0.069], ['SYMPHAR SP. Z O.O.', 0.069]], 5.572531746031745), 'Vildagliptinum': ([['VIPHARM S.A.', 0.167], ['NOVARTIS EUROPHARM LIMITED', 0.167], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.167], ['KRKA, D.D., NOVO MESTO', 0.167], ['STADA ARZNEIMITTEL AG', 0.167], ['ZENTIVA, K.S.', 0.167]], 2.3065238095238096), 'Miconazoli nitras': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.9013333333333334), 'Atropini sulfas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 2.722), 'Rivastigminum': ([['ZENTIVA, K.S.', 0.232], ['DELFARMA SP. Z O.O.', 0.312], ['NOVARTIS EUROPHARM LIMITED', 0.3], ['ADAMED PHARMA S.A.', 0.156]], 2.256454365079365), 'Dihydrocodeini tartras': ([['MUNDIPHARMA A/S', 1.0]], 0.7771666666666668), 'Beclometasoni dipropionas anhydricus (': ([['CHIESI FARMACEUTICI S.P.A.', 1.0]], 136.18), 'Amiodaroni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.4348333333333334), 'Perazini dimaleas': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.24038333333333334), 'Mebendazolum': ([['DELFARMA SP. Z O.O.', 0.425], ['GEDEON RICHTER PLC.', 0.575]], 2.6616666666666666), 'Naproxenum natricum': ([['ADAMED PHARMA S.A.', 0.429], ['KRKA, D.D., NOVO MESTO', 0.571]], 0.49175), 'Cefuroximum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.003], ['S-LAB SP. Z O.O.', 0.033], ['RANBAXY (POLAND) SP. Z O.O.', 0.49], ['KRKA, D.D., NOVO MESTO', 0.032], ['SANDOZ GMBH', 0.328], ['DELFARMA SP. Z O.O.', 0.032], ['TEVA B.V.', 0.026], ['INPHARM SP. Z O.O.', 0.031], ['POLFARMEX S.A.', 0.025]], 53.71180330882352), 'Piribedilum': ([['LES LABORATOIRES SERVIER', 1.0]], 0.5486666666666667), 'Acenocoumarolum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.15733333333333335), 'Morphini hydrochloridum': ([['G.L. PHARMA GMBH', 1.0]], 1.575), 'Adrenalinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 28.49), 'Atorvastatinum calcicum': ([['BIOFARM SP. Z O.O.', 0.042], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.065], ['KRKA, D.D., NOVO MESTO', 0.166], ['MYLAN IRELAND LIMITED', 0.083], ['SYNOPTIS PHARMA SP. Z O.O.', 0.097], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.222], ['RANBAXY (POLAND) SP. Z O.O.', 0.104], ['ZENTIVA, K.S.', 0.222]], 3.751703703703704), 'Ropinirolum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.155], ['ORION CORPORATION', 0.161], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.161], ['GLAXOSMITHKLINE (IRELAND) LIMITED', 0.161], ['KRKA, D.D., NOVO MESTO', 0.173], ['DELFARMA SP. Z O.O.', 0.187]], 10.574077380952382), 'Salmeterolum + Fluticasoni propionas': ([['ORION CORPORATION', 1.0]], 82.955), 'Levothyroxine sodium': ([['ARISTO PHARMA SP. Z O.O.', 1.0]], 0.060050000000000006), 'Dorzolamidi hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.229], ['SANTEN OY', 0.285], ['BAUSCH+LOMB IRELAND LTD.', 0.149], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.337]], 66.25983333333333), 'Phenobarbitalum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.5]], 0.7420000000000001), 'Phenoxymethylpenicillinum kalicum': ([['SANDOZ GMBH', 1.0]], 1.0400416666666668), 'Clindamycini phosphas': ([['SANDOZ GMBH', 1.0]], 6.086), 'Penicillaminum': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 1.0]], 2.590333333333333), 'Semaglutidum': ([['NOVO NORDISK A/S', 1.0]], 275.86), 'Triptorelini acetas': ([['IPSEN PHARMA', 0.877], ['FERRING GMBH', 0.123]], 196.92142857142855), 'Cyproteroni acetas': ([['BAYER AG', 0.333], ['SUN-FARM SP. Z O.O.', 0.333], ['SYMPHAR SP. Z O.O.', 0.333]], 0.7601587301587301), 'Dinatrii pamidronas': ([['VIPHARM S.A.', 1.0]], 205.9333333333333), 'Estradiolum (zmikronizowany)': ([['THERAMEX IRELAND LIMITED', 1.0]], 2.04625), 'Levodopum': ([['ROCHE POLSKA SP. Z O.O.', 0.607], ['SANDOZ GMBH', 0.393]], 1.58125), 'Lacosamidum': ([['ACCORD HEALTHCARE S.L.U.', 0.235], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.23], ['TEVA B.V.', 0.23], ['G.L. PHARMA GMBH', 0.22], ['UCB PHARMA S.A.', 0.084]], 7.503200892857143), 'Acidum ursodeoxycholicum': ([['POLFARMEX S.A.', 0.312], ['BAUSCH HEALTH IRELAND LTD.', 0.375], ['AS GRINDEKS', 0.312]], 1.8688000000000002), 'Roxithromycinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.4414999999999999), 'Propafenoni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.2725), 'Formoteroli fumaras dihydricus': ([['ASTRAZENECA AB', 1.0]], 143.69), 'Finerenonum': ([['BAYER AG', 1.0]], 7.185714285714285), 'Midazolamu chlorowodorek': ([['EXELTIS POLAND SP. Z O.O.', 1.0]], 67.8675), 'Sulfasalazinum (w postaci mieszaniny z powidonem)': ([['PFIZER EUROPE MA EEIG', 1.0]], 0.453525), 'Inhibitor C': ([['CSL BEHRING GMBH', 1.0]], 2303.74), 'Olanzapiny dichlorowodorek trójwodny': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 2.2617410714285713), 'Amlodipinum': ([['DELFARMA SP. Z O.O.', 0.078], ['KRKA, D.D., NOVO MESTO', 0.179], ['BLUEFISH PHARMACEUTICALS AB', 0.073], ['MYLAN IRELAND LIMITED', 0.074], ['INPHARM SP. Z O.O.', 0.115], ['SANDOZ GMBH', 0.179], ['PROTERAPIA SP. Z O.O.', 0.071], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.082], ['POLFARMEX S.A.', 0.149]], 2.9861746031746033), 'Aripiprazolum': ([['OTSUKA PHARMACEUTICAL NETHERLANDS B.V.', 0.954], ['ARISTO PHARMA SP. Z O.O.', 0.003], ['ADAMED PHARMA S.A.', 0.004], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.004], ['G.L. PHARMA GMBH', 0.003], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.004], ['+PHARMA ARZNEIMITTEL GMBH', 0.004], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.004], ['ORION CORPORATION', 0.003], ['SANDOZ GMBH', 0.003], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.003], ['KRKA, D.D., NOVO MESTO', 0.004], ['VIPHARM S.A.', 0.003], ['PROTERAPIA SP. Z O.O.', 0.004]], 980.5109035383598), 'Loperamidi hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.134), 'Ondansetronum': ([['BLUEFISH PHARMACEUTICALS AB', 0.394], ['SANDOZ GMBH', 0.606]], 6.9515), 'Amisulpridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.093], ['PRO.MED.CS PRAHA A.S.', 0.159], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.159], ['SANOFI WINTHROP INDUSTRIE', 0.161], ['DELFARMA SP. Z O.O.', 0.154], ['INPHARM SP. Z O.O.', 0.154], ['SYMPHAR SP. Z O.O.', 0.12]], 23.139222222222223), 'Natrii valproas': ([['SANOFI-AVENTIS SP. Z O.O.', 0.224], ['DELFARMA SP. Z O.O.', 0.203], ['ORION CORPORATION', 0.162], ['G.L. PHARMA GMBH', 0.402], ['SANOFI WINTHROP INDUSTRIE', 0.009]], 3.410166666666668), 'Tiotropium bromide monohydrate': ([['BOEHRINGER INGELHEIM INTERNATIONAL GMBH', 1.0]], 2.9018333333333333), 'Quetiapinum': ([['VIPHARM S.A.', 0.156], ['ARISTO PHARMA SP. Z O.O.', 0.108], ['EGIS PHARMACEUTICALS PLC', 0.121], ['ORION CORPORATION', 0.085], ['SANDOZ GMBH', 0.219], ['KRKA, D.D., NOVO MESTO', 0.117], ['ADAMED PHARMA S.A.', 0.084], ['+PHARMA ARZNEIMITTEL GMBH', 0.11]], 12.8767), 'Bromocriptini mesylas': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.52), 'Amoxicillinum trihydricum': ([['KRKA, D.D., NOVO MESTO', 0.301], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.699]], 1.2882142857142858), 'Degarelix': ([['FERRING PHARMACEUTICALS A/S', 1.0]], 682.98), 'Umeclidini bromidum': ([['GLAXOSMITHKLINE (IRELAND) LIMITED', 1.0]], 94.02000000000001), 'Formoteroli fumaras': ([['CHIESI FARMACEUTICI S.P.A.', 0.266], ['SANDOZ GMBH', 0.004], ['ADAMED PHARMA S.A.', 0.004], ['BAUSCH HEALTH IRELAND LTD.', 0.004], ['ORION CORPORATION', 0.529], ['ASTRAZENECA AB', 0.187], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.004]], 207.65143518518516), 'Doxazosinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.182], ['SYNOPTIS PHARMA SP. Z O.O.', 0.182], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.233], ['+PHARMA ARZNEIMITTEL GMBH', 0.233], ['KRKA, D.D., NOVO MESTO', 0.169]], 2.1033055555555555), 'Acidum undecylenicum': ([['PRO.MED.CS PRAHA A.S.', 1.0]], 0.584), 'Bimatoprost': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['ABBVIE DEUTSCHLAND GMBH & CO. KG', 0.199], ['BAUSCH+LOMB IRELAND LTD.', 0.2], ['ADAMED PHARMA S.A.', 0.2], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.2]], 164.57), 'Voriconazolum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.498], ['ACCORD HEALTHCARE S.L.U.', 0.502]], 13.535333333333334), 'Pilocarpini hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.347), 'Dexamethasonum': ([['SUN-FARM SP. Z O.O.', 0.047], ['DELFARMA SP. Z O.O.', 0.356], ['KRKA, D.D., NOVO MESTO', 0.322], ['INPHARM SP. Z O.O.', 0.152], ['ADAMED PHARMA S.A.', 0.123]], 36.173425), 'Selegilini hydrochloridum': ([['BAUSCH HEALTH IRELAND LTD.', 1.0]], 0.2766), 'Insulinum humanum': ([['NOVO NORDISK A/S', 0.332], ['BIOTON S.A.', 0.332], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.335]], 55.888000000000005), 'Tolterodini tartras': ([['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.222], ['SYMPHAR SP. Z O.O.', 0.167], ['RECORDATI POLSKA SP. Z O.O.', 0.222], ['HOLSTEN PHARMA GMBH', 0.167], ['ZENTIVA, K.S.', 0.222]], 1.852734126984127), 'Rifampicinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 2.3798500000000002), 'Ipatropii bromidum momonydricum': ([['GLENMARK PHARMACEUTICALS S.R.O.', 1.0]], 16.290000000000003), 'Fenofibratum': ([['BIOFARM SP. Z O.O.', 0.252], ['BAUSCH HEALTH IRELAND LTD.', 0.252], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.243], ['MYLAN HEALTHCARE SP. Z O.O.', 0.252]], 2.0502777777777776), 'Candesartanum cilexetilum': ([['KRKA, D.D., NOVO MESTO', 0.375], ['SANDOZ GMBH', 0.625]], 1.4266666666666667), 'Pantoprazolum': ([['ADAMED PHARMA S.A.', 0.07], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.068], ['TAKEDA PHARMA SP. Z O.O.', 0.093], ['SANDOZ GMBH', 0.07], ['EGIS PHARMACEUTICALS PLC', 0.07], ['KRKA, D.D., NOVO MESTO', 0.07], ['DELFARMA SP. Z O.O.', 0.084], ['PHARMAPOINT SA', 0.084], ['ZENTIVA, K.S.', 0.07], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.07], ['ACTAVIS GROUP PTC EHF.', 0.093], ['SYNOPTIS PHARMA SP. Z O.O.', 0.088], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.07]], 2.3818988095238094), 'Ciclesonidum': ([['COVIS PHARMA EUROPE B.V.', 1.0]], 100.195), 'Paroxetini hydrochloridum (semihydricum)': ([['ORION CORPORATION', 1.0]], 0.3216666666666666), 'Doxycyclinum': ([['POLFARMEX S.A.', 0.5], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.5]], 1.084), 'Silodosinum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.492], ['RECORDATI IRELAND LIMITED', 0.508]], 0.6626666666666667), 'Rosuvastatinum calicum': ([['BAUSCH HEALTH IRELAND LTD.', 0.144], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.124], ['BIOFARM SP. Z O.O.', 0.114], ['KRKA, D.D., NOVO MESTO', 0.121], ['SANDOZ GMBH', 0.109], ['ADAMED PHARMA S.A.', 0.113], ['ZAKŁAD FARMACEUTYCZNY ADAMED PHARMA S.A.', 0.137], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.14]], 3.2550813822751326), 'Levomepromazini maleas': ([['PROTERAPIA SP. Z O.O.', 1.0]], 0.2394), 'Chlorprothixeni hydrochloridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZENTIVA, K.S.', 0.5]], 0.39590000000000003), 'Rosuvastatin calcium': ([['MEDICAL VALLEY INVEST AB', 1.0]], 0.29410714285714284), 'Insulinum glulisinum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 1.0]], 34.234), 'Salbutamolum': ([['EXELTIS POLAND SP. Z O.O.', 1.0]], 7.410000000000001), 'Megestroli acetas': ([['POLFARMEX S.A.', 0.25], ['BAUSCH HEALTH IRELAND LTD.', 0.25], ['VIPHARM S.A.', 0.25], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.25]], 2.212833333333333), 'Dapagliflozinum': ([['ASTRAZENECA AB', 1.0]], 3.7353333333333336), 'Dutasteridum': ([['ADAMED PHARMA S.A.', 0.338], ['ARISTO PHARMA SP. Z O.O.', 0.304], ['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.357]], 1.843), 'Oxycodoni hydrochloridum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.196], ['MUNDIPHARMA A/S', 0.198], ['G.L. PHARMA GMBH', 0.192], ['ACTAVIS GROUP PTC EHF.', 0.16], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.254]], 10.957126851851852), 'Lanreotidi acetas': ([['IPSEN PHARMA', 1.0]], 5209.405), 'Febuxostatum': ([['MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.', 0.258], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.258], ['KRKA, D.D., NOVO MESTO', 0.258], ['SYNOPTIS PHARMA SP. Z O.O.', 0.226]], 2.2366964285714284), 'Metoprololi tartras': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.377], ['MEDREG S.R.O.', 0.623]], 0.2925), 'Prednisonum': ([['ADAMED PHARMA S.A.', 1.0]], 0.6162562499999998), 'Tolterodini hydrogenotartras': ([['ZENTIVA, K.S.', 1.0]], 0.2057142857142857), 'Morphini sulfas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.077], ['MUNDIPHARMA A/S', 0.05], ['L.MOLTENI & C. DEI F.LII ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.872]], 23.003333333333334), 'Acidum valproicum + Natrii valproas': ([['SANDOZ GMBH', 1.0]], 0.5578333333333334), 'Brivaracetamum': ([['UCB PHARMA S.A.', 1.0]], 6.400535714285715), 'Valsartanum': ([['AUROVITAS PHARMA POLSKA SP. Z O.O.', 0.057], ['POLFARMEX S.A.', 0.062], ['TEVA PHARMACEUTICALS POLSKA SP. Z O.O.', 0.066], ['NOVARTIS POLAND SP. Z O.O.', 0.083], ['SANDOZ GMBH', 0.103], ['EGIS PHARMACEUTICALS PLC', 0.072], ['KRKA, D.D., NOVO MESTO', 0.103], ['DELFARMA SP. Z O.O.', 0.128], ['MEDICAL VALLEY INVEST AB', 0.053], ['ZENTIVA, K.S.', 0.062], ['CELON PHARMA S.A.', 0.062], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.066], ['INPHARM SP. Z O.O.', 0.083]], 6.474502999811036), 'Biperideni hydrochloridum': ([['DESMA GMBH', 0.667], ['DELFARMA SP. Z O.O.', 0.333]], 0.5945333333333334)}\n",
      "--------------------------------------\n",
      "Monopolists: 220\n",
      "Podmiot odpowiedzialny: SANDOZ GMBH, Liczba wygranych: 18\n",
      "Podmiot odpowiedzialny: ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A., Liczba wygranych: 13\n",
      "Podmiot odpowiedzialny: DELFARMA SP. Z O.O., Liczba wygranych: 11\n",
      "Podmiot odpowiedzialny: KRKA, D.D., NOVO MESTO, Liczba wygranych: 10\n",
      "Podmiot odpowiedzialny: ADAMED PHARMA S.A., Liczba wygranych: 9\n"
     ]
    }
   ],
   "source": [
    "entity_nodes_g_avg = {n for n, d in g_avg.nodes(data=True) if d['bipartite'] == 1}\n",
    "substance_nodes_g_avg = {n for n, d in g_avg.nodes(data=True) if d['bipartite'] == 0}\n",
    "\n",
    "entity_share = network_util.get_entity_share(g_avg, substance_nodes_g_avg)\n",
    "print(entity_share)\n",
    "print(\"--------------------------------------\")\n",
    "\n",
    "favored_producers, n_monopolists = network_util.get_favored_producer(entity_share)\n",
    "print(f\"Monopolists: {n_monopolists}\")\n",
    "for elem in sorted(list(favored_producers.items()), key=lambda x : x[1], reverse=True)[:5]:\n",
    "    print(f\"Podmiot odpowiedzialny: {elem[0]}, Liczba wygranych: {elem[1]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Quinaprilum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 1.0]], 0.212), 'Travoprostum + Timololum': ([['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 1.0]], 28.97), 'Insulinum glarginum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS S.P.A.', 0.247], ['SANOFI-AVENTIS DEUTSCHLAND GMBH', 0.753]], 219.70499999999998), 'Pyridostigmini bromidum': ([['ICN POLFA RZESZÓW S.A. LABIANA PHARMACEUTICALS, S.L.', 1.0]], 0.6540666666666667), 'Cenobamate': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA SWISS CAPS GMBH', 1.0]], 17.5725), 'Ergotamini tartras': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.156), 'Fentanylu cytrynian -': ([['ARDENA PAMPLONA S.L. BLUEPHARMA INDUSTRIA FARMACEUTICA S.A.', 1.0]], 15.229642857142858), 'Cefaclorum': ([['ACS DOBFAR S.P.A TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 2.9758571428571425), 'Anastrozolum': ([['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.126], ['IVAX PHARMACEUTICALS, S.R.O. MERCKLE GMBH PHARMACHEMIE B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.127], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES GENERIS FARMACEUTICA, S.A.', 0.118], ['DOPPEL FARMACEUTICI S.R.L. GENEPHARM S.A.', 0.127], ['HAUPT PHARMA MUENSTER GMBH', 0.127], ['VIPHARM S.A.', 0.127], ['EGIS PHARMACEUTICALS PLC SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.127], [nan, 0.119]], 14.83045238095238), 'Azytromycyna dwuwodna': ([['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH SANDOZ S.R.L.', 0.5], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.5]], 30.78666666666666), 'Pancreatinum': ([['ABBOTT LABORATORIES GMBH, WERK NEUSTADT', 1.0]], 1.2598), 'Furaginum (': ([['ADAMED PHARMA S.A.', 1.0]], 0.09033333333333333), 'Paliperidonum': ([['PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.158], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.158], ['ADAMED PHARMA S.A. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.182], ['ACTAVIS GROUP PTC EHF.', 0.158], ['JANSSEN PHARMACEUTICA N.V.', 0.343]], 9992.043333333335), 'Tetrabenazinum': ([['AOP ORPHAN PHARMACEUTICALS GMBH', 1.0]], 3.846964285714286), 'Enalaprili maleas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.27808333333333335), 'Chloroquini phosphas': ([['ADAMED PHARMA S.A.', 1.0]], 0.471), 'Dienogestum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.143], ['ARISTO PHARMA GMBH', 0.143], [nan, 0.143], ['LABORATORIOS LEON FARMA, S.A.', 0.143], ['SYMPHAR SP. Z O.O.', 0.143], ['BAYER WEIMAR GMBH UND CO. KG', 0.143], ['GEDEON RICHTER PLC.', 0.143]], 8.305), 'Amantadini hydrochloridum': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.29540000000000005), 'Enoxaparinum natricum': ([['CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. - CSANYIKVOLGY SITE SANOFI WINTHROP INDUSTRIE SANOFI WINTHROP INDUSTRIE SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.333], ['SANOFI WINTHROP INDUSTRIE SANOFI WINTHROP INDUSTRIE SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.333], [nan, 0.333]], 283.698), 'Clopidogrelum hydrosulfas': ([['ACTAVIS LTD.', 0.198], ['ADAMED PHARMA S.A.', 0.202], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.202], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.197], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.202]], 3.263571428571429), 'Lansoprazolum': ([['KRKA, D.D., NOVO MESTO', 0.5], ['LABORATORIOS LICONSA, S.A.', 0.5]], 0.6657142857142857), 'Posaconazolum': ([['GENEPHARM S.A. RAFARM S.A.', 0.336], ['GENEPHARM S.A. RAFARM S.A. STADA ARZNEIMITTEL AG STADA ARZNEIMITTEL AG', 0.332], ['GENEPHARM S.A. MERCKLE GMBH RAFARM S.A. TEVA OPERATIONS POLAND SP. Z O.O.', 0.331]], 20.164571428571428), 'Glyceroli trinitras': ([['EGIS PHARMACEUTICALS PLC', 0.897], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.103]], 1.5073939393939393), 'Dornasum alfa': ([[nan, 1.0]], 81.79566666666668), 'Beclometasoni dipropionas': ([['CHIESI PHARMACEUTICALS GMBH CHIESI PHARMACEUTICI S.P.A. CHIESI SAS', 0.42], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI SAS', 0.085], [nan, 0.074], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI S.A.S.', 0.42]], 1160.3574999999998), 'Calcipotriolum': ([['ARISTO PHARMA GMBH C.P.M. CONTRACTPHARMA GMBH', 0.195], ['LEO LABORATOIRES LTD. LEO PHARMA A/S', 0.202], ['LEO LABORATOIRES LTD.', 0.135], ['C.P.M. CONTRACTPHARMA GMBH', 0.194], ['COLEP LAUPHEIM GMBH & CO. KG LEO LABORATORIES LTD. LEO PHARMA A/S', 0.004], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.27]], 274.192), 'Tamoxifeni citras': ([['SALUTAS PHARMA GMBH', 0.434], ['EGIS PHARMACEUTICALS PLC', 0.566]], 1.193), 'Ropiniroli hydrochloridum': ([['ACTAVIS LTD.', 0.19], ['VIPHARM S.A.', 0.119], ['ACTAVIS LTD. ADAMED PHARMA S.A.', 0.19], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.19], ['GLAXO WELLCOME S.A.', 0.068], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.054], ['EGIS PHARMACEUTICALS PLC PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.19]], 26.984571428571428), 'Ethambutoli dihydrochloridum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 0.44612), 'Donepezili hydrochloridum monohydricum': ([['BIOFARM SP. Z O.O.', 0.106], ['ACTAVIS GROUP PTC EHF. ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.108], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMAPATH S.A.', 0.072], ['BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A. ICN POLFA RZESZÓW', 0.072], ['CELON PHARMA S.A.', 0.108], ['BLUEFISH PHARMACEUTICALS AB', 0.099], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.108], ['ADAMED PHARMA S.A. GENEPHARM S.A.', 0.108], ['KRKA, D.D., NOVO MESTO', 0.108], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.108]], 12.995845238095239), 'Pyrazinamidum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE FARMAPOL SP. Z O.O.', 1.0]], 0.63844), 'Fentanyli citras': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ETYPHARM', 0.5], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ETHYPHARM', 0.5]], 242.21599999999998), 'Buprenorphinum': ([['G.L. PHARMA GMBH', 0.5], ['GRUENENTHAL GMBH', 0.5]], 96.062), 'Omeprazolum': ([['LABORATORIOS LICONSA, S.A.', 0.066], ['TOWA PHARMACEUTICALS EUROPE, S.L.', 0.044], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U.', 0.022], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.066], ['S.C. ZENTIVA S.A.', 0.066], ['INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A.', 0.035], ['TEVA PHARMA S.L.U. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.066], ['ADAMED PHARMA S.A.', 0.022], ['TEVA PHARMA, S.L.U.', 0.614]], 10.111988095238097), 'Dabigatranu eteksylan w postaci mezylanu': ([['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 3.003703703703704), 'Duloxetini hydrochloridum': ([['TOWA PHARMACEUTICALS EUROPE, S.L.', 0.428], ['GENERICON PHARMA GES.M.B.H.', 0.425], ['TERAPIA S.A. TOWA PHARMACEUTICALS EUROPE, S.L.', 0.147]], 2.5368809523809523), 'Ezetimibum': ([['ACTAVIS LTD. BALKANPHARMA - DUPNITSA AD', 0.072], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.068], ['ADAMED PHARMA S.A. GENERICON PHARMA GESELLSCHAFT M.B.H.', 0.072], ['ZENTIVA, K.S.', 0.072], ['LABORATORIOS LICONSA S.A.', 0.072], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.072], ['GLENMARK ARZNEIMITTEL GMBH GLENMARK PHARMACEUTICALS EUROPE LIMITED GLENMARK PHARMACEUTICALS S.R.O. ORION CORPORATION PHARMADOX HEALTHCARE LTD.', 0.072], [nan, 0.072], ['HENNIG ARZNEIMITTEL GMBH & CO. KG', 0.215], ['ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS, D.D.', 0.215]], 4.6321626984126985), 'Acebutololi hydrochloridum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.11), 'Spironolactonum': ([['ORION CORPORATION ORION CORPORATION', 0.353], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.295], ['GEDEON RICHTER PLC.', 0.299], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.052]], 2.6745666666666668), 'Haloperidoli decanoas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 7.22), 'Acidum zoledronicum': ([['EGIS PHARMACEUTICALS PLC SM FARMACEUTICI SRL', 0.203], [nan, 0.203], ['ACTAVIS ITALY S.P.A.', 0.195], ['DEMO S.A. PHARMACEUTICAL INDUSTRY', 0.196], ['VIPHARM S.A.', 0.203]], 522.025), 'Methylprednisoloni acetas': ([['PFIZER MANUFACTURING BELGIUM NV', 1.0]], 15.22), 'Esomeprazolum magnesicum': ([['KRKA, D.D., NOVO MESTO', 0.332], ['ETHYPHARM ETHYPHARM S.C. ZENTIVA S.A.', 0.334], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.333]], 1.3214186507936507), 'Vortioxetini hydrobromidum': ([['H. LUNDBECK A/S', 1.0]], 3.319464285714286), 'Clarithromycinum': ([['KRKA, D.D., NOVO MESTO', 0.023], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.023], ['ALKALOIDA CHEMICAL CO. ZRT. S.C. TERAPIA S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.524], ['ABBOTT S.R.L.', 0.372], ['ABBVIE S.R.L.', 0.025], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.017], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.017]], 63.810009523809526), 'Fentanylum': ([['JANSSEN PHARMACEUTICA N.V.', 0.021], ['ACTAVIS GROUP PTC EHF. LUYE PHARMA AG', 0.024], ['CURIDA AS', 0.728], ['LTS LOHMANN THERAPIE SYSTEME AG', 0.027], ['LTS LOHMANN TERAPIE-SYSTEME GMBH NYCOMED DANMARK APS NYCOMED GMBH', 0.027], ['LTS LOHMANN TERAPIE-SYSTEME GMBH', 0.027], ['LTS LOHMANN THERAPIE SYSTEME AG NYCOMED GMBH', 0.027], ['L. MOLTENI & C. DEI F.LLI ALITTI SOCIETÀ DI ESERCIZIO SPA', 0.12]], 2643.0025000000005), 'Cefuroximum axetilum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.115], [nan, 0.068], ['APL SWIFT SERVICES (MALTA) LTD.', 0.07], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.599], ['ALKALOIDA CHEMICAL CO. ZRT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.071], ['GLAXOSMITHKLINE TRADING SERVICES LIMITED LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.)', 0.077]], 23.820071428571428), 'Budesonidum': ([['GENETIC S.P.A', 0.002], ['GENETIC S.P.A ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.006], ['ORION CORPORATION ORION PHARMA', 0.2], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.0], ['ALL-GEN PHARMACEUTICALS & GENERICS BV CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH', 0.032], ['ADAMED PHARMA S.A. GENETIC S.P.A. ', 0.004], ['COSMO S.P.A.', 0.008], ['ASTREA FONTAINE', 0.002], ['DR. FALK PHARMA GMBH', 0.013], ['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.0], ['MERCKLE GMBH', 0.006], ['ASTRAZENECA AB', 0.184], [nan, 0.002], ['AEROPHARM GMBH LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.029], ['AEROPHARM GMBH LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.) SALUTAS PHARMA GMBH', 0.06], ['ORION CORPORATION', 0.2], ['NORTON (WATERFORD) LIMITED T/A TEVA PHARMACEUTICALS IRELAND TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL EUROPE B.V.', 0.119], ['AEROPHARM GMBH LEK PHARMACEUTICALS, D.D. SALUTAS PHARMA', 0.089], ['ASTRAZENECA DUNKERQUE PRODUCTION', 0.043]], 1524.5116388888887), 'Buspironi hydrochloridum': ([[nan, 0.25], ['EGIS PHARMACEUTICALS PLC', 0.375], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.375]], 1.2915000000000003), 'Itraconazolum': ([['JOINT-STOCK COMPANY \"OLAINFARM\"', 0.343], ['JANSSEN-CILAG S.P.A.', 0.303], ['LICONSA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.354]], 4.265357142857143), 'Mercaptopurinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 1.0]], 1.7200000000000002), 'Perindoprili tosilas': ([['TEVA GYOGYSZERGYAR ZRT. TEVA OPERATIONS POLAND SP. Z O.O.', 0.5], ['PHARMACHEMIE B.V. TEVA GYÓGYSZERGYÁR ZRT. (TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.25], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.25]], 0.9533333333333331), 'Methotrexatum': ([['ACCORD HEALTHCARE POLSKA SP. Z O.O. WESSLING HUNGARY KFT.', 0.183], ['ACTAVIS ITALY S.P.A. S.C. SINDAN-PHARMA S.R.L.', 0.678], ['ORION CORPORATION ORION PHARMA ORION CORPORATION, ORION PHARMA', 0.002], ['BASIC PHARMA MANUFACTURING B.V.', 0.137]], 306.76166666666666), 'Indapamidum': ([['POLFARMEX S.A.', 0.108], ['PHARMACHEMIE B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.095], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.108], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.151], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.093], ['ORION CORPORATION', 0.108], ['KRKA, D.D., NOVO MESTO', 0.092], [nan, 0.096], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 0.108], ['LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 0.04]], 1.9784166666666667), 'Nadroparinum calcicum': ([['ASPEN NOTRE DAME DE BONDEVILLE GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 87.138), 'Ganirelixum': ([['GEDEON RICHTER PLC.', 1.0]], 48.55), 'Methylphenidati hydrochloridum': ([['JANSSEN PHARMACEUTICA N.V.', 0.326], ['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.674]], 13.014), 'Acitretinum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.505], ['CENEXI ROCHE POLSKA SP. Z O.O.', 0.495]], 10.908700000000001), 'Ethinylestradiolum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.248], ['BAYER PHARMA AG', 0.251], [nan, 0.251], ['GEDEON RICHTER PLC.', 0.251]], 1.0103174603174603), 'Methylprednisolonum': ([['PFIZER ITALIA S.R.L.', 0.025], ['MIBE GMBH ARZNEIMITTEL', 0.046], ['PFIZER MANUFACTURING BELGIUM NV', 0.929]], 32.3928), 'Fludrocortisoni acetas': ([['ADAMED PHARMA S.A.', 1.0]], 0.5980000000000001), 'Hydrocortisonum': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 1.0]], 0.22099999999999997), 'Perindoprilum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 1.0]], 0.0793333333333333), 'Cholecalciferolum koncentrat olejowy (vit. D': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.663), 'Levonorgestrelum': ([['HAUPT PHARMA MUENSTER GMBH PFIZER IRELAND PHARMACEUTICALS', 1.0]], 0.25333333333333335), 'Insulinum degludecum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 43.388), 'Tacrolimus': ([['ASTELLAS IRELAND CO., LTD.', 0.313], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.233], ['LEK PHARMACEUTICALS D.D.', 0.454]], 72.26733333333334), 'Terbinafinum': ([['BAUSCH HEALTH POLAND SP. Z O.O. LABORATORIOS LICONSA S.A.', 1.0]], 0.827857142857143), 'Medroxyprogesteroni acetas': ([['PFIZER ITALIA S.R.L.', 0.5], ['PFIZER ITALIA S.R.L. PFIZER MANUFACTURING BELGIUM NV', 0.5]], 1.1400000000000001), 'Acarbosum': ([['POLFARMEX S.A.', 1.0]], 0.6633333333333333), 'Everolimusum': ([['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY LTD. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S. NOVARTIS S.R.O. NOVARTIS SVERIGE AG SANDOZ S.R.L.', 0.5], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY LTD. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG SANDOZ S.R.L.', 0.5]], 88.80166666666666), 'Icatibanti acetas': ([['UNIVERSAL FARMA, S.L.', 1.0]], 2208.4100000000003), 'Acidum mycophenolicum': ([['ACCORD HEALTHCARE B.V. PHARMADOX HEALTHCARE LTD. STADA ARZNEIMITTEL AG', 1.0]], 2.31725), 'Buprenorphini hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 1.7560000000000002), 'Clobetasoli propionas': ([[nan, 0.5], ['ASPEN BAD OLDESLOE GMBH', 0.5]], 0.33319999999999994), 'Ipratropii bromidum': ([['LABORATORIO ALDO-UNION S.L. LABORATORIO ECHEVARNE, S.A.', 0.414], ['INSTITUTO DE ANGELI S.R.L.', 0.171], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.414]], 39.78), 'Nimesulidum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA BOEHRINGER INGELHEIM HELLAS S.A. CHINOIN PRIVATE CO. LTD DOVEMA S.R.O. FARMACIA MARTIN A.S. HELSINN BIREX PHARMACEUTICALS LTD. MEDICOM INTERNATIONAL S.R.O. MIPHARM S.P.A.', 0.175], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA DOVEMA S.R.O. FARMACIA MARTIN A.S. HELSINN BIREX PHARMACEUTICALS LTD. MEDICOM INTERNATIONAL S.R.O. MIPHARM S.P.A.', 0.413], ['FINE FOOD & PHARMACEUTICALS NTM S.P.A. LABORATORIOS MENARINI S.A.', 0.413]], 0.7301666666666666), 'Diclofenacum natricum': ([['EXCELVISION', 0.395], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.039], ['LEK PHARMACEUTICALS D.D.', 0.102], ['SWISS CAPS GMBH TEMMLER WERKE GMBH', 0.023], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.179], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.03], ['KRKA, D.D., NOVO MESTO', 0.105], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.023], ['MEPHA PHARMA GMBH MEPHA POLSKA SP. Z O.O. MERCKLE GMBH', 0.105]], 8.399666666666667), 'Denosumabum': ([['AMGEN EUROPE B.V. AMGEN NV AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY', 1.0]], 441.46), 'Methadoni hydrochloridum': ([['L.MOLTENI & C. DEI F.LII ALITTI SOCIETA DI ESERCIZIO S.P.A.', 1.0]], 0.06899999999999999), 'Natrii alendronas trihydricus': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 1.0]], 2.1675), 'Terbinafini hydrochloridum': ([['POLFARMEX S.A.', 0.5], ['ACTAVIS LTD. ', 0.5]], 1.6557142857142857), 'Mometasoni furoas monohydricum': ([['FARMEA', 0.5], ['ADAMED PHARMA S.A. FARMEA', 0.5]], 15.0), 'Quetiapini fumaras': ([['GENEPHARM S.A.', 0.049], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.049], ['MCDERMOTT LABORATORIES LTD T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.049], ['EGIS PHARMACEUTICALS PLC', 0.096], ['CELON PHARMA S.A.', 0.049], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A. SALUTAS PHARMA GMBH', 0.085], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.102], ['ADAMED PHARMA S.A. MERCKLE GMBH TEVA PHARMA S.L.U.', 0.171], ['ADAMED PHARMA S.A. MERCKLE GMBH PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.171], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.096], ['ELPEN PHARMACEUTICAL CO.INC. LABORATORI FUNDACIÓ DAU SYMPHAR SP. Z O.O. TERAPIA S.A.', 0.084]], 45.179833333333335), 'Tiagabinum': ([['ALMAC PHARMA SERVICES (IRELAND) LIMITED ALMAC PHARMA SERVICES LTD. BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['ALMAC PHARMA SERVICES (IRLANDIA) LIMITED ALMAC PHARMA SERVICES LTD. BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5]], 22.2208), 'Finasteridum': ([['ADAMED PHARMA S.A. APL SWIFT SERVICES (MALTA) LTD.', 0.068], ['HAUPT PHARMA MUENSTER GMBH SIEGFRIED MALTA LTD.', 0.068], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.068], ['ACTAVIS GROUP PTC EHF. ZENTIVA, K.S.', 0.068], [nan, 0.067], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.068], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.068], ['BLUEFISH PHARMACEUTICALS AB PHARMADOX HEALTHCARE LTD.', 0.051], ['ACTAVIS EHF. KRKA, D.D., NOVO MESTO', 0.068], ['ACTAVIS GROUP PTC EHF. GENERICON PHARMA GMBH G.L. PHARMA GMBH', 0.068], ['ZENTIVA, K.S.', 0.068], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.068], ['QUINTA-ANALYTICA S.R.O. SYMPHAR SP. Z O.O. ZENTIVA K.S.', 0.065], ['HEUMANN PHARMA GMBH PHARMADOX HEALTHCARE LTD.', 0.068], ['GEDEON RICHTER PLC.', 0.068]], 11.475165343915345), 'Insulinum glargine': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 1.0]], 21.694000000000003), 'Bimatoprostum': ([['RAFARM S.A.', 1.0]], 32.935), 'Donepezili hydrochloridum': ([[nan, 0.588], ['ORION CORPORATION ORION PHARMA ORION CORPORATION ORION PHARMA', 0.412]], 1.5937500000000002), 'Leflunomidum': ([['OPELLA HEALTHCARE INTERNATIONAL SAS', 0.207], ['BLUEFISH PHARMACEUTICALS AB HAUPT PHARMA MUENSTER GMBH', 0.205], ['HAUPT PHARMA MUENSTER GMBH MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.318], ['ORION CORPORATION PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.127], ['HAUPT PHARMA MUENSTER GMBH SALUTAS PHARMA GMBH', 0.143]], 26.125444444444447), 'Fenoksymetyolpenicylina potasowa': ([[nan, 1.0]], 24.884999999999998), 'Corifollitropin alfa': ([['N.V. ORGANON', 1.0]], 2718.88), 'Levocetirizini dihydrochloridum -': ([['ADAMED PHARMA S.A. MEDANA PHARMA S.A.', 1.0]], 15.950000000000001), 'sól sodowa atorwastatyny': ([['BIOFARM SP. Z O.O.', 1.0]], 0.40235185185185185), 'Flutamidum': ([[nan, 0.515], ['EGIS PHARMACEUTICALS PRIVATE LIMITED COMPANY', 0.485]], 1.4175111111111112), 'Triamcinolonum': ([['ADAMED PHARMA S.A.', 1.0]], 0.7729999999999999), 'Pojedyncze alergoidy pyłków roślin': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Betaxololi hydrochloridum': ([['ALCON-COUVREUR', 1.0]], 0.7714999999999999), 'Ramiprilum': ([[nan, 0.026], ['KRKA, D.D., NOVO MESTO', 0.039], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.033], ['ACTAVIS (BALKANPHARMA) DUPNISTA AD ACTAVIS LTD. ADAMED PHARMA S.A. EXTRACTUM PHARMA LTD.', 0.042], ['LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH', 0.04], ['ACTAVIS EHF. ACTAVIS LTD. BALKANPHARMA DUPNITSA AD ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.041], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.127], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.023], ['DELPHARM DIJON SANOFI AVENTIS DEUTSCHLAND GMBH SANOFI S.R.L. S.C. ZENTIVA S.A', 0.059], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD ORFICE MEDICAL AB', 0.038], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.038], ['BALKANPHARMA-DUPNITSA AD ORFICE MEDICAL AB', 0.038], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.091], ['EGIS PHARMACEUTICALS PLC', 0.091], ['ADAMED PHARMA S.A. IASIS PHARMACEUTICALS HELLAS S.A.', 0.09], ['LEK PHARMACEUTICALS D.D. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.091], ['CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. (CHINOIN PRIVATE CO. LTD.) - CSANYIKVOLGY SITE CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO. LTD. (CHINOIN PRIVATE CO. LTD.) - UJPEST SITE OPELLA HUNGARY LIMITED LIABILITY COMAPNY (OPELLA HEALTHCARE HUNGARY LTD.)', 0.017], ['OPELLA HUNGARY LIMITED LIABILITY COMAPNY (OPELLA HEALTHCARE HUNGARY LTD.)', 0.017], ['SANOFI AVENTIS DEUTSCHLAND GMBH SANOFI S.R.L. S.C. ZENTIVA S.A.', 0.059]], 13.276523809523809), 'Timololi maleas': ([['SIEGFRIED EL MASNOU, S.A.', 0.714], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.286]], 5.404), 'Felodipinum': ([['ASTRAZENECA AB ASTRAZENECA GMBH ASTRAZENECA REIMS PRODUCTION', 1.0]], 0.6064285714285714), 'Amiloridi hydrochloridum': ([['IPCA LABORATORIES LIMITED ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.4776), 'Phenytoinum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.2076666666666667), 'Tapentadolum': ([['GRUENENTHAL GMBH', 1.0]], 25.271833333333333), 'Benazeprili hydrochloridum': ([['MADAUS GMBH', 1.0]], 0.27017857142857143), 'Amoxicillinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.02], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACEUTICA, S.A.', 0.01], ['SANDOZ GMBH', 0.022], ['SALUTAS PHARMA GMBH SANDOZ GMBH', 0.457], [nan, 0.013], ['PANCEF PHARMA GMBH', 0.018], ['PENCEF PHARMA GMBH', 0.014], ['HAUPT PHARMA LATINA S.R.L.', 0.143], ['HAUPT PHARMA LATINA S.R.L. PENCEF PHARMA GMBH', 0.193], ['GLAXO WELLCOME PRODUCTION', 0.097], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.013]], 82.71532857142857), 'Cetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.014], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.014], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.014], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.343], ['KRKA, D.D., NOVO MESTO', 0.014], ['AESICA PHARMACEUTICALS S.R.L.', 0.014], [nan, 0.561], ['AESICA PHARMACEUTICALS S.R.L. PHOENIX PHARMA POLSKA SP. Z O.O.', 0.028]], 23.212000000000003), 'Estradioli valeras': ([['DELPHARM LILLE S.A.S. ORION CORPORATION', 0.545], ['DR. KADE PHARMAZEUTISCHE FABRIK GMBH HAUPT PHARMA MUENSTER GMBH', 0.455]], 0.891904761904762), 'Sulfamethoxazolum': ([['EUMEDICA PHARMACEUTICALS GMBH', 0.529], [nan, 0.047], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.343], ['ADAMED PHARMA S.A.', 0.08]], 22.210000000000004), 'Travoprostum': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.285], ['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.142], ['JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.144], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.285], ['ADAMED PHARMA S.A. BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 0.144]], 203.4083333333333), 'Aprepitantum': ([['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.255], ['ETHYPHARM ETHYPHARM', 0.255], ['LEK PHARMACEUTICALS D.D. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.255], ['CENTRAFARM SERVICES B.V. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. STADA ARZNEIMITTEL AG', 0.236]], 101.70333333333335), 'Olodaterolum': ([['BOEHRINGER INGELHEIM ESPANA S.A. BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 48.577000000000005), 'Atorvastatinum calcicum trihydricum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.215], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.082], ['LEK S.A.', 0.244], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.244], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.215]], 6.393666666666667), 'Simvastatinum': ([['APOTEX NEDERLAND B.V. FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.093], ['APOTEX NEDERLAND B.V. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.093], ['BALKANPHARMA-DUPNITSA AD', 0.05], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.058], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.058], ['ZENTIVA, K.S.', 0.058], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.025], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.05], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.058], ['APL SWIFT SERVICES (MALTA) LTD. FAREVA AMBOISE', 0.093], ['BLUEFISH PHARMACEUTICALS AB', 0.058], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.058], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.058], ['KRKA, D.D., NOVO MESTO', 0.058], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.025], ['ROTTENDORF PHARMA GMBH SYNTHON HISPANIA S.L.', 0.05], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.058]], 8.375904761904762), 'Ziprasidonum': ([['KRKA, D.D., NOVO MESTO', 1.0]], 3.7164285714285716), 'Midazolamum': ([['LABORATORIOS LESVI S.L. NEURAXPHARM ARZNEIMITTEL GMBH SHIRE PHARMACEUTICALS IRELAND LIMITED', 1.0]], 271.46999999999997), 'Losartanum kalicum': ([['BIOFARM SP. Z O.O.', 0.017], ['MERCK SHARP & DOHME B.V. ORGANON HEIST BV', 0.1], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.251], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.251], ['LABORATORIOS LICONSA S.A.', 0.014], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.251], ['PLIVA CROATIA LTD. (PLIVA HRVATSKA D.O.O.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.017], ['ZENTIVA, K.S.', 0.017], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMAPATH S.A.', 0.067], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.017]], 16.00704365079365), 'Fenofibratum (zmikronizowany)': ([[\"ASTREA FONTAINE DELPHARM L'AIGLE FAMAR L'AIGLE\", 1.0]], 0.44333333333333336), 'Ondansetroni hydrochloridum dihydricum': ([['EGIS PHARMACEUTICALS PLC', 0.289], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.289], ['GLAXOSMITHKLINE PHARMACEUTICALS S.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.422]], 14.589000000000002), 'Fluticasoni propionas': ([['TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.008], ['GLAXO WELLCOME S.A.', 0.001], ['GLAXO WELLCOME PRODUCTION GLAXO WELLCOME S.A.', 0.201], ['GLAXO WELLCOME PRODUCTION', 0.201], [nan, 0.001], ['ADAMED PHARMA S.A.', 0.002], ['POLFARMEX S.A.', 0.293], ['CELON PHARMA SP. Z O.O.', 0.294]], 797.0055416666667), 'Sertralinum': ([['BIOFARM SP. Z O.O.', 0.218], [nan, 0.169], ['KRKA, D.D., NOVO MESTO', 0.218], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.191], ['ACTAVIS LTD.', 0.204]], 4.532222222222222), 'Amoksycylina trójwodna': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.1118), 'Gliclazidum': ([['BALKANPHARMA-DUPNITSA AD', 0.145], ['L.MOLTENI & C. DEI F.LLI ALITTI SOCIETA DI ESERCIZIO S.P.A.', 0.037], ['MCDERMOTT LABORATORIES LIMITED (T.A. GERARD LABORATORIES) MYLAN HUNGARY KFT.', 0.096], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A.', 0.048], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.048], ['KRKA, D.D., NOVO MESTO', 0.145], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.144], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.096], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.096], ['SYMPHAR SP. Z O.O.', 0.145]], 2.293222222222222), 'Azithromycinum': ([['KRKA POLSKA SP. Z O.O.', 0.084], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.126], ['PSI SUPPLY N.V. SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.081], ['LEK PHARMACEUTICALS D.D. SANDOZ GMBH S.C. SANDOZ S.R.L.', 0.126], ['LEK PHARMACEUTICALS D.D. SANDOZ GMBH SANDOZ S.R.L.', 0.126], ['ZENTIVA, K.S.', 0.084], ['ADAMED PHARMA S.A. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.019], ['ADAMED PHARMA S.A.', 0.126], ['ICN POLFA RZESZÓW', 0.084], ['PLIVA CROATIA LTD. (PLIVA HRVATSKA D.O.O.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.105], ['PLIVA CROATIA LTD. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.042]], 21.098), 'Diltiazemi hydrochloridum': ([['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 1.0]], 0.9433333333333332), 'Leuprorelini acetas': ([['RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A', 0.565], ['EBEWE PHARMA GES.M.B.H NFG. KG EVER PHARMA JENA GMBH EVER PHARMA JENA GMBH SANDOZ GMBH', 0.251], ['AMW GMBH', 0.184]], 2951.9700000000003), 'Theophyllinum': ([['BIOFARM SP. Z O.O.', 0.51], ['TAKEDA GMBH', 0.49]], 0.7028666666666668), 'Sirolimusum': ([['PFIZER IRELAND PHARMACEUTICALS  PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.503], ['PFIZER SERVICE COMPANY BVBA', 0.497]], 33.586), 'Paroxetinum': ([['FARMACEUTISCH ANALYTISCH LABORATORIUM DUIVEN BV MEDOCHEMIE LTD. (FACTORY A) SANICO N.V.', 0.2], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.2], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.6]], 1.64625), 'Mometasoni furoas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.011], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.011], ['LEK PHARMACEUTICALS D.D.', 0.495], ['MERCKLE GMBH TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V.', 0.483]], 15.1457), 'Venlafaxinum': ([['KRKA, D.D., NOVO MESTO', 0.097], [nan, 0.081], ['LABORATORIOS LICONSA, S.A.', 0.101], ['BIOCHEM LABOR FUER BIOLOGISCHE UND CHEMISCHE ANALYTIK GMBH EUROPHARTECH MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. PHARMA-PACK KFT. PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.014], ['ADAMED PHARMA S.A. MYLAN HUNGARY KFT. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.102], ['ADAMED PHARMA S.A. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.102], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON', 0.099], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS', 0.099], ['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 0.102], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.102], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.102]], 19.248404761904762), 'Pantoprazolum -': ([['ACTAVIS DEUTSCHLAND GMBH & CO. KG ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 1.0]], 0.11098214285714286), 'Melphalanum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 4.7976), 'Insulina ludzka biosyntetyczna wysokooczyszczona': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 18.744), 'Flupentixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.7796), 'Venlafaxini hydrochloridum': ([['PFIZER IRELAND PHARMACEUTICALS PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.129], ['BALKANPHARMA-DUPNITSA AD', 0.149], ['BIOCHEM LABOR FUER BIOLOGISCHE UND CHEMISCHE ANALYTIK GMBH EUROPHARTECH MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. PHARMA-PACK KFT. PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.113], ['ORION CORPORATION ORION CORPORATION', 0.182], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.182], ['PHARMATHEN INTERNATIONAL S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.15], [nan, 0.094]], 13.039744897959185), 'Amlodipini besilas': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.106], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 0.135], ['POLFARMEX S.A.', 0.151], ['ADAMED PHARMA S.A.', 0.107], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.147], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 0.354]], 3.7818333333333336), 'stiripentolum': ([['BIOCODEX', 1.0]], 36.82766666666666), 'Desloratadinum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.013], ['BALKANPHARMA-TROYAN AD WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA', 0.396], ['PHARMAPATH S.A. WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA', 0.012], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.013], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.011], ['FAMAR A.V.E. FAMAR S.A. GENEPHARM S.A. GLENMARK PHARMACEUTICALS S.R.O.', 0.003], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.013], ['ADAMED PHARMA S.A. FAMAR A.V.E. GENEPHARM S.A.', 0.495], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.019], [nan, 0.012], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.013]], 24.180231481481485), 'Kalii chloridum': ([['DELPHARM POZNAŃ S.A.', 1.0]], 0.09266666666666666), 'Mianserini hydrochloridum': ([['ADAMED PHARMA S.A.', 0.261], ['BAUSCH HEALTH POLAND SP. Z O.O. PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.11], ['GERARD LABORATOIRES LTD. MYLAN HUNGARY KFT./MYLAN HUNGARY LTD', 0.26], ['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT./MYLAN HUNGARY LTD', 0.26], ['ORGANON HEIST BV', 0.11]], 7.649638888888889), 'Tizanidinum': ([[nan, 1.0]], 1.0539999999999998), 'Collagenasum N (o aktywności klostrydiopeptydazy A nie mniej niż': ([['NORDMARK PHARMA GMBH', 1.0]], 1.038), 'Valganciclovirum': ([['PRESTIGE PROMOTION VERKAUFSFÖRDERUNG & WERBESERVICE GMBH PRESTIGE PROMOTION VERKAUFSFÖRDERUNG & WERBESERVICE GMBH', 0.99], ['ACCORD HEALTHCARE POLSKA SP. Z O.O. PHARMADOX HEALTHCARE LTD.', 0.01]], 793.2343333333332), 'Nitrendipinum': ([['EGIS PHARMACEUTICALS PLC, SITE 3', 1.0]], 0.2401666666666667), 'Wirus grypy (inaktywowany, rozszczepiony) Szczepy:  A/Victoria/': ([['SANOFI PASTEUR SANOFI PASTEUR SANOFI-AVENTIS ZRT.', 1.0]], 26.6), 'Olanzapinum': ([[nan, 0.001], ['ORION CORPORATION', 0.004], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.001], ['MCDERMOTT LABORATORIES LIMITED (T.A. GERARD LABORATORIES) MYLAN HUNGARY KFT.', 0.004], ['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.004], ['ADAMED PHARMA S.A.', 0.005], ['ADAMED PHARMA S.A. ADAMED SP. Z O.O.', 0.002], ['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.002], ['BASICS GMBH CEMELOG BRS KFT. RANBAXY IRELAND LIMITED TERAPIA S.A.', 0.005], ['CEMELOG BRS LTD. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.001], ['CEMELOG BRS KFT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.001], ['ACTAVIS GROUP PTC EHF. ACTAVIS LTD. BALKANPHARMA DUPNITSA AD', 0.002], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.005], ['VIPHARM S.A.', 0.002], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.002], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.005], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\"', 0.002], ['ADAMED PHARMA S.A. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.002], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.005], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A.', 0.005], ['LILLY S.A.', 0.938]], 2804.469239229025), 'Fluoxetini hydrochloridum': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.286], ['EGIS PHARMACEUTICALS LTD. EGIS PHARMACEUTICALS PLC', 0.286], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.286], ['ORION CORPORATION', 0.143]], 1.1525857142857143), 'Octreotidi acetas': ([['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARIA KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.001], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.001], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.499], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS FARMA-PRODUCTOS FAMACEUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) SA NOVARTIS HUNGARY KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O.', 0.499]], 7340.384), 'Natrii alendronas': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.504], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.496]], 4.34375), 'Thymolum': ([['ALLERGAN PHARMACEUTICALS IRELAND', 1.0]], 23.29), 'Atorvastatin calcium trihydrate': ([['LABORATORIOS LICONSA S.A.', 1.0]], 0.5479999999999999), 'Flupentixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 13.740000000000002), 'Indakaterol': ([['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.5], ['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 0.5]], 21.960666666666665), 'Tianeptinum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.333], [nan, 0.333], ['ADAMED PHARMA S.A. LABORATORIOS LICONSA, S.A.', 0.333]], 0.7470000000000001), 'Pregabalinum': ([['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.238], ['VIPHARM S.A.', 0.241], ['NEURAXPHARM PHARMACEUTICALS, S.L.', 0.274], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.247]], 10.689678571428571), 'Quinaprili hydrochloridum': ([['BIOFARM SP. Z O.O.', 0.462], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.538]], 0.22933333333333333), 'Dulaglutidum': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE', 1.0]], 275.86), 'Dorzolamidum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 0.386], ['ADAMED PHARMA S.A. RAFARM S.A.', 0.386], ['EXCELVISION PHARMATHEN S.A.', 0.228]], 97.09500000000001), 'Lisinoprilum dihydricum': ([['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.059], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.059], ['GEDEON RICHTER PLC.', 0.255], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.058], ['FARMACOL S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.058], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.255], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.255]], 4.016880952380952), 'Telmisartanum': ([['BIOFARM SP. Z O.O. DELORBIS PHARMACEUTICALS LTD.', 0.047], ['ACTAVIS EHF. ACTAVIS LTD.', 0.041], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DELPHARM REIMS S.A.S. ROTTENDORF PHARMA GMBH', 0.023], ['ACTAVIS LTD.', 0.041], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.017], ['LABORATORIOS LICONSA, S.A. ', 0.017], ['EGIS PHARMACEUTICALS PLC GLENMARK PHARMACEUTICALS S.R.O.', 0.017], [nan, 0.047], ['LABORATORIOS LICONSA, S.A. SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.047], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.017], ['ACTAVIS LTD. ADAMED PHARMA S.A.', 0.047], ['ZENTIVA, K.S. ZENTIVA S.A.', 0.041], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.081], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.017], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW LABORATORIOS LICONSA, S.A. PHARMASWISS D.O.O.', 0.047], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.082], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.081], ['ACTAVIS LTD. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.023], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 0.023], ['ACTAVIS LTD. EGIS PHARMACEUTICALS PLC', 0.029], ['S.C. ZENTIVA S.A. ZENTIVA, A.S.', 0.006], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.041], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.081], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.029], ['LABORATORIOS LICONSA, S.A.', 0.047], ['PRO.MED.CS PRAHA A.S.', 0.012]], 45.90171768707483), 'Duloxetine hydrochloride': ([['ADAMED PHARMA S.A.', 1.0]], 1.120625), 'Oxcarbazepinum': ([['MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.26], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.26], ['ADAMED PHARMA S.A. ATLANTIC PHARMA - PRODUCOES FARMACEUTICAS SA FARMALABOR - PRODUTOS FARMACEUTICOS, S.A.', 0.226], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.226], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS POLAND SP. Z O.O.', 0.029]], 11.18644), 'Furazidinum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['ADAMED PHARMA S.A.', 0.5]], 0.36133333333333334), 'Travoprostum + Timololi maleas': ([['BALKANPHARMA-RAZGRAD AD JADRAN-GALENSKI LABORATORIJ D.D. PHARMATHEN S.A.', 1.0]], 28.970000000000002), 'Ciprofibratum': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE SANOFI WINTHROP INDUSTRIE', 1.0]], 0.44333333333333336), 'Salmeterolu ksynafonian': ([['AEROPHARM GMBH', 0.245], ['ADAMED PHARMA S.A. GENETIC S.P.A', 0.347], ['ELPEN PHARMACEUTICAL CO.INC.', 0.245], ['POLFARMEX S.A.', 0.081], ['GLAXO WELLCOME PRODUCTION', 0.081]], 676.3800000000001), 'Ganirelixi acetas': ([['N.V. ORGANON', 1.0]], 48.55000000000001), 'Famotidinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.32399999999999995), 'Sotaloli hydrochloridum': ([['LEK S.A. SALUTAS PHARMA GMBH', 1.0]], 0.7815), 'Insulinum detemirum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 21.694), 'Trazodoni hydrochloridum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. ISTITUTO DE ANGELI S.R.L', 0.25], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. INSTITUTO DE ANGELI S.R.L.', 0.25], ['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.', 0.5]], 2.241), 'Pancreatinum o aktywności: Lipazy': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.6854166666666668), 'Sitagliptin hydrochloride monohydrate': ([['LABORATORIOS LICONSA S.A.', 0.1], ['GALENICUM HEALTH, S.L. SAG MANUFACTURING S.L.U.', 0.2], ['CENTRAFARM SERVICES B.V. LABORATORIOS LICONSA S.A. STADA ARZNEIMITTEL AG STADA ARZNEIMITTEL GMBH', 0.2], ['ADAMED PHARMA S.A.', 0.4], ['ADAMED PHARMA S.A. MERCKLE GMBH MERCKLE GMBH', 0.1]], 3.842952380952381), 'Thiethylperazini dimaleas': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4046), 'Tacrolimusum monohydricum': ([['ASTELLAS IRELAND CO., LTD.', 0.271], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH ROTTENDORF PHARMA GMBH', 0.729]], 41.93644444444445), 'Chlorambucilum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 3.6395999999999997), 'Topiramatum': ([['APL SWIFT SERVICES (MALTA) LTD. LACHIFARMA S.R.L. LABORATORIO CHIMICO FARMACEUTICO SALENTINO', 0.017], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.017], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.017], ['ORION CORPORATION, ORION PHARMA', 0.008], ['JANSSEN CILAG S.P.A JANSSEN PHARMACEUTICA N.V. LUSOMEDICAMENTA - SOCIEDADE TECNICA FARMACEUTICA S.A.', 0.463], ['JANSSEN PHARMACEUTICA N.V. JANSSEN-CILAG S.P.A. LUSOMEDICAMENTA - SOCIEDADE TECNICA FARMACEUTICA S.A.', 0.463], ['GLENMARK ARZNEIMITTEL GMBH GLENMARK PHARMACEUTICALS S.R.O.', 0.016]], 251.50909523809526), 'Fenoteroli hydrobromidum': ([['BOEHRINGER INGELHEIM PHARMA KG', 0.497], ['INSTITUTO DE ANGELI S.R.L.', 0.007], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.497]], 49.58100000000001), 'Lisinoprilum': ([[nan, 1.0]], 0.15899999999999997), 'Letrozolum': ([['CELON PHARMA SP. Z O.O.', 0.17], ['S.C. SINDAN-PHARMA S.R.L.', 0.17], ['ROTTENDORF PHARMA GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.163], ['VIPHARM S.A.', 0.17], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.161], ['BLUEFISH PHARMACEUTICALS AB GENEPHARM S.A.', 0.167]], 11.139958333333333), 'Fluticasoni furoas': ([['GLAXO WELLCOME PRODUCTION', 1.0]], 143.69), 'Amoxicillin trihydrate': ([[nan, 0.334], ['PENCEF PHARMA GMBH', 0.325], ['ALKALOIDA CHEMICAL CO. ZRT. ECOPHARM EOOD SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.342]], 2.9190714285714288), 'Duloxetinum': ([['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.08], ['MCDERMOTT LABORATORIES LIMITED T/A GERARD LABORATORIES T/A MYLAN DUBLIN MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.081], ['S.C. ZENTIVA S.A', 0.076], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.158], [nan, 0.05], ['NEURAXPHARM PHARMACEUTICALS, S.L.', 0.25], ['LABORATORIOS LESVI S.L.', 0.25], ['TERAPIA S.A. TOWA PHARMACEUTICALS EUROPE, S.L.', 0.054]], 13.819800264550265), 'Montelukastum natricum': ([['POLFARMEX S.A.', 0.087], ['ADAMED PHARMA S.A.', 0.087], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.087], ['BLUEFISH PHARMACEUTICALS AB', 0.096], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.097], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.087], [nan, 0.097], ['ORION CORPORATION ORION CORPORATION, ORION PHARMA', 0.087], ['HBM PHARMA S.R.O. SANECA PHARMACEUTICALS A.S.', 0.087], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.097], ['SUN PHARMACEUTICALS INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.087]], 5.982547619047618), 'Diazepamum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 1.0]], 8.9), 'Amlodipini besilas -': ([['ADAMED PHARMA S.A.', 1.0]], 0.2023333333333333), 'Cyclophosphamidum': ([['BAXTER ONCOLOGY GMBH', 1.0]], 1.7624), 'Filgrastimum': ([['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE LIMITED ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.495], ['SANDOZ GMBH', 0.505]], 167.31885714285715), 'Mieszanki alergoidów pyłku roślin (zgodnie z załącznikeim I)': ([['HAL ALLERGY B.V.', 1.0]], 265.0), 'Insulini injectio neutralis aspartum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 1.0]], 19.356), 'Clindamycinum': ([['HAUPT PHARMA WÜLFING GMBH', 0.667], ['FAREVA AMBOISE', 0.333]], 1.9402083333333335), 'Oxybutynini hydrochloridum': ([['ASTREA FONTAINE', 0.5], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.5]], 0.4095), 'Carvedilolum': ([['ZENTIVA, K.S.', 0.122], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.122], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.122], ['MERCKLE GMBH TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICAL WORKS PVT. LTD.', 0.122], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.13], ['KRKA, D.D., NOVO MESTO', 0.13], ['KRKA, D.D., NOVO MESTO SCANPHARM A/S', 0.13], ['EGIS PHARMACEUTICALS PLC', 0.122]], 2.910583333333333), 'Nebivololi hydrochloridum': ([['LABORATORI FUNDACIO DAU SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.12], ['GENERICON PHARMA GMBH PHARMAPATH S.A.', 0.127], ['ACTAVIS HF. ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.123], ['PHARMAPATH S.A.', 0.126], ['BERLIN-CHEMIE AG (MENARINI GROUP)', 0.127], ['SPECIFAR S.A.', 0.127], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.124], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.127]], 2.5202916666666666), 'Fluvoxamini maleas': ([['MYLAN LABORATOIRES SAS', 1.0]], 0.494), 'Naldemedinum': ([['SHIONOGI B.V.', 1.0]], 8.73857142857143), 'Levocetirizini dihydrochloridum': ([['BIOFARM SP. Z O.O.', 0.006], ['MEDIS INTERNATIONAL A.S. PHARMADOX HEALTHCARE LTD.', 0.006], ['KRKA, D.D., NOVO MESTO', 0.006], [nan, 0.319], ['ADAMED PHARMA S.A.', 0.006], ['ADAMED PHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.319], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.006], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.006], ['AESICA PHARMACEUTICALS S.R.L.', 0.319], ['ZENTIVA, K.S.', 0.006]], 50.04762499999999), 'Isosorbidi mononitras': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE', 1.0]], 0.9153333333333333), 'Fluconazolum': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.165], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE', 0.089], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.384], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.045], ['GENERIS FARMACÊUTICA, S.A.,', 0.026], ['POLFARMEX S.A.', 0.001], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.054], ['PHARMAPATH S.A.', 0.087], [nan, 0.087], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.027], ['GEDEON RICHTER PLC.', 0.035]], 84.16237619047618), 'Tafluprostum': ([['SANTEN OY TUBILUX PHARMA S.P.A.', 0.5], ['SANTEN OY', 0.5]], 52.24133333333333), 'Candesartanum cilexetilum + Amlodipinum': ([['ZENTIVA, K.S.', 1.0]], 0.5349999999999999), 'Glucagoni hydrochloridum': ([['NOVO NORDISK A/S', 1.0]], 62.53999999999999), 'Nebivololum': ([['BIOFARM SP. Z O.O.', 0.267], ['BIOFARM SP. Z O.O. PHARMAPATH S.A.', 0.267], ['ADAMED PHARMA S.A.', 0.094], ['PHARMAPATH S.A.', 0.094], ['KRKA, D.D., NOVO MESTO', 0.094], ['ORION CORPORATION', 0.092], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.094]], 3.4104476190476194), 'Amlodipini maleas': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 1.0]], 0.5596666666666668), 'Gentamicini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 4.55), 'Verapamili hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.40249999999999997), 'Naproxenum': ([['ADAMED PHARMA S.A.', 0.14], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.14], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.486], ['SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.14], ['POLFARMEX S.A.', 0.094]], 2.731638888888889), 'Busulfanum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 8.5168), 'Sertralini hydrochloridum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.135], ['ORION CORPORATION ORION CORPORATION', 0.157], ['KRKA, D.D., NOVO MESTO SPECIFAR ABEE TAD PHARMA GMBH', 0.144], ['TEVA PHARMA, S.L.U.', 0.169], ['EGIS PHARMACEUTICALS PLC', 0.056], ['HAUPT PHARMA LATINA S.R.L. PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.169], ['ACTAVIS LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.169]], 5.834380952380952), 'Methylprednisoloni natrii succinas': ([['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.984], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.016]], 64.39999999999999), 'Icatibantum': ([['SHIRE PHARMACEUTICALS IRELAND LIMITED TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH', 0.208], ['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.208], ['FRESENIUS KABI AUSTRIA GMBH', 0.189], ['EUROFINS PROXY LABORATORIES BV PHARMADOX HEALTHCARE LTD.', 0.204], ['EUROFINS PROXY LABORATORIES BV PHARMADOX HEALTHCARE LTD. TERAPIA S.A.', 0.191]], 11696.760000000002), 'Nabumetonum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.12758333333333327), 'Zuclopenthixoli dihydrochloridum': ([['H. LUNDBECK A/S', 1.0]], 0.7801), 'Lithii carbonas': ([['DELPHARM POZNAŃ S.A.', 1.0]], 0.261), 'Menotropina': ([[nan, 0.888], ['IBSA FARMACEUTICI ITALIA S.R.L.', 0.112]], 2285.58), 'Montelukastum': ([['HBM PHARMA S.R.O. NYCOMED PHARMA SP. Z O.O. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.258], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.258], ['MEDIS INTERNATIONAL A.S.', 0.249], [nan, 0.235]], 2.2525476190476192), 'Brinzolamidum': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH S.A. ALCON-COUVREUR N.V. SIEGFRIED EL MASNOU, S.A.', 0.332], ['BALKANPHARMA-RAZGRAD AD FAMAR S.A., PLANT A HEUMANN PHARMA GMBH & CO. GENERICA KG PHARMATEN S.A.', 0.332], ['LUSOMEDICAMENTA SOCIEDADE TECNICA FARMACEUTICA, S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.336]], 70.13666666666666), 'Follitropinum alfa': ([['GEDEON RICHTER PLC.', 0.369], ['MERCK SERONO S.P.A.', 0.041], ['MERCKLE GMBH TEVA BIOTECH GMBH TEVA PHARMACEUTICALS EUROPE B.V.', 0.591]], 2079.33), 'Ivabradini hydrochloridum': ([['KRKA, D.D., NOVO MESTO', 0.342], ['REMEDICA LTD', 0.314], ['GENEPHARM S.A.', 0.344]], 9.227946428571428), 'Alfuzosini hydrochloridum': ([['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.363], ['ORION CORPORATION ORION CORPORATION', 0.275], ['SANOFI WINTHROP INDUSTRIE', 0.363]], 1.9610000000000003), 'Vigabatrinum': ([['PATHEON FRANCE S.A.', 1.0]], 2.7886), 'Conestatum alfa': ([['PHARMING TECHNOLOGIES B.V.', 1.0]], 3943.96), 'Wyciągi alergenowe roztoczy kurzu domowego -': ([['ALLERGOPHARMA GMBH & CO. KG', 1.0]], 263.37833333333333), 'Colistimethatum natricum': ([['LYOCONTRACT GMBH TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 19.896), 'Danazolum': ([['POLFARMEX S.A.', 1.0]], 2.3287999999999998), 'Spiramycinum': ([['SANOFI S.R.L.', 1.0]], 1.59), 'Ciprofloxacini hydrochloridum': ([['ZENTIVA, A.S. ZENTIVA, K.S.', 0.15], ['KRKA, D.D., NOVO MESTO', 0.231], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.233], ['GEDEON RICHTER POLSKA SP. Z O.O. GEDEON RICHTER ROMANIA S.A.', 0.155], ['S.C. LABORMED-PHARMA S.A. WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE', 0.231]], 3.802), 'Insulinum lisprum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.127], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 0.373], ['LILLY FRANCE S.A.S.', 0.127], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 0.373]], 152.635), 'Sulpiridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.636], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.364]], 0.8690833333333334), 'Glipizidum': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY „GALENA”', 1.0]], 0.05699999999999997), 'Calcitriolum': ([['MIBE GMBH ARZNEIMITTEL', 1.0]], 1.1187777777777779), 'Clozapinum': ([['LABORATORI FUNDACIÓ DAU', 0.217], ['EGIS PHARMACEUTICALS PLC', 0.217], ['SYMPHAR SP. Z O.O.', 0.565]], 2.42295), 'Apixaban': ([['CATALENT ANAGNI S.R.L. PFIZER IRELAND PHARMACEUTICALS PFIZER MANUFACTURING DEUTSCHLAND GMBH SWORDS LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS, EXTERNAL MANUFACTURING', 1.0]], 3.607678571428572), 'Rivastigmini hydrogenotartras': ([['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. GENEPHARM S.A.', 0.345], ['GENEPHARM S.A. NEURAXPHARM ARZNEIMITTEL GMBH', 0.345], ['ORION CORPORATION', 0.31]], 3.404821428571428), 'Febuxostatum hemihydricum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACEUTICA, S.A.', 1.0]], 1.1544642857142855), 'Glimepiridum': ([['SANOFI S.R.L. SANOFI WINTHROP INDUSTRIE', 0.169], ['BIOFARM SP. Z O.O. PHARMAPATH S.A.', 0.165], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.18], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.251], ['PHARMAPATH S.A.', 0.235]], 5.827), 'Allopurinol': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.40866666666666673), 'Riluzolum': ([['PRO.MED.CS. PRAHA A.S. PRO.MED.CS. PRAHA A.S.', 1.0]], 3.22), 'tert-Butylamini perindoprilum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.262], ['GEDEON RICHTER PLC. GRODZISKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" SP. Z O.O.', 0.071], ['KRKA, D.D., NOVO MESTO LEK PHARMACEUTICALS D.D. TAD PHARMA GMBH', 0.262], ['ADAMED PHARMA S.A. LEK PHARMACEUTICALS D.D.', 0.143], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.262]], 3.3375), 'Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum A/Victoria/': ([['ABBOTT BIOLOGICALS B.V.', 1.0]], 26.37), 'Atomoxetinum': ([['G.L. PHARMA GMBH LANNACHER HEILMITTEL GMBH PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.63], [nan, 0.37]], 9.283619047619048), 'Clopidogrelum': ([[nan, 0.332], ['ORIFARM GENERICS A/S PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.34], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O.', 0.327]], 1.6846428571428573), 'Terazosini dihydricum hydrochloridum': ([['AESICA PHARMACEUTICALS S.R.L. FAMAR ITALIA S.P.A.', 0.713], ['LEK PHARMACEUTICALS D.D.', 0.287]], 2.28497619047619), 'Hydroxycarbamidum': ([['PLIVA KRAKÓW ZAKŁADY FARMACEUTYCZNE S.A. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.5], ['MEDAC GESELLSCHAFT FUR KLINISCHE SPECIALPRAPARATE MBH', 0.5]], 2.1038), 'Empagliflozinum': ([['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 1.0]], 3.7353571428571435), 'Agomelatinum': ([['MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.167], ['GENERICON PHARMA GESELLSCHAFT M.B.H. MEDIS INTERNATIONAL A.S.', 0.165], ['G.L. PHARMA GMBH MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.165], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LABORATORIOS SERVIER S.L. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER IRELAND INDUSTRIES LTD.', 0.167], ['BIOFARM SP. Z O.O. MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE', 0.167], ['MEDIS INTERNATIONAL A.S. VYROBNI ZAVOD BOLATICE SYMPHAR SP. Z O.O.', 0.167]], 9.39847619047619), 'Ibuprofenum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.03183333333333332), 'Dermatophagoides pteronyssinus': ([['ALK-ABELLO S.A.', 1.0]], 9.438666666666666), 'Warfarinum natricum': ([['ORION CORPORATION ORION CORPORATION', 1.0]], 0.2097), 'Meloxicamum': ([['BIOFARM SP. Z O.O.', 0.139], ['ZENTIVA, K.S.', 0.145], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.14], ['CHANELLE MEDICAL UNLIMITED COMPANY STADA ARZNEIMITTEL AG', 0.145], ['BOEHRINGER INGELHEIM HELLAS SINGLE MEMBER S.A. BOEHRINGER INGELHEIM INTERNATIONAL GMBH ROTTENDORF PHARMA GMBH', 0.145], ['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 0.141], [nan, 0.145]], 1.7601666666666669), 'Cyanocobalaminum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 1.8039999999999998), 'Ticlopidini hydrochloridum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.4181666666666667), 'Mesalazinum': ([['SEVER PHARMA SOLUTIONS AB', 0.053], ['TEMMLER ITALIA S.R.L.', 0.096], ['FARMINA SP. Z O.O.', 0.23], ['FERRING GMBH', 0.108], ['FERRING LEČIVA A.S.', 0.239], ['FAES FARMA, S.A.', 0.036], ['LABORATORIOS VITÓRIA S.A.', 0.203], ['DR. FALK PHARMA GMBH', 0.035]], 19.81597261904762), 'Mycophenolas mofetil': ([['ROCHE PHARMA AG', 0.2], [nan, 0.1], ['LABORATORI FUNDACIO DAU', 0.2], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SANDOZ GMBH', 0.099], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.2], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.2]], 7.5763), 'Tianeptinum': ([['LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 1.0]], 0.24900000000000003), 'Azathioprinum': ([['ZAKŁADY CHEMICZNO-FARMACEUTYCZNE \"VIS\" SP. Z O.O.', 0.488], ['ASPEN BAD OLDESLOE GMBH EXCELLA GMBH & CO. KG', 0.512]], 1.0514333333333332), 'Estradioli valeras tabletki białe -': ([['BAYER AG BAYER WEIMAR GMBH UND CO. KG', 1.0]], 0.3347619047619048), 'mikonazol': ([['GEDEON RICHTER PLC.', 1.0]], 0.8079999999999999), 'Urofollitropinum': ([['IMED POLAND SP. Z O.O. LABORATOIRES GENEVRIER S.A.', 1.0]], 73.00999999999999), 'Triptorelini pamoas': ([['IPSEN PHARMA BIOTECH SAS', 1.0]], 555.95), 'Ciclosporinum': ([['MEDIS INTERNATIONAL AS, PRODUCTION PLANT BOLATICE MONTERESEARCH S.R.L.', 0.14], ['TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.094], [nan, 0.091], ['EXCELVISION SANTEN OY', 0.138], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.148], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD INTERNATIONAL SERVICE LABORATORY BRANCH IRELAND NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.148], ['DEMETRIADES & PAPAELLINAS LTD. NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S. NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.094], ['DEMETRIADES & PAPAELLINAS LTD. LEK D.D., PE PROIZODNJA LENDAVA NOVARTIS FARMA -PRODUCTOS FARMACEUTICOS S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS FINLAND OY NOVARTIS HEALTHCARE A/S NOVARTIS (HELLAS) S.A.C.I. NOVARTIS HUNGARIA KFT. NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD NOVARTIS NORGE AS NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA NV NOVARTIS PHARMA S.A.S NOVARTIS S.R.O. NOVARTIS SVERIGE AG', 0.148]], 66.4004), 'Carbamazepinum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.082], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.254], ['GEROT PHARMAZEUTIKA GMBH', 0.385], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O.O.', 0.031], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.249]], 2.38948), 'Insulinum aspartum': ([['NOVO NORDISK A/S', 0.4], ['SANOFI-AVENTIS DEUTSCHLAND GMBH SANOFI-AVENTIS PRIVATE CO. LTD.', 0.2], ['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.4]], 96.76400000000001), 'Ketoprofenum': ([['FAMAR LYON OPELLA HEALTHCARE INTERNATIONAL SAS', 0.1], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.1], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.1], ['LEK PHARMACEUTICALS D.D.', 0.15], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A.', 0.1], ['MIBE GMBH ARZNEIMITTEL', 0.1], ['HAUPT PHARMA LIVRON UNITHER LIQUID MANUFACTURING', 0.348]], 1.6966666666666668), 'Loratadinum': ([['LEK PHARMACEUTICALS D.D.', 0.444], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY GALENA - ZAKŁAD NR 2', 0.444], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.113]], 0.7077600000000002), 'Levothyroxinum natricum': ([[nan, 0.307], ['CORDEN PHARMA GMBH FAMAR HEALTH CARE SERVICES MADRID SAU MERCK HEALTHCARE KGAA', 0.504], ['BERLIN-CHEMIE AG', 0.189]], 2.2350000000000003), 'Cariprazine': ([['GEDEON RICHTER PLC.', 1.0]], 25.309285714285714), 'Clopamidum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.3295), 'Lurasidonum': ([['AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA MILLMOUNT HEALTHCARE LTD.', 1.0]], 24.724285714285713), 'Benzathini phenoxymethylpenicillinum': ([['SANDOZ GMBH', 1.0]], 0.2733333333333333), 'Tizanidini hydrochloridum': ([['ORION CORPORATION', 1.0]], 0.7026666666666667), 'Furosemidum': ([['MEDIS INTERNATIONAL A.S.', 0.191], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.259], ['POLFARMEX S.A.', 0.275], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.275]], 0.777), 'Glycopyrronii bromidum': ([['NOVARTIS FARMACÉUTICA S.A NOVARTIS PHARMA GMBH', 1.0]], 2.227), 'Zuclopenthixoli decanoas': ([['H. LUNDBECK A/S', 1.0]], 15.36), 'Betamethasoni dipropionas': ([['MIBE GMBH ARZNEIMITTEL', 0.332], ['ORGANON HEIST BV', 0.22], ['BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.448]], 31.075000000000003), 'Hydrochlorothiazidum': ([['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.143], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.571], ['BOEHRINGER INGELHEIM ELLAS AE BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG ROTTENDORF PHARMA GMBH', 0.286]], 1.8725), 'Estradiolum': ([['ORION CORPORATION', 0.099], [nan, 0.066], ['NOVO NORDISK A/S', 0.161], ['BESINS MANUFACTURING BELGIUM S.A. LABORATOIRES BESINS INTERNATIONAL', 0.04], ['AESICA PHARMACEUTICALS GMBH LTS LOHMANN TERAPIE-SYSTEME AG', 0.309], ['BAYER AG', 0.046], ['ABBOTT BIOLOGICALS B.V.', 0.046], ['AESICA PHARMACEUTICALS GMBH', 0.232]], 8.818672619047618), 'Latanoprostum': ([['PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH', 0.066], ['S.C. ROMPHARM COMPANY S.R.L.', 0.017], ['RAFARM S.A.', 0.068], ['EXCEL VISION LABORATOIRES THEA LABORATOIRES UNITHER', 0.001], ['ADAMED PHARMA S.A. RAFARM S.A.', 0.07], ['ADAMED PHARMA S.A. GENETIC S.P.A', 0.07], ['PFIZER MANUFACTURING BELGIUM NV', 0.051], ['LOMAPHARM GMBH', 0.134], ['FAMAR S.A. FARMIGEA S.P.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.134], ['GENETIC S.P.A', 0.134], ['ADAMED PHARMA S.A. S.C. ROMPHARM COMPANY S.R.L.', 0.07], ['PFIZER MANUFACTURING BELGIUM N.V.', 0.051], ['JADRAN-GALENSKI LABORATORIJ D.D. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.134]], 831.3872777777777), 'Clomipramini hydrochloridum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 1.205), 'Fluoxetinum': ([['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE', 0.333], ['APL SWIFT SERVICES (MALTA) LTD.', 0.333], ['PRO.MED.CS PRAHA A.S.', 0.333]], 0.988), 'Insulinum lisprum injectio neutralis': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 1.0]], 19.356), 'Thioguaninum': ([['EXCELLA GMBH & CO. KG GLAXOSMITHKLINE PHARMACEUTICALS S.A.', 1.0]], 18.0212), 'Amlodipine besilate': ([['ZENTIVA, K.S.', 1.0]], 0.49241666666666667), 'all-rac-Fitomenadion (witamina K': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 1.7853333333333332), 'Insulinum humanum isophanum': ([['BIOTON S.A.', 0.5], ['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.5]], 37.144000000000005), 'Atorvastatinum': ([['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O., DPC JASTREBARSKO', 0.105], ['KRKA, D.D., NOVO MESTO', 0.105], ['HAUPT PHARMA LATINA S.R.L.', 0.189], ['MEDIS INTERNATIONAL A.S.', 0.112], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.061], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.061], [nan, 0.03], ['BIOFARM SP. Z O.O.', 0.07], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A. SUPROBION SP. Z O.O. SPÓŁKA KOMANDYTOWA', 0.06], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. SUPROBION SP. Z O.O. SPÓŁKA KOMANDYTOWA', 0.06], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.024], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.061], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, A.S.', 0.061]], 11.890277777777778), 'Cloxacillinum natrium': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 1.25625), 'Natrii risedronas': ([['ZENTIVA, K.S.', 1.0]], 2.1875), 'Progesteronum': ([['ADAMED PHARMA S.A.', 0.039], ['CYNDEA PHARMA S.L.', 0.961]], 2.7263333333333337), 'Goserelini acetas': ([['AMW GMBH ARZNEIMITTELWERK WARNGAU', 0.336], ['AMW GMBH ARZNEIMITTELWERK WARNGAU MERCKLE GMBH', 0.327], [nan, 0.337]], 2051.83), 'Kalii citras': ([['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.476], ['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 0.524]], 0.42986363636363634), 'Clopidogrelum besilate': ([['DOCPHARMA NV PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. SGS LABORATORIES SIMON S.A.', 0.487], ['PHARMATEN S.A. PHARMATHEN INTERNATIONAL S.A.', 0.513]], 1.117142857142857), 'Prednisolonum': ([['ADAMED PHARMA S.A.', 0.155], ['MIBE GMBH ARZNEIMITTEL SUN-FARM SP. Z O.O.', 0.845]], 1.8929999999999998), 'Salmeterolum': ([[nan, 0.311], ['GENETIC S.P.A ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.311], ['GENETIC S.P.A', 0.303], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.001], ['GLAXO WELLCOME GMBH & CO. KG GLAXO WELLCOME PRODUCTION', 0.073]], 753.6860000000001), 'Sertindolum': ([['H. LUNDBECK A/S', 1.0]], 25.396904761904764), 'Fentanylu cytrynian': ([['MERCKLE GMBH TEVA PHARMACEUTICAL EUROPE B.V.', 1.0]], 60.53142857142856), 'Pantoprazolum natricum sesquihydricum': ([['NYCOMED GMBH', 0.062], [nan, 0.188], ['LOGITERS, LOGISTICA, PORTUGAL, S.A. MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN GERMANY GMBH MYLAN HUNGARY KFT.', 0.188], ['BLUEFISH PHARMACEUTICALS AB TEVA PHARMA, S.L.U.', 0.188], ['CEMELOG BRF KFT. IMED POLAND SP. Z O.O. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.188], ['ALKALOIDA CHEMICAL CO. ZRT. CEMELOG BRF KFT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.188]], 1.775178571428571), 'Sulfasalazinum w postaci granulatu z powidonem -': ([['KRKA, D.D., NOVO MESTO', 1.0]], 0.4455), 'Ethosuximidum': ([['G.L. PHARMA GMBH', 1.0]], 0.5944999999999999), 'Acidum alendronicum': ([['CEMELOG BRS KFT. FARMACOL S.A. RANBAXY IRELAND LTD.', 0.38], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.328], ['BLUEFISH PHARMACEUTICALS AB', 0.292]], 5.665000000000001), 'Aciclovirum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.308], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.344], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.348]], 4.242666666666667), 'Relugolixum': ([['MILLMOUNT HEALTHCARE LIMITED', 1.0]], 14.965333333333332), 'Tramadoli hydrochloridum': ([['MEDANA PHARMA S.A.', 0.757], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.012], ['MEDOCHEMIE LTD., FACILITY A-Z ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.05], ['APL SWIFT SERVICES (MALTA) LTD.', 0.006], ['KRKA, D.D., NOVO MESTO', 0.006], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE \"SYNTEZA\" SP. Z O.O.', 0.006], ['STADA ARZNEIMITTEL AG', 0.055], [nan, 0.017], ['GRUENENTHAL GMBH STADA ARZNEIMITTEL AG', 0.055], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.012], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW', 0.004], ['PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.) PLIVA LJUBLJANA D.O.O. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.004], ['ZENTIVA, K.S.', 0.008], ['MEDIS INTERNATIONAL A.S.', 0.004], ['POLFARMEX S.A.', 0.004]], 48.53609351851851), 'Propranololi hydrochloridum': ([[nan, 0.5], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.5]], 0.24400000000000002), 'Clindamycini hydrochloridum': ([['CHEPHASAAR, CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH', 0.637], ['FAREVA AMBOISE', 0.163], ['S.C. SANDOZ S.R.L.', 0.2]], 2.978444444444444), 'Indacateroli maleas': ([['NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH', 1.0]], 3.1340000000000003), 'Rivaroxaban': ([['BAYER AG BAYER BITTERFELD GMBH BAYER HEALTHCARE MANUFACTURING S.R.L.', 1.0]], 11.534571428571429), 'Haloperidolum': ([['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.474], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.051], ['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ MEDANA W SIERADZU', 0.474]], 10.770124999999998), 'Etaksylan dabigatranu': ([['BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 2.468666666666667), 'Cefuroximum natricum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.046], ['ACS DOBFAR S.P.A', 0.954]], 5.955294117647059), 'Risperidonum': ([['ORION CORPORATION ORION CORPORATION', 0.003], ['ORION CORPORATION', 0.031], ['PHARMAPATH S.A.', 0.003], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.)', 0.476], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.003], ['JANSSEN-CILAG S.P.A.', 0.003], ['JANSSEN PHARMACEUTICA N.V.', 0.0], ['CAP PHARMACY LINE JANSSEN PHARMACEUTICA N.V.', 0.477], ['ACTAVIS LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.003], ['KRKA, D.D., NOVO MESTO', 0.001]], 1100.0458166666667), 'Clonazepamum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.5586666666666666), 'Folitropinum delta': ([['FERRING GMBH', 1.0]], 1833.42), 'Esomeprazolum (esomeprazol magnezowy, amorficzny)': ([['PHARMACHEMIE B.V. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.5], ['PHARMACHEMIE B.V. TERAPIA S.A. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PVT. LTD.', 0.5]], 0.8878571428571429), 'Sitagliptini hydrochloridum monohydricum': ([['PHARMADOX HEALTHCARE LTD. SYMPHAR SP. Z O.O.', 0.667], ['GALENICUM HEALTH S.L. SAG MANUFACTURING S.L.U.', 0.333]], 1.152857142857143), 'Bisoprololi fumaras': ([['BIOFARM SP. Z O.O.', 0.155], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.181], ['ICN POLFA RZESZÓW S.A.', 0.147], ['MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.166], ['SANECA PHARMACEUTICALS A.S. S.C. ZENTIVA S.A.', 0.16], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.192]], 2.40325), 'Ofloxacinum': ([['OPELLA HEALTHCARE INTERNATIONAL SAS', 1.0]], 0.8849999999999999), 'Lamotriginum': ([['ACTAVIS GROUP PTC EHF. BALKANPHARMA-DUPNITSA AD SPECIFAR S.A. TJOAPACK NETHERLANDS BV', 0.156], [nan, 0.171], ['BALKANPHARMA DUPNITSA AD MERCKLE GMBH PHARMACHEMIE B.V. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICALS LTD.', 0.109], ['DELPHARM POZNAŃ S.A.', 0.388], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.176]], 6.401555555555555), 'Rywastygmina': ([['LUYE PHARMA AG ZENTIVA SA', 1.0]], 0.9863333333333334), 'Tamsulosini hydrochloridum': ([['A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.R.L. ADAMED PHARMA S.A. MENARINI-VON HEYDEN GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['ADAMED PHARMA S.A.', 0.053], ['APL SWIFT SERVICES (MALTA) LTD.', 0.053], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.053], [nan, 0.04], ['ZENTIVA, K.S.', 0.053], ['GEDEON RICHTER PLC.', 0.053], ['QUINTA-ANALYTICA S.R.O. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.053], ['SYMPHAR SP. Z O.O.', 0.049], ['ORION CORPORATION ORION CORPORATION', 0.044], ['LABORATOIROS NORMON S.A. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. ROWA PHARMACEUTICALS LTD. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.051], ['GENERICON PHARMA GESELLSCHAFT M.B.H. G.L. PHARMA GMBH INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.043], ['SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT. SYNTHON HISPANIA S.L.', 0.049], ['MEDIS INTERNATIONAL A.S. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.039], ['KRKA, D.D., NOVO MESTO QUINTA-ANALYTICA S.R.O. SYNTHON B.V. SYNTHON HISPANIA S.L.', 0.053], ['KRKA, D.D., NOVO MESTO SYNTHON HISPANIA S.L. TAD PHARMA GMBH', 0.053], ['ASTELLAS PHARMA EUROPE B.V.', 0.053]], 10.126296296296298), 'Brimonidini tartras': ([['ALLERGAN PHARMACEUTICALS IRELAND', 0.066], ['ADAMED PHARMA S.A. PHARMA STULLN GMBH UAB SANTONIKA', 0.296], ['RAFARM S.A.', 0.276], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.066], ['BAUSCH HEALTH POLAND SP. Z O.O. PHARMA STULLN GMBH UAB SANTONIKA', 0.296]], 70.88033333333334), 'Rupatadini fumaras': ([['MARTIN DOW PHARMACEUTICALS MEIJI PHARMA SPAIN S.A.', 1.0]], 0.2463), 'Exemestanum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['SYMPHAR SP. Z O.O.', 0.5]], 3.7813333333333334), 'Doxazosini mesilas': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.114], ['ADAMED PHARMA S.A. APL SWIFT SERVICES (MALTA) LTD.', 0.07], ['GENERICS FARMACEUTICA, S.A.', 0.114], ['GENERIS FARMACEUTICA, S.A.', 0.114], ['PFIZER MANUFACTURING DEUTSCHLAND GMBH R-PHARM GERMANY GMBH', 0.172], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.093], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.09], ['ACTAVIS GROUP PTC EHF.', 0.057], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.026], ['KRKA, D.D., NOVO MESTO', 0.057], ['ZENTIVA, K.S.', 0.093]], 8.560638888888889), 'Methotrexatum natricum': ([['EBEWE PHARMA GES.M.B.H NFG. KG FAREVA UNTERACH GMBH SALUTAS PHARMA GMBH', 0.476], ['MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH', 0.524]], 94.22452380952382), 'Tiotropium': ([['ACTAVIS LTD.  LABORATORIOS LICONSA S.A. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMA B.V.', 0.523], ['HELM AG', 0.477]], 5.552666666666666), 'Atomoxetini hydrochloridum': ([['MEDICE ARZNEIMITTEL PUETTER GMBH & CO. KG', 0.239], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.382], ['GLENMARK PHARMACEUTICALS S.R.O. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.379]], 24.4975), 'Metformini hydrochloridum': ([['BIOTON S.A.', 0.061], [nan, 0.057], ['LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.141], ['DRAGENOPHARM APOTHEKER PUESCHL GMBH & CO. KG ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.071], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L. N.PETSIAVAS S.A. PETSIAVAS S.A.', 0.053], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L. N.PETSIAVAS S.A. PETSIAVAS S.A. PHARMA-PACH GYOGYSZERGYARTO ES SZOLGALTATO KFT', 0.053], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. MERCK S.L.', 0.008], ['MERCK HEALTHCARE KGAA MERCK SANTE S.A.S. CENTRE DE PRODUCTION DE SEMOY MERCK S.L.', 0.053], ['MERCK HEALTHCARE KGAA MERCK SANTÉ S.A.S MERCK S.L.', 0.053], ['SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.011], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.011], ['TEVA OPERATIONS POLSKA SP. Z O.O.', 0.037], ['BALKANPHARMA-DUPNITSA AD TEVA OPERATIONS POLAND SP. Z O.O.', 0.049], ['BLUEFISH PHARMACEUTICALS AB', 0.044], ['BERLIN-CHEMIE AG MENARINI-VON HEYDEN GMBH', 0.039], ['BERLIN-CHEMIE AG', 0.061], ['SYMPHAR SP. Z O.O.', 0.057], ['LEK D.D., PE PROIZODNJA LENDAVA LEK S.A.', 0.141]], 6.0042024470899475), 'Acidum valproicum': ([['G.L. PHARMA GMBH', 0.5], ['G.L. PHARMA GMBH G.L. PHARMA GMBH', 0.5]], 1.6383999999999999), 'Moclobemidum': ([['MEDA PHARMA GMBH & CO. KG MYLAN HUNGARY KFT.', 0.333], ['BAUSCH HEALTH POLAND SP. Z O.O. PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.333], ['GLENMARK PHARMACEUTICALS S.R.O.', 0.333]], 1.1470000000000002), 'Candesartanum cilexetili': ([[nan, 0.098], ['ZENTIVA, A.S. ZENTIVA, K.S.', 0.159], ['ORION CORPORATION ORION CORPORATION', 0.023], ['KRKA, D.D., NOVO MESTO', 0.129], ['BASICS GMBH CEMELOG BRF KFT RANBAXY PHARMACIE GENERIGUES SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.023], ['CEMELOG BRF KFT RANBAXY PHARMACIE GENERIGUES SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.023], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.129], ['ADAMED PHARMA S.A. ADAMED PHARMA S.A.', 0.045], ['ZENTIVA, K.S.', 0.159], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.053], ['DELORBIS PHARMACEUTICALS LTD. HBM PHARMA S.R.O. S.C. ZENTIVA S.A.', 0.159]], 35.30422718253968), 'Cilazaprilum': ([['KRKA, D.D., NOVO MESTO', 0.492], ['POLFARMEX S.A.', 0.508]], 0.4694047619047619), 'Insulinum lisprum zinci protaminati injectio': ([['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S. LILLY S.A.', 0.5], ['ELI LILLY ITALIA S.P.A. LILLY FRANCE S.A.S.', 0.5]], 77.42399999999999), 'Ivabradinum': ([[nan, 0.134], ['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LABORATORIOS SERVIER, S.L. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 0.138], ['LABORATORIOS LICONSA S.A.', 0.055], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.138], ['PHARMATHEN FARMAKEFTIKI S.A. PHARMATHEN INTERNATIONAL S.A.', 0.138], ['DELORBIS PHARMACEUTICALS LTD. HBM PHARMA S.R.O.', 0.138], ['S.C. ZENTIVA S.A. ZENTIVA, K.S.', 0.126], ['GEDEON RICHTER ROMANIA S.A.', 0.133]], 22.91517857142857), 'Allopurinolum': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 0.099], ['LEK PHARMACEUTICALS D.D. SALUTAS PHARMA GMBH', 0.435], ['EGIS PHARMACEUTICALS PLC', 0.466]], 1.1339333333333332), 'Pramipexolum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 1.0]], 6.667095238095238), 'Tiotropii bromidum monohydricum': ([['BOEHRINGER INGELHEIM ESPANA S.A. BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.962], ['BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 0.038]], 75.91183333333332), 'Gabapentinum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.189], ['PHARMACHEMIE B.V. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.369], [nan, 0.071], ['PFIZER MANUFACTURING DEUTSCHLAND GMBH', 0.372]], 6.133299999999999), 'Insulina ludzka rekombinowana': ([['BIOTON S.A.', 1.0]], 18.568), 'Perindoprilum argininum': ([['ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE S.A. LES LABORATOIRES SERVIER INDUSTRIE (LSI) SERVIER (IRELAND) INDUSTRIES LTD. (SII)', 1.0]], 0.1590000000000001), 'Desmopressinum': ([['FERRING GMBH', 1.0]], 18.101833333333335), 'Levetiracetamum': ([['REMEDICA LTD', 0.001], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.011], ['REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.011], ['NEXTPHARMA SAS', 0.352], ['G.L. PHARMA GMBH', 0.007], ['WESSLING HUNGARY KFT.', 0.347], ['ACCORD HEALTHCARE POLSKA SP. Z O.O.', 0.011], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACÊUTICA, S.A.,', 0.011], ['NEURAXPHARM ARZNEIMITTEL GMBH', 0.021], ['ZENTIVA, K.S.', 0.011], ['PHAROS MT LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.011], ['GLENMARK PHARMACEUTICALS S.R.O. PHAROS MT LTD REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.021], ['ADAMED PHARMA S.A. REMEDICA LTD', 0.176], ['ADAMED PHARMA S.A. PHAROS MT LTD REMEDICA LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.011]], 202.45421666666667), 'Lacidipinum': ([['BIOFARM SP. Z O.O.', 0.261], ['DELPHARM POZNAŃ S.A. GLAXO WELLCOME S.A.', 0.261], ['GLAXO WELLCOME S.A.', 0.261], [nan, 0.217]], 2.324642857142857), 'Lovastatinum': ([['BIOFARM SP. Z O.O.', 0.5], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.5]], 0.185), 'Furaginum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 0.09033333333333333), 'Hydrocortisoni acetas': ([['AFLOFARM FARMACJA POLSKA SP. Z O.O.', 1.0]], 3.7800000000000002), 'Paroxetini hydrochloridum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.318], ['GEDEON RICHTER PLC.', 0.341], ['ACTAVIS EHF. ACTAVIS LTD. ACTAVIS NORDIC A/S BALKANPHARMA-DUPNITSA AD', 0.341]], 0.966), 'Perazinum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.639], ['LABOR PRZEDSIĘBIORSTWO FARMACEUTYCZNO-CHEMICZNE SP. Z O.O.', 0.361]], 1.4300833333333334), 'Tropicamidum': ([['JADRAN-GALENSKI LABORATORIJ D.D.', 1.0]], 2.3169999999999997), 'Salbutamoli sulfas': ([['ORION CORPORATION', 0.008], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.494], ['GLAXO WELLCOME PRODUCTION GLAXO WELLCOME S.A.', 0.498]], 14.8865), 'Solifenacini succinas': ([['ADAMED PHARMA S.A. S.C. ZENTIVA S.A.', 0.083], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.083], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.083], ['BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.066], ['ALKALOIDA CHEMICAL CO. ZRT. S.C. TERAPIA S.A. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.081], ['SANECA PHARMACEUTICALS A.S.', 0.055], ['AFLOFARM FARMACJA POLSKA SP. Z O.O. GENEPHARM S.A.', 0.055], ['GENERICON PHARMA GESELLSCHAFT M.B.H. S.C. ZENTIVA S.A.', 0.083], ['LABORATORIOS LESVI S.L.', 0.083], ['ORION CORPORATION ORION CORPORATION', 0.083], ['G.L. PHARMA GMBH PRO.MED.CS. PRAHA A.S.', 0.083], ['S.C. ZENTIVA S.A.', 0.083], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.079]], 14.856522222222221), 'Pantoprazolum natricum sesquihydricum -': ([[nan, 1.0]], 0.10794642857142858), 'Rosuvastatinum': ([['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.196], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.193], [nan, 0.049], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.173], ['ADAMED PHARMA S.A. BELUPO LIJEKOVI I KOZMETIKA D.D.', 0.13], ['ELPEN PHARMACEUTICAL CO.INC.', 0.13], ['ADAMED PHARMA S.A. LEK PHARMACEUTICALS D.D.', 0.13]], 7.669311507936509), 'Sitagliptinum': ([['MERCK SHARP & DOHME B.V.', 0.091], ['GEDEON RICHTER PLC. GEDEON RICHTER ROMANIA S.A.', 0.121], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.121], ['PHARMACARE PREMIUM LTD. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA SA', 0.121], ['LEK PHARMACEUTICALS D.D. LEK S.A.', 0.061], ['ADAMED PHARMA S.A.', 0.091], ['LABORATORIOS LICONSA S.A.', 0.061], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.091], ['GALENICUM HEALTH, S.L. SAG MANUFACTURING S.L.U.', 0.061], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.121], ['PHARMADOX HEALTHCARE LTD. SYMPHAR SP. Z O.O.', 0.061]], 12.682238095238095), 'Vildagliptinum': ([['ADIPHARM EAD COMBINO PHARM (MALTA) LTD GENEPHARM S.A. VIPHARM S.A.', 0.111], ['LEK D.D. NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.111], ['PHARMADOX HEALTHCARE LTD. PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.111], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.222], ['STADA ARZNEIMITTEL AG', 0.111], [nan, 0.111], ['ADIPHARM EAD GENEPHARM S.A.', 0.222]], 3.459476190476191), 'Miconazoli nitras': ([['GEDEON RICHTER POLSKA SP. Z O.O.', 1.0]], 0.9013333333333334), 'Atropini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 2.722), 'Rivastigminum': ([['LUYE PHARMA AG ZENTIVA SA', 0.216], [nan, 0.146], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.42], ['ADAMED PHARMA S.A.', 0.218]], 4.838029761904762), 'Dihydrocodeini tartras': ([['FIDELIO HEALTHCARE LIMBURG GMBH', 1.0]], 1.5543333333333336), 'Beclometasoni dipropionas anhydricus (': ([['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH CHIESI SAS', 1.0]], 136.18), 'Amiodaroni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.4348333333333334), 'Perazini dimaleas': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 1.0]], 0.4807666666666667), 'Mebendazolum': ([[nan, 0.425], ['GEDEON RICHTER PLC.', 0.575]], 2.6616666666666666), 'Naproxenum natricum': ([['ADAMED PHARMA S.A.', 0.6], ['KRKA, D.D., NOVO MESTO', 0.4]], 0.7025), 'Cefuroximum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W DUCHNICACH', 0.003], [nan, 0.021], ['ALKALOIDA CHEMICAL CO. ZRT. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA SA O COMPANIE RANBAXY', 0.011], ['RANBAXY LABORATORIES LTD. SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.', 0.33], ['KRKA, D.D., NOVO MESTO', 0.022], ['SANDOZ GMBH', 0.034], ['PENCEF PHARMA GMBH SANDOZ GMBH', 0.034], ['ARISTO PHARMA GMBH MERCKLE GMBH TEVA OPERATIONS POLAND SP. Z O.O.', 0.034], ['ARISTO PHARMA GMBH MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.034], ['GLAXOSMITHKLINE TRADING SERVICES LIMITED LEK FARMACEVTSKA DRUŽBA D.D. (LEK PHARMACEUTICALS D.D.)', 0.442], ['POLFARMEX S.A.', 0.034]], 79.74934322478991), 'Piribedilum': ([['LES LABORATOIRES SERVIER INDUSTRIE (LSI)', 1.0]], 0.5486666666666667), 'Acenocoumarolum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.15733333333333335), 'Morphini hydrochloridum': ([['G.L. PHARMA GMBH', 1.0]], 7.875), 'Adrenalinum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 28.49), 'Atorvastatinum calcicum': ([['BIOFARM SP. Z O.O.', 0.035], ['APL SWIFT SERVICES (MALTA) LTD.', 0.082], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. KRKA-FARMA D.O.O., DPC JASTREBARSKO', 0.141], ['KRKA, D.D., NOVO MESTO', 0.141], ['LOGITERS, LOGISTICA, PORTUGAL, S.A. MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.071], ['PHARMACHEMIE B.V. SYNOPTIS INDUSTRIAL SP. Z O.O. TEVA CZECH INDUSTRIES S.R.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY TEVA PHARMACEUTICAL WORKS PVT. LTD. TEVA SANTE SA', 0.164], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.094], ['SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. TERAPIA S.A.', 0.177], ['SANECA PHARMACEUTICALS A.S. ZENTIVA, K.S.', 0.094]], 8.83614814814815), 'Ropinirolum': ([['KRKA, D.D., NOVO MESTO MERCKLE GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.15], ['KRKA, D.D., NOVO MESTO TEVA OPERATIONS POLSKA SP. Z O.O.', 0.15], ['ORION CORPORATION ORION CORPORATION PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.156], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.156], ['GLAXO WELLCOME S.A.', 0.156], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.111], [nan, 0.121]], 32.83113095238096), 'Salmeterolum + Fluticasoni propionas': ([['ORION CORPORATION', 1.0]], 82.955), 'Levothyroxine sodium': ([['ARISTO PHARMA GMBH LINDOPHARM GMBH', 1.0]], 0.12010000000000001), 'Dorzolamidi hydrochloridum': ([['RAFARM S.A.', 0.132], [nan, 0.329], ['EXCELVISION PHARMATHEN S.A.', 0.172], ['FAMAR S.A., PLANT A PHARMATHEN S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.194], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. FAMAR S.A. PHARMATHEN S.A.', 0.172]], 114.84933333333333), 'Phenobarbitalum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZAKŁADY FARMACEUTYCZNE \"UNIA\" SPÓŁDZIELNIA PRACY', 0.5]], 0.7420000000000001), 'Phenoxymethylpenicillinum kalicum': ([['SANDOZ GMBH', 1.0]], 2.0800833333333335), 'Clindamycini phosphas': ([['LEK PHARMACEUTICALS D.D.', 1.0]], 6.086), 'Penicillaminum': ([['TEVA OPERATIONS POLSKA SP. Z O.O.', 1.0]], 2.590333333333333), 'Semaglutidum': ([['NOVO NORDISK A/S', 1.0]], 827.58), 'Triptorelini acetas': ([['IPSEN PHARMA BIOTECH SAS', 0.877], ['FERRING GMBH', 0.123]], 196.92142857142855), 'Cyproteroni acetas': ([['BAYER WEIMAR GMBH UND CO. KG', 0.628], ['MIBE GMBH ARZNEIMITTEL', 0.124], ['BAYER AG BAYER PHARMA AG', 0.124], ['SYMPHAR SP. Z O.O.', 0.124]], 2.04395873015873), 'Dinatrii pamidronas': ([['VIPHARM S.A.', 1.0]], 617.8), 'Estradiolum (zmikronizowany)': ([['AESICA PHARMACEUTICALS GMBH', 1.0]], 2.04625), 'Levodopum': ([[nan, 0.435], ['LEK PHARMACEUTICALS D.D.', 0.565]], 2.2031), 'Lacosamidum': ([['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O. LABORATORI FUNDACIÓ DAU', 0.251], ['COMBINO PHARM (MALTA) LTD GALENICA PHARMACEUTICAL INDUSTRY S.A. GLENMARK PHARMACEUTICALS S.R.O. SVUS PHARMA A.S.', 0.246], ['MERCKLE GMBH TEVA GYOGYSZERGYAR ZRT. TEVA OPERATIONS POLSKA SP. Z O.O.', 0.246], ['DELORBIS PHARMACEUTICALS LTD. G.L. PHARMA GMBH', 0.235], ['AESICA PHARMACEUTICALS GMBH UCB PHARMA S.A.', 0.022]], 28.117553571428573), 'Acidum ursodeoxycholicum': ([['POLFARMEX S.A.', 0.312], ['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 0.375], ['AS GRINDEKS', 0.312]], 1.8688000000000002), 'Roxithromycinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 0.8829999999999998), 'Propafenoni hydrochloridum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 1.0]], 0.2725), 'Formoteroli fumaras dihydricus': ([['ASTRAZENECA DUNKERQUE PRODUCTION', 1.0]], 143.69), 'Finerenonum': ([['BAYER AG', 1.0]], 14.37142857142857), 'Midazolamu chlorowodorek': ([['LABORATORIOS LICONSA S.A.', 1.0]], 271.47), 'Sulfasalazinum (w postaci mieszaniny z powidonem)': ([['RECIPHARM, UPPSALA AB', 1.0]], 0.453525), 'Inhibitor C': ([['CSL BEHRING GMBH', 1.0]], 2303.74), 'Olanzapiny dichlorowodorek trójwodny': ([['EGIS PHARMACEUTICALS PLC EGIS PHARMACEUTICALS PLC', 1.0]], 4.523482142857143), 'Amlodipinum': ([[nan, 0.043], ['KRKA, D.D., NOVO MESTO', 0.067], ['BLUEFISH PHARMACEUTICALS AB', 0.054], ['MCDERMOTT LABORATORIES T/A GERARD LABORATORIES MYLAN HUNGARY KFT.', 0.055], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. ROWA PHARMACEUTICALS LTD. SALUTAS PHARMA GMBH', 0.076], ['EGIS PHARMACEUTICALS PLC', 0.079], ['GEDEON RICHTER PLC. GEDEON RICHTER POLSKA SP. Z O.O.', 0.061], ['BALKANPHARMA - DUPNITSA AD POLFARMEX S.A.', 0.166], ['NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. NOVARTIS PHARMA GMBH SALUTAS PHARMA', 0.2], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.2]], 8.033666666666667), 'Aripiprazolum': ([['ELAIAPHARM ZAMBON S.P.A.', 0.012], ['ELAIAPHARM H. LUNDBECK A/S', 0.894], ['PHARMADOX HEALTHCARE, LTD. ', 0.003], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.012], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 0.012], ['GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.003], ['GE PHARMACEUTICALS LTD G.L. PHARMA GMBH', 0.003], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.012], ['GENERICON PHARMA GESELLSCHAFT M.B.H. SYNTHON HISPANIA S.L. SYNTHON S.R.O.', 0.003], ['BETAPHARM ARZNEIMITTEL GMBH SYNTHON HISPANIA S.L. SYNTHON S.R.O.', 0.003], ['ORION CORPORATION ORION CORPORATION, ORION PHARMA', 0.003], ['LEK PHARMACEUTICALS D.D. LEK S.A. S.C. SANDOZ S.R.L.', 0.006], ['LABORATORIOS LESVI S.L.', 0.012], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.012], ['VIPHARM S.A.', 0.006], ['EGIS PHARMACEUTICALS PLC', 0.003]], 1046.3527507936508), 'Loperamidi hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. ODDZIAŁ PRODUKCYJNY W NOWEJ DĘBIE ', 1.0]], 0.134), 'Ondansetronum': ([['BLUEFISH PHARMACEUTICALS AB SOFARIMEX INDUSTRIA QUIMICA E FARMACEUTICA S.A.', 0.565], ['ASPEN BAD OLDESLOE GMBH NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA GMBH', 0.435]], 9.689), 'Amisulpridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.242], ['PRO.MED.CS PRAHA A.S.', 0.138], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON', 0.138], ['DELPHARM DIJON', 0.14], [nan, 0.134], ['MEDOCHEMIE LTD.', 0.208]], 26.639), 'Natrii valproas': ([['SANOFI AVENTIS S.A. SANOFI WINTHROP INDUSTRIE', 0.141], [nan, 0.085], ['SANOFI WINTHROP INDUSTRIE', 0.468], ['ORION CORPORATION ORION CORPORATION', 0.135], ['G.L. PHARMA GMBH', 0.168], ['UNITHER LIQUID MANUFACTURING', 0.004]], 8.173666666666668), 'Tiotropium bromide monohydrate': ([['BOEHRINGER INGELHEIM FRANCE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG', 1.0]], 2.9018333333333333), 'Quetiapinum': ([['GENEPHARM S.A.', 0.089], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.13], ['EGIS PHARMACEUTICALS PLC PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.167], ['ORION CORPORATION ORION PHARMA ORION CORPORATION ORION PHARMA', 0.094], ['ORION CORPORATION ORION CORPORATION ORION PHARMA', 0.094], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A. SALUTAS PHARMA GMBH', 0.061], ['KRKA, D.D., NOVO MESTO KRKA-FARMA D.O.O.', 0.093], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.065], ['ADAMED PHARMA S.A. GENEPHARM S.A. RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.116], ['ACTAVIS LTD.', 0.091]], 46.54478888888889), 'Bromocriptini mesylas': ([['FARMACEUTYCZNA SPÓŁDZIELNIA PRACY FILOFARM', 1.0]], 0.52), 'Amoxicillinum trihydricum': ([['KRKA, D.D., NOVO MESTO', 0.301], ['APL SWIFT SERVICES (MALTA) LTD. GENERIS FARMACEUTICA, S.A.', 0.699]], 1.2882142857142858), 'Degarelix': ([['FERRING GMBH', 1.0]], 1365.96), 'Umeclidini bromidum': ([['GLAXO WELLCOME PRODUCTION', 1.0]], 94.02000000000001), 'Formoteroli fumaras': ([['CHIESI PHARMACEUTICALS GMBH CHIESI PHARMACEUTICI S.P.A. CHIESI SAS', 0.268], ['NOVARTIS PHARMA GMBH NOVARTIS PHARMACEUTICA SA', 0.002], ['ADAMED PHARMA S.A.', 0.002], ['CHIESI FARMACEUTICI S.P.A. CHIESI PHARMACEUTICALS GMBH', 0.268], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. SMB TECHNOLOGY S.A.', 0.002], ['ORION CORPORATION', 0.267], ['ASTRAZENECA AB', 0.188], ['SMB TECHNOLOGY S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.002]], 412.4362685185185), 'Doxazosinum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.156], ['LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH SANDOZ A/S SYNOPTIS INDUSTRIAL SP. Z O.O.', 0.156], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.2], ['TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.2], ['KRKA, D.D., NOVO MESTO', 0.289]], 2.4583055555555555), 'Acidum undecylenicum': ([['PRO.MED.CS PRAHA A.S.', 1.0]], 0.584), 'Bimatoprost': ([['S.C. ROMPHARM COMPANY S.R.L. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.167], ['ALLERGAN PHARMACEUTICALS IRELAND', 0.333], ['EXCELVISION PHARMATHEN S.A.', 0.167], ['ADAMED PHARMA S.A. S.C. ROMPHARM COMPANY S.R.L.', 0.167], ['RAFARM S.A.', 0.167]], 197.4), 'Voriconazolum': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.498], ['ACCORD HEALTHCARE B.V. ACCORD HEALTHCARE POLSKA SP. Z O.O. PHARMADOX HEALTHCARE LTD.', 0.502]], 13.535333333333334), 'Pilocarpini hydrochloridum': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A.', 1.0]], 1.347), 'Dexamethasonum': ([['CYNDEA PHARMA S.L. FORMULA PHARMAZEUTISCHE UND CHEMISCHE ENTWICKLUNGS GMBH', 0.044], [nan, 0.07], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.599], ['ADAMED PHARMA S.A.', 0.287]], 77.82600000000001), 'Selegilini hydrochloridum': ([['BAUSCH HEALTH POLAND SP. Z O.O. ICN POLFA RZESZÓW S.A.', 1.0]], 0.2766), 'Insulinum humanum': ([['NOVO NORDISK A/S NOVO NORDISK PRODUCTION SAS', 0.333], ['BIOTON S.A.', 0.166], ['NOVO NORDISK A/S', 0.333], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.168]], 111.616), 'Tolterodini tartras': ([['MERCKLE GMBH PHARMACARE PREMIUM LTD. PHARMACHEMIE B.V. PHARMADOX HEALTHCARE, LTD.  PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA B.V. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.222], ['PHARMATHEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.333], ['PHARMATEN INTERNATIONAL S.A. PHARMATHEN S.A.', 0.222], ['PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.222]], 1.852734126984127), 'Rifampicinum': ([['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 1.0]], 9.519400000000001), 'Ipatropii bromidum momonydricum': ([['GLENMARK PHARMACEUTICALS S.R.O.', 1.0]], 16.290000000000003), 'Fenofibratum': ([['BIOFARM SP. Z O.O. LABORATOIRES BTT', 0.153], ['BIOFARM SP. Z O.O.', 0.153], ['BAUSCH HEALTH POLAND SP. Z O.O. BAUSCH HEALTH POLAND SP. Z O.O. SMB TECHNOLOGY S.A.', 0.153], ['GEDEON RICHTER POLSKA SP. Z O.O.', 0.147], [\"ASTREA FONTAINE DELPHARM L'AIGLE FAMAR L'AIGLE\", 0.087], ['ASTREA FONTAINE FAMAR L’AIGLE', 0.153], [\"ASTREA FONTAINE DELPHARM L'AIGLE\", 0.153]], 6.762222222222222), 'Candesartanum cilexetilum': ([['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.167], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 0.833]], 3.21), 'Pantoprazolum': ([['ADAMED PHARMA S.A.', 0.091], ['PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM SP. Z O.O.', 0.089], ['DELPHARM NOVARA S.R.L. NYCOMED GMBH', 0.061], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH SANDOZ S.R.L.', 0.091], ['EGIS PHARMACEUTICALS PLC PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A.', 0.091], ['KRKA, D.D., NOVO MESTO', 0.091], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.091], [nan, 0.057], ['OPELLA HEALTHCARE POLAND SP. Z O.O. ODDZIAŁ W RZESZOWIE ROTTENDORF PHARMA GMBH SC ZENTIVA SA', 0.091], ['TEVA PHARMA, S.L.U.', 0.091], ['ACTAVIS DEUTSCHLAND GMBH & CO. KG ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.061], ['FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. LACHIFARMA S.R.L. LAMP SAN PROSPERO S.P.A SOFARIMEX INDUSTRIA QUIMICA E FARMACEUTICA S.A.', 0.091]], 3.6407202380952377), 'Ciclesonidum': ([[nan, 1.0]], 100.195), 'Paroxetini hydrochloridum (semihydricum)': ([['ORION CORPORATION, ORION PHARMA', 1.0]], 0.3216666666666666), 'Doxycyclinum': ([['POLFARMEX S.A.', 0.5], ['TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE \"POLFA\" S.A.', 0.5]], 1.084), 'Silodosinum': ([['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES SAS GENERIS FARMACEUTICA, S.A.', 0.492], ['LABIRATOIRES BOUCHARA-RECORDATI RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A', 0.508]], 1.3253333333333335), 'Rosuvastatinum calicum': ([['ADAMED PHARMA S.A.', 0.108], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.179], ['BIOFARM SP. Z O.O.', 0.109], ['KRKA, D.D., NOVO MESTO', 0.175], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH', 0.131], ['ADAMED SP. Z O.O. PABIANICKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁAD FARMACEUTYCZNY ADAMED PHARMA S.A.', 0.033], ['GEDEON RICHTER PLC.', 0.135], ['ELPEN PHARMACEUTICAL CO.INC. LEK PHARMACEUTICALS D.D.', 0.131]], 13.523964285714285), 'Levomepromazini maleas': ([['EGIS PHARMACEUTICALS PLC', 1.0]], 0.2394), 'Chlorprothixeni hydrochloridum': ([['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.5], ['ZENTIVA, K.S.', 0.5]], 0.7918000000000001), 'Rosuvastatin calcium': ([['LABORATORIOS LICONSA S.A.', 1.0]], 0.8823214285714286), 'Insulinum glulisinum': ([['SANOFI-AVENTIS DEUTSCHLAND GMBH', 1.0]], 34.234), 'Salbutamolum': ([['LABORATORIO ALDO-UNION S.A.', 1.0]], 7.410000000000001), 'Megestroli acetas': ([['POLFARMEX S.A.', 0.25], ['BAUSCH HEALTH POLAND SP. Z O.O.', 0.25], ['VIPHARM S.A.', 0.25], ['PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK S.A.', 0.25]], 2.212833333333333), 'Dapagliflozinum': ([['ASTRAZENECA AB ASTRAZENECA UK LTD.', 1.0]], 3.7353333333333336), 'Dutasteridum': ([['ADAMED PHARMA S.A. GENERICON PHARMA GESELLSCHAFT M.B.H. LABORATORIOS LEON FARMA, S.A.', 0.263], ['CYNDEA PHARMA S.L. GALENICUM HEALTH, S.L.U. PHARMADOX HEALTHCARE LTD. SAG MANUFACTURING, S.L.U.', 0.236], ['APL SWIFT SERVICES (MALTA) LTD.', 0.223], ['APL SWIFT SERVICES (MALTA) LTD. ARROW GENERIQUES - LYON GENERIS FARMACÊUTICA, S.A.,', 0.278]], 2.3721666666666668), 'Oxycodoni hydrochloridum': ([[nan, 0.11], ['FIDELIO HEALTHCARE LIMBURG GMBH MUNDIPHARMA DC B.V.', 0.25], ['G.L. PHARMA GMBH', 0.243], ['BALKANPHARMA-DUPNITSA AD', 0.113], ['DEVELCO PHARMA GMBH TEVA OPERATIONS POLSKA SP. Z O.O.', 0.142], ['DEVELCO PHARMA GMBH PLIVA HRVATSKA D O.O. (PLIVA CROATIA LTD.) TEVA OPERATIONS POLSKA SP. Z O.O.', 0.142]], 78.0627), 'Lanreotidi acetas': ([['IPSEN PHARMA BIOTECH SAS', 1.0]], 10418.81), 'Febuxostatum': ([['MENARINI-VON HEYDEN GMBH PATHEON FRANCE S.A.', 0.225], ['PHAROS MT LTD PHAROS MT LTD RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.225], ['RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A.', 0.225], ['KRKA, D.D., NOVO MESTO TAD PHARMA GMBH', 0.225], ['HEUMANN PHARMA GMBH & CO. GENERICA KG PHARMADOX HEALTHCARE LTD. PHARMATEN INTERNATIONAL S.A. PHARMATEN S.A.', 0.099]], 5.122857142857142), 'Metoprololi tartras': ([['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.547], ['MEDIS INTERNATIONAL A.S.', 0.453]], 0.4026666666666666), 'Prednisonum': ([['ADAMED PHARMA S.A.', 1.0]], 2.4650249999999994), 'Tolterodini hydrogenotartras': ([['ZENTIVA, K.S.', 1.0]], 0.2057142857142857), 'Morphini sulfas': ([['WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.144], ['FIDELIO HEALTHCARE LIMBURG GMBH', 0.047], ['L. MOLTENI & C. DEI F.LLI ALITTI SOCIETÀ DI ESERCIZIO SPA', 0.81]], 24.782833333333333), 'Acidum valproicum + Natrii valproas': ([['HEXAL A/S LEK PHARMACEUTICALS D.D. LEK S.A. SALUTAS PHARMA GMBH', 1.0]], 0.5578333333333334), 'Brivaracetamum': ([['UCB PHARMA S.A.', 1.0]], 6.400535714285715), 'Valsartanum': ([['APL SWIFT SERVICES (MALTA) LTD.', 0.029], ['POLFARMEX S.A.', 0.013], ['MERCKLE GMBH PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.033], ['NOVARTIS FARMACEUTICA S.A. NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS PHARMA GMBH', 0.008], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH SALUTAS PHARMA GMBH', 0.083], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH', 0.083], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. NOVARTIS FARMACÉUTICA, S.A. SALUTAS PHARMA GMBH S.C.SANDOZ S.R.L.', 0.083], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD', 0.029], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O.', 0.084], [nan, 0.008], ['LABORATORIOS CINFA, S.A. LABORATORIOS LICONSA, S.A. ZENTIVA, K.S.', 0.011], ['ZENTIVA, K.S.', 0.025], ['CELON PHARMA S.A.', 0.013], ['ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.', 0.033], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMA, S.L.U. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.033], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLSKA SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.033], ['PHARMACHEMIE B.V. TEVA CZECH INDUSTRIES S.R.O. TEVA OPERATIONS POLAND SP. Z O.O. TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY', 0.033], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.083], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. NOVARTIS FARMA S.P.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.083], ['LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. LEK S.A. LEK S.A. SALUTAS PHARMA GMBH S.C. SANDOZ S.R.L.', 0.083], ['KRKA, D.D., NOVO MESTO KRKA POLSKA SP. Z O.O. TAD PHARMA GMBH', 0.084], ['ACTAVIS LTD. BALKANPHARMA-DUPNITSA AD EGIS PHARMACEUTICALS PLC', 0.029]], 63.975643235071814), 'Biperideni hydrochloridum': ([['LABORATORIO FARMACEUTICO S.I.T. SRL', 0.667], [nan, 0.333]], 0.5945333333333334)}\n"
     ]
    }
   ],
   "source": [
    "entity_nodes_g_sum_producer = {n for n, d in g_sum_producer.nodes(data=True) if d['bipartite'] == 1}\n",
    "substance_nodes_g_sum_producer = {n for n, d in g_sum_producer.nodes(data=True) if d['bipartite'] == 0}\n",
    "\n",
    "print(network_util.get_entity_share(g_sum_producer, substance_nodes_g_sum_producer))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "183\n"
     ]
    }
   ],
   "source": [
    "entity_substances = network_util.get_substances(g_avg, entity_nodes_g_avg)\n",
    "print(len(entity_substances))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "n_substances = [len(substances) for substances in entity_substances.values()]\n",
    "\n",
    "plt.hist(n_substances, bins=50)\n",
    "\n",
    "plt.xlabel(\"Liczba unikalnych substancji czynnych\")\n",
    "plt.ylabel(\"Częstość\")\n",
    "plt.title(\"Różnorodność substancji czynnych użwana przez podmioty odpowiedzialne\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "SANDOZ GMBH:\n",
      "count:60\n",
      "substances:['Allopurinolum', 'Amlodipinum', 'Amlodipini besilas', 'Amoxicillinum', 'Aprepitantum', 'Aripiprazolum', 'Atorvastatinum calcicum trihydricum', 'Azytromycyna dwuwodna', 'Azithromycinum', 'Benzathini phenoxymethylpenicillinum', 'Budesonidum', 'Candesartanum cilexetili', 'Candesartanum cilexetilum', 'Hydrochlorothiazidum', 'Cefuroximum', 'Cefuroximum natricum', 'Cefuroximum axetilum', 'Clindamycini hydrochloridum', 'Clindamycini phosphas', 'Clopidogrelum hydrosulfas', 'Desloratadinum', 'Diclofenacum natricum', 'Ezetimibum', 'Filgrastimum', 'Salmeterolu ksynafonian', 'Formoteroli fumaras', 'Gliclazidum', 'Glimepiridum', 'Ketoprofenum', 'Leflunomidum', 'Leuprorelini acetas', 'Levodopum', 'Lisinoprilum dihydricum', 'Loratadinum', 'Metformini hydrochloridum', 'Mometasoni furoas', 'Montelukastum natricum', 'Mycophenolas mofetil', 'Acidum valproicum + Natrii valproas', 'Nebivololi hydrochloridum', 'Ondansetroni hydrochloridum dihydricum', 'Ondansetronum', 'Pantoprazolum', 'Paroxetinum', 'Phenoxymethylpenicillinum kalicum', 'Pregabalinum', 'Quetiapini fumaras', 'Quetiapinum', 'Ramiprilum', 'Rosuvastatinum calicum', 'Rosuvastatinum', 'Simvastatinum', 'Sitagliptinum', 'Sotaloli hydrochloridum', 'Tacrolimus', 'Tamoxifeni citras', 'Telmisartanum', 'Terazosini dihydricum hydrochloridum', 'Tizanidinum', 'Valsartanum']\n",
      "AUROVITAS PHARMA POLSKA SP. Z O.O.:\n",
      "count:50\n",
      "substances:['Aciclovirum', 'Amisulpridum', 'Amlodipini besilas', 'Amoxicillinum', 'Amoxicillinum trihydricum', 'Anastrozolum', 'Aripiprazolum', 'Atomoxetini hydrochloridum', 'Atorvastatinum calcicum', 'Atorvastatinum calcicum trihydricum', 'Budesonidum', 'Cefuroximum axetilum', 'Ciclosporinum', 'Clopidogrelum hydrosulfas', 'Desloratadinum', 'Doxazosini mesilas', 'Doxazosinum', 'Duloxetini hydrochloridum', 'Dutasteridum', 'Febuxostatum hemihydricum', 'Fentanylu cytrynian -', 'Finasteridum', 'Fluconazolum', 'Fluoxetinum', 'Flutamidum', 'Salmeterolum', 'Furosemidum', 'Gabapentinum', 'Ivabradinum', 'Latanoprostum', 'Levetiracetamum', 'Levocetirizini dihydrochloridum', 'Naproxenum', 'Nebivololi hydrochloridum', 'Pantoprazolum', 'Paroxetini hydrochloridum', 'Quetiapini fumaras', 'Ramiprilum', 'Ropiniroli hydrochloridum', 'Rosuvastatinum', 'Sertralini hydrochloridum', 'Silodosinum', 'Simvastatinum', 'Solifenacini succinas', 'Tamsulosini hydrochloridum', 'Topiramatum', 'Tramadoli hydrochloridum', 'Valsartanum', 'Venlafaxinum', 'Vildagliptinum']\n",
      "KRKA, D.D., NOVO MESTO:\n",
      "count:69\n",
      "substances:['Agomelatinum', 'Amlodipinum', 'Amlodipini maleas', 'Amoksycylina trójwodna', 'Amoxicillinum trihydricum', 'Amoxicillinum', 'Aripiprazolum', 'Atorvastatinum', 'Atorvastatinum calcicum', 'Azithromycinum', 'Bisoprololi fumaras', 'Candesartanum cilexetili', 'Candesartanum cilexetilum', 'Hydrochlorothiazidum', 'Carvedilolum', 'Cefuroximum', 'Cetirizini dihydrochloridum', 'Cilazaprilum', 'Ciprofloxacini hydrochloridum', 'Clarithromycinum', 'Clopidogrelum', 'Desloratadinum', 'Dexamethasonum', 'Diclofenacum natricum', 'Donepezili hydrochloridum monohydricum', 'Doxazosinum', 'Doxazosini mesilas', 'Duloxetinum', 'Esomeprazolum magnesicum', 'Ezetimibum', 'Febuxostatum', 'Finasteridum', 'Gliclazidum', 'Indapamidum', 'Ivabradini hydrochloridum', 'Lansoprazolum', 'Levocetirizini dihydrochloridum', 'Losartanum kalicum', 'Montelukastum', 'Montelukastum natricum', 'Naproxenum natricum', 'Nebivololum', 'Olanzapinum', 'Omeprazolum', 'Pantoprazolum', 'Perindoprilum', 'Pramipexolum', 'Quetiapinum', 'Quetiapini fumaras', 'Ramiprilum', 'Risperidonum', 'Ropinirolum', 'Ropiniroli hydrochloridum', 'Rosuvastatinum calicum', 'Rosuvastatinum', 'Sertralinum', 'Sertralini hydrochloridum', 'Simvastatinum', 'Sitagliptinum', 'Sulfasalazinum w postaci granulatu z powidonem -', 'Tamsulosini hydrochloridum', 'Telmisartanum', 'tert-Butylamini perindoprilum', 'Thiethylperazini dimaleas', 'Tramadoli hydrochloridum', 'Valsartanum', 'Venlafaxinum', 'Vildagliptinum', 'Ziprasidonum']\n",
      "DELFARMA SP. Z O.O.:\n",
      "count:43\n",
      "substances:['Natrii valproas', 'Amisulpridum', 'Amlodipinum', 'Amoxicillinum', 'Anastrozolum', 'Atorvastatinum', 'Biperideni hydrochloridum', 'Budesonidum', 'Candesartanum cilexetili', 'Cefuroximum', 'Cetirizini dihydrochloridum', 'Ciclosporinum', 'Clobetasoli propionas', 'Clopidogrelum', 'Desloratadinum', 'Dexamethasonum', 'Dienogestum', 'Donepezili hydrochloridum', 'Duloxetinum', 'Ethinylestradiolum', 'Finasteridum', 'Salmeterolum', 'Gabapentinum', 'Ivabradinum', 'Lamotriginum', 'Levocetirizini dihydrochloridum', 'Lisinoprilum', 'Mebendazolum', 'Metformini hydrochloridum', 'Montelukastum', 'Olanzapinum', 'Pantoprazolum', 'Ramiprilum', 'Rivastigminum', 'Ropinirolum', 'Rosuvastatinum', 'Sertralinum', 'Tamsulosini hydrochloridum', 'Telmisartanum', 'Tianeptinum natricum', 'Tramadoli hydrochloridum', 'Valsartanum', 'Venlafaxinum']\n",
      "ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.:\n",
      "count:88\n",
      "substances:['Acenocoumarolum', 'Aciclovirum', 'Natrii alendronas', 'Adrenalinum', 'Amiloridi hydrochloridum', 'Amiodaroni hydrochloridum', 'Amoxicillinum', 'Aripiprazolum', 'Atorvastatinum', 'Atorvastatinum calcicum', 'Atropini sulfas', 'Bimatoprost', 'Brimonidini tartras', 'Brinzolamidum', 'Budesonidum', 'Buprenorphini hydrochloridum', 'Carbamazepinum', 'Carvedilolum', 'Cefuroximum natricum', 'Cefuroximum', 'Cefuroximum axetilum', 'Cetirizini dihydrochloridum', 'Ciprofloxacini hydrochloridum', 'Cyanocobalaminum', 'Desloratadinum', 'Diazepamum', 'Diclofenacum natricum', 'Dienogestum', 'Dorzolamidum', 'Dorzolamidi hydrochloridum', 'Doxazosini mesilas', 'Doxazosinum', 'Duloxetinum', 'Enalaprili maleas', 'Esomeprazolum magnesicum', 'Ezetimibum', 'Famotidinum', 'Febuxostatum', 'Fluconazolum', 'Fluoxetini hydrochloridum', 'Salmeterolum', 'Formoteroli fumaras', 'Furosemidum', 'Gentamicini sulfas', 'Glimepiridum', 'Glyceroli trinitras', 'Haloperidoli decanoas', 'Haloperidolum', 'Indapamidum', 'Ipratropii bromidum', 'Itraconazolum', 'Ketoprofenum', 'Latanoprostum', 'Loperamidi hydrochloridum', 'Lovastatinum', 'Metformini hydrochloridum', 'Metoprololi tartras', 'Mometasoni furoas monohydricum', 'Montelukastum', 'Morphini sulfas', 'Olanzapinum', 'Omeprazolum', 'Pancreatinum o aktywności: Lipazy', 'Pantoprazolum', 'Phenytoinum', 'all-rac-Fitomenadion (witamina K', 'Pilocarpini hydrochloridum', 'Propafenoni hydrochloridum', 'Propranololi hydrochloridum', 'Quetiapini fumaras', 'Ramiprilum', 'Risperidonum', 'Ropinirolum', 'Rosuvastatinum calicum', 'Sertralini hydrochloridum', 'Simvastatinum', 'Sitagliptinum', 'Solifenacini succinas', 'Sulfamethoxazolum', 'Telmisartanum', 'Tianeptinum natricum', 'Timololi maleas', 'Tramadoli hydrochloridum', 'Tropicamidum', 'Valsartanum', 'Venlafaxini hydrochloridum', 'Verapamili hydrochloridum', 'Voriconazolum']\n",
      "ADAMED PHARMA S.A.:\n",
      "count:63\n",
      "substances:['Amlodipini besilas', 'Amlodipini besilas -', 'Aripiprazolum', 'Azithromycinum', 'Bimatoprost', 'Brimonidini tartras', 'Budesonidum', 'Candesartanum cilexetili', 'Chloroquini phosphas', 'Clopidogrelum hydrosulfas', 'Desloratadinum', 'Dexamethasonum', 'Donepezili hydrochloridum monohydricum', 'Dorzolamidum', 'Doxazosini mesilas', 'Duloxetine hydrochloride', 'Dutasteridum', 'Ezetimibum', 'Finasteridum', 'Fludrocortisoni acetas', 'Fluticasoni propionas', 'Salmeterolu ksynafonian', 'Salmeterolum', 'Formoteroli fumaras', 'Furaginum (', 'Furazidinum', 'Latanoprostum', 'Levetiracetamum', 'Levocetirizini dihydrochloridum -', 'Levocetirizini dihydrochloridum', 'Losartanum kalicum', 'Mianserini hydrochloridum', 'Mometasoni furoas monohydricum', 'Montelukastum natricum', 'Naproxenum', 'Naproxenum natricum', 'Nebivololum', 'Olanzapinum', 'Omeprazolum', 'Oxcarbazepinum', 'Paliperidonum', 'Pantoprazolum', 'Prednisolonum', 'Prednisonum', 'Progesteronum', 'Quetiapinum', 'Quetiapini fumaras', 'Ramiprilum', 'Rivastigminum', 'Ropiniroli hydrochloridum', 'Rosuvastatinum calicum', 'Rosuvastatinum', 'Sitagliptinum', 'Sitagliptin hydrochloride monohydrate', 'Solifenacini succinas', 'Sulfamethoxazolum', 'Tamsulosini hydrochloridum', 'Telmisartanum', 'tert-Butylamini perindoprilum', 'Tianeptinum natricum', 'Travoprostum', 'Triamcinolonum', 'Venlafaxinum']\n",
      "ZENTIVA, K.S.:\n",
      "count:43\n",
      "substances:['Amlodipine besilate', 'Amoxicillin trihydrate', 'Atorvastatinum calcicum', 'Atorvastatinum', 'Azithromycinum', 'Beclometasoni dipropionas', 'Candesartanum cilexetili', 'Candesartanum cilexetilum + Amlodipinum', 'Carvedilolum', 'Chlorprothixeni hydrochloridum', 'Ciprofloxacini hydrochloridum', 'Doxazosini mesilas', 'Duloxetinum', 'Esomeprazolum magnesicum', 'Ezetimibum', 'Finasteridum', 'Salmeterolum', 'Goserelini acetas', 'Icatibantum', 'Ivabradinum', 'Levetiracetamum', 'Levocetirizini dihydrochloridum', 'Levothyroxinum natricum', 'Losartanum kalicum', 'Meloxicamum', 'Metformini hydrochloridum', 'Natrii risedronas', 'Omeprazolum', 'Pantoprazolum', 'Rywastygmina', 'Rivastigminum', 'Rosuvastatinum', 'Simvastatinum', 'Sitagliptin hydrochloride monohydrate', 'Solifenacini succinas', 'Tamsulosini hydrochloridum', 'Telmisartanum', 'Tiotropium', 'Tolterodini hydrogenotartras', 'Tolterodini tartras', 'Tramadoli hydrochloridum', 'Valsartanum', 'Vildagliptinum']\n"
     ]
    }
   ],
   "source": [
    "for key in entity_substances.keys():\n",
    "    if len(entity_substances[key]) > 40:\n",
    "        print(f\"{key}:\")\n",
    "        print(f\"count:{len(entity_substances[key])}\")\n",
    "        print(f\"substances:{entity_substances[key]}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
